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Metallosupramolecular capsules represent a facile route to three-dimensional structures that possess 
a central cavity. The synthetic accessibility is provided by self-assembly, which allows carefully 
designed components to form complex three-dimensional structures under thermodynamic control. 
The cavities allow the non-covalent binding of guests, changing their properties in a quick and 
reversible manner, thereby making capsules promising for catalytic, storage, extraction and 
biomedical applications.  
 
However, the requirement for thermodynamic control makes capsules susceptible to degradation by 
changes in conditions such as heat, dilution, pH, or the presence of nucleophiles, making them 
insufficiently robust for biomedical applications. This project constitutes the continuation of a project 
which sought to synthesise more robust capsules. This was achieved by exploiting the cobalt II/III 
redox couple, assembling the tetrahedra with labile cobalt (II) and then oxidatively “locking” them as 
inert cobalt (III). This led to the development of the tetrahedron C19, which proved stable over a range 
of temperatures, dilutions and pH values.  C19 was shown to bind the common SPECT imaging agent 
precursor [99mTc]TcO4-, suggesting  radioimaging  as a potential  application of the cage. 
 
During this project, C19 was found to be degraded in biological environments by reducing agents such 
as glutathione. Therefore, a ligand with electron donating amine groups, L20, was developed to 
increase the strength of interaction with metal centres, and overall stability. A two-step assembly 
using C19 as a template and substituting L20 into this prearranged tetrahedron was required to 
prevent kinetically trapped byproducts. The resulting cage, C20, was found to have increased 
resistance to biological conditions relative to C19, and was able to significantly alter the uptake of 
[99mTc]TcO4- in vivo, proving the potential of the system to act as a delivery agent. 
 
Further functionalisation of C20 was explored to allow bioconjugation and targeting. To this end, the 
ligand was functionalised with a terminal alkyne to allow versatile Huisgen “click” functionalisation. A 
methyl ether was trialled as an alternative to the amines of L20, and the resulting ligand, L38, was 
found to confer similar properties onto its assemblies. Incorporation of alkyne Raman labels into a 
cage allowed stimulated Raman scattering imaging of its interaction with cells.  
 
Overall, a robust cage system capable of retaining and altering the uptake of a significant diagnostic 
agent in vivo was developed. Progress was also made towards improving the properties, targeting and 





This thesis aims to explore the medical applications of small stable molecular capsules. These capsules 
are easily made by combining carefully designed components which can be induced to self-assemble 
into the desired capsule under appropriate conditions. These capsules are then chemically locked in 
order to make them robust enough to remain intact inside a living organism.  
 
They can be used to encapsulate molecules reversibly in order to alter their properties without 
physically altering them. This means that these capsules can be used as delivery agents for 
pharmaceuticals. It was found that the sequential substitution of the components of an already locked 
container made a capsule that was able to bind a radioactive cargo inside living mice to provide images 
of their internal organs.  
 
Attempts were then made to develop means to label the outside of this capsule in order to allow 
targeting of specific tissues. Alternative capsules were labelled with groups which absorb infrared 
radiation in a manner that cells do not, allowing the capsule to be detected within cells without 
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Chapter 1: Introduction: Biomedical 


















1.1 Supramolecular Coordination Complexes 
Compounds within the thesis are numbered in the following manner: Assemblies and ligands 
have been numbered sequentially with a qualifying letter to describe nature of the species. 
Ligands are denoted as L#, cages as C#, helicates as H# and metallocycles as M#. Non-ligand 
organic species are numbered sequentially as N# with no relation to ligand or assemblies.  
Supramolecular interactions are incredibly important in the world around us, with much of 
the function of biological systems driven by supramolecular interactions; from the hydrogen 
bonding between nuclear bases defining the structure of the DNA double helix, to the 
hydrophobic effects maintaining the folding of proteins to form receptors, enzymes, and 
biological machinery. 
Supramolecular coordination complexes (SCCs) are discrete two- or three-dimensional 
compounds containing multiple metal centres and multitopic ligands held together by 
coordination bonds. These complexes are synthesised through coordination driven self-
assembly, in which careful design of the components leads to the selective self-assembly of 
the architecture under appropriate conditions. The self-assembly of complex three-
dimensional architectures is aided by the “maximum site occupancy” principle, which states 
that a system will seek to satisfy the maximum number of possible “non-covalent” or 
coordination bonds. Therefore, combining metal centres of defined coordination geometry 
with semi-rigid multitopic ligands of appropriate dimensions in the correct stoichiometry will 
lead to an assembly that satisfies all the possible bonds.  
The process of self-assembly requires reversible interactions between the metals and ligands 
in order to allow the system to reach equilibrium, and self-correcting interactions which do 
not lead to the thermodynamic product. Coordination assemblies offer advantages over 
other forms of supramolecular assemblies, such as those driven by hydrogen bonding, in that 
the metal centres offer well-defined geometries and have tuneable interaction strengths 
intermediate between covalent and hydrogen bonds to provide both accessibility and 
reasonable kinetic stability. 
Metallosupramolecular cages possess an intrinsic central cavity in which guests may be 
bound (Fig. 1.1). This provides the opportunity for applications such as catalysis,1 storage,2 as 
well as biomedical opportunities such as anion transport and drug delivery. Binding is 
affected by a number of different factors including the nature of the cavity, guest, solvent 
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and the counterions in the system. There are both enthalpic and entropic factors that govern 
the strength of the binding. Enthalpic contributions can be made by electrostatic 
interactions, π-π stacking, and hydrogen bonding between the guest and cavity of the cage. 
However, these can often be complicated by competition with solvent molecules or the 
counterions.3   
 
 
𝐾𝑎 =  
[Host − Guest complex]
[𝐻𝑜𝑠𝑡][𝐺𝑢𝑒𝑠𝑡]
 
Figure 1.1: Depiction of guest binding within a tetrahedral cage, and the formula of the 
binding constant.  
Many systems utilised in water rely on the hydrophobic effect to drive the binding of 
nonpolar guests in the hydrophobic cavities of capsules. This relies on the liberation of high 
energy water molecules, which possess unsatisfied hydrogen bonds within the constrained 
environment of the cavity. The displacement of these species enthalpically drives the binding 
of neutral molecules.4 Charged species can also be bound within supramolecular capsules, 
and indeed, a large number of assemblies are templated by their counterions, implying that 
the binding of the guest is the driving force in the assembly. Oppositely charged species will 
have increased electrostatic interactions due to ion pairing with the charged capsules but at 
the potential cost of increased affinity of the guest for polar bulk solvent.5 
1.2 Challenges in Using Supramolecular Coordination Complexes in Biological 
Systems 
The nature of coordination complexes can lead to some issues when attempting to use them 
in biological applications. Many species are not intrinsically water soluble and require 
functionalisation with solubilising groups in order to be suitable for aqueous applications, 
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such as hydroxyl groups6 or polyethylene glycol groups.7 However, it has been demonstrated 
that selection of appropriate metal ions and anions can render these highly charged species 
water-soluble and stable (Fig. 1.2.1).8  
 
Figure 1.2.1: Representation of how the different choice of metal ion can drastically affect the 
relative stability of M8L6 cubes (C1a,b,c,d,e) in water. (a) Half-lives (t1/2) at 20 °C, (b) ionic radii 
(IR, Å), and (c) ligand-exchange rates for water (KH2O, s-1) for the different metal ions. Figure 
adapted from reference 8. 
However, when moving into aqueous systems, the dynamic nature of supramolecular 
systems is a fundamental issue that at present limits their effective use in biological 
applications. Self-assembly inherently requires the system to possess some dynamic 
properties that allows the desired “equilibrium” product to be accessed. While it is hoped 
that cooperative chelate effects will make the assembly a significant energy minima, offering 
some kinetic stability, the system is still effectively in equilibrium. Therefore, the desired 
assembly may no longer be the favoured product when removed from the assembly 
conditions, leading to rearrangement or disassembly.  
This can mean that dilution, increase in temperature, exposure to coordinating solvents or 
competing ligands, or extremes in pH can lead to degradation of the cages. As water is a 
highly coordinating solvent, it poses a particular challenge to supramolecular systems, 
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especially as it is present in vast excess, meaning many systems require specific design 
features to be stable in water.  
Stability issues become even more prominent under biological conditions, which can be 
considered relatively harsh compared to those under which coordination assemblies are 
commonly formed. Biological conditions are chemically complex, containing a plethora of 
reactive biological compounds and competing ligands that can compete for the structural 
metals of any coordination assembly,9 an example of which is seen in Crowley and co-
workers’ amine-based Pd2L4 cages C2 (Fig. 1.2.2).10 This competitive environment, coupled 
with the low cage concentration required for biological use, makes rapid cage degradation 
both highly probable and irreversible. This loss of structure would remove the capacity to 
retain an encapsulated guest. It is therefore highly likely that almost all current SCCs are not 
robust enough for in vivo applications, certainly for any that require structural integrity.  
  
Figure 1.2.2: Depiction of Pd2L4 (C2) cage undergoing reversible nucleophilic attack by chloride 
anions to form a Pd2L2Cl2 metallocycle (M2). Modified from reference 10. 
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1.3 Direct Biomedical Application of SCCs 
Many SCCs have been reported to be biologically active in their own right, often as cytotoxic 
anti-cancer agents. Their methods of activity vary, including interactions with cellular 
components or acting as prodrugs with cytotoxic metabolites. 
A large number of cytotoxic platinum, palladium and ruthenium metallocycles have been 
reported with range a of activities against various cell lines. The platinum metallocycle (M3, 
Fig. 1.3.1) was shown to be more cytotoxic and selective than the ubiquitous anticancer agent 
cisplatin. It was also shown that the cytotoxicity is greater than the sum of its individual 
components.11 
 
Figure 1.3.1: Chemical structure of the cytotoxic hetero-bimetallic metallocycle (M3). Figure 
adapted from reference 11. 
Yoshizawa and co-workers developed two anthracene containing spherical M2L4 capsules 
C4a,b, which were shown to be cytotoxic against a range of cancer lines (Fig. 1.3.2). 
Interestingly, the cytotoxicity of the cages appeared to be related to the degradation of the 
cages within the cells, with the palladium C4a variant being the more active, while being 




Figure 1.3.2: (a) Chemical structure of a M2L4 capsules (M = Pd, C4a or Pt, C4b, R = -
OCH2CH2OCH3). (b) Time dependent cytotoxicity of C4b and C4a against HL-60, estimated as 
IC50 (in µM) at different time intervals. Figure adapted from reference 12. 
Conversely, Crowley and co-workers found that the cytotoxicity of several Pd2L4 constructs 
against cancer lines was found to increase with stability (Fig. 1.3.3). Their results indicated 
that the activity stemmed from the assembly’s three-dimensional architecture disrupting cell 
membranes rather than the release of palladium complexes. Interestingly, the stability of the 





















   
Figure 1.3.3: (left) Chemical structures of the ligands used to form Pd2L4 capsules (L5a,b,c,d) . 
(right) Molecular structures of C5a (top) and C5b (bottom). The order stability to nucleophilic 
attack is C5a<C5b<C5c≈C5d. The cytotoxicity follows the same order C5a<C5b<C5c apart from 
C5d which showed negligible toxicity. Figure adapted from reference 13.  
Other helicates have been shown to interact with other cell components, including a number 
of Fe2L3 helicates which are able to bind to a various DNA and RNA structures including the 
major groove of DNA,14 RNA 3-way junctions,15 and G-quadruplex DNA (H6, Fig. 1.3.4).16 The 
specificity of these interactions imply the potential for targeting of specific cellular processes 







Figure 1.3.4: (a) Depiction of the (Δ)-Fe2L3 cationic helicate (H6). (b) Schematic representation 
of how H6 selectively interacts with the human telomeric hybrid G-quadruplex DNA. Figure 
adapted from reference 16.  
Overall, it has been demonstrated that many assemblies are “biologically active”, some 
appearing to act as prodrugs which become active upon degradation and some being active 
while intact due to their overall structure. Many of these complexes are non-selectively 
cytotoxic but promise of specific targeting has been indicated.  
1.4 Utilisation of SCCs for Drug Delivery 
The access that self-assembled coordination capsules give to architectures with internal 
cavities make them an obvious candidate for drug delivery. The aim is to bind a 
pharmaceutical or diagnostic agent in order to alter its pharmacokinetics and increase 
activity and selectivity.  
The enhanced permeability and retention effect (EPR) is one of the reasons for the interest 
in using macromolecules for drug delivery. The EPR effect is a consequence of poor 
circulation and clearance in tumours, which can lead to increased uptake and retention of 
macromolecules in solid tumours, providing passive selectivity.17 While many SCCs are not 
large enough to be generally considered viable for the EPR effect, they do present a platform 
for small molecule hosts which can be conjugated in order to take advantage of the EPR 
effect. However, the efficacy of the EPR effect has come under question, with limited success 
in human trials,18 raising further doubt about its significance in the use of metallocapsules, 
though their potential for use as targeted capsules remains. 
There has been some exploration of the binding of medically significant compounds within 
metallosupramolecular capsules, with varying levels of success. A number of groups have 
reported the binding of other anticancer agents including Zhou and co-workers, who 




release of the drug was shown to be challenging and they do not report any biological 
assays.19  
A Pd2L4 paddle wheel complex from Crowley and co-workers (C5a) has been shown to bind 
two molecules of cisplatin (Fig. 1.4.1).20 Functionalisation was required to render the cage 
sufficiently water soluble but unfortunately, and perhaps unsurprisingly, the binding was 
found to not occur in water.21  
 
Figure 1.4.1: Crystal structure of a C5a with two molecules of cisplatin bound. 
Despite the reported challenges associated with binding cisplatin in water, Kuhn, Cassini and 
co-workers reported 20-fold increased cytotoxicity when a Pd2L4 was administered 
simultaneously with the cisplatin to cancer cells, implying some unidentified form of synergy 
between the two species.22 
Therrien and co-workers have had more success in developing drug delivery systems. While 
their highly water soluble ruthenium capsules possess intrinsic toxicity23 which limits their 
potential applications, this could be considered advantageous in the case of anti-cancer 
treatments. The capsule bound palladium and platinum acetylacetonates, which are more 
effectively bound than cisplatin due to their hydrophobic nature. This also rendered them 
inactive without encapsulation due to poor bioavailability. The host-guest complex exhibited 
far greater cytotoxicity compared to individual components, implying synergistic effects 
between the species.24  
The same group probed this further when they developed an alternative cage system (C7, 
Fig. 1.4.2),25 which was able to bind a fluorescent compound. When encapsulated, the guest’s 
fluorescence was quenched, meaning that the liberation of the guest by cage degradation 
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could be visualised. Through fluorescence imaging of the cells dosed with C7 and stained with 
lysosome and endocytosis markers, found that the guest appeared to be delivered into cells 
by endocytosis of the host-guest complex followed by degradative liberation. 
 
Figure 1.4.2: (a) Chemical structure of the ruthenium trigonal prism (C7) with bound pyrene 
guest. (b and c) Confocal microscopy of A2780 cells incubated with Host-Guest complex 
2mM for 24 h. Pyrene-R fluorescence (blue), FITC-dextran (fluid-phase endocytosis marker, 
green) and Lysotracker Red (red) were imaged. (b) Fluorescence image. (c) Transmitted-light 
picture (scale bar = 10mm). Figure adapted from reference 25. 
Similarly, Zheng and co-workers were able to bind a fluorescein molecule with a tethered 
platinum prodrug in a previously developed Fujita cage (C8, Fig. 1.4.3).26 C8 was formulated 
into nanoparticles through the use of an anionic block copolymer, methoxy polyethylene 
glycol-block-polyglutamic acid. These nanoparticles were able to release the drug through 
pH stimuli but were found to not exhibit greater toxicity than cisplatin.  
 
a b c 
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Figure 1.4.3: Prodrug-containing Pt6L4 capsules (C8) are formulated into block copolymer-
based nanoparticles.  Figure adapted from reference 26. 
Isaacs and co-workers have explored two methods for cages to aid in the delivery of the anti-
cancer drug doxorubicin. One capsule (C9a) had the drug tethered to the exterior of the cage 
through supramolecular interactions with cucurbit[n]urils and was found to increase the 
cytotoxicity of the drug 10-fold (Fig. 1.4.4a).27 They then went on to develop a cage covalently 
functionalised with a cucurbit[n]uril (C10), through which they tethered alkyl chains which 
occupy the cavity of the cage to form a hydrophobic pocket within which doxorubicin could 
be bound (Fig. 1.4.4b). Though an interesting approach, the system behaved similarly to C9b, 




Figure 1.4.4: (a) Pd12L24 system (C9a) self-assembled with viologen moieties on the periphery, 
which are able to bind cucurbit[7]uril molecules. (b) A modified mixed ligand (L10a,b) Pd12L24 
system can self-assemble to C10, allowing the encapsulation of doxorubicin in the 
hydrophobic core. Figure (a) and (b) adapted from references 27 and 28, respectively.  
As previously discussed, biological systems present serious challenges for the use of SCCs and 
this is particularly true for in vivo environments. A number of metallocycles have been shown 
to be effective anti-tumour agents in mouse models, including ruthenium and platinum 
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examples.29,30 An example of a metallocage utilised in vivo is a platinum square prism 
developed by Chen, Stang and co-workers (C11a, Fig. 1.4.5).31 The cage is comprised of 
porphyrins, platinum salts and terephthalate building blocks with the aim of combining their 
activity in a single system. The platinum salts and terephthalate are known anticancer agents, 
and the porphyrins act as both fluorophores and a photosensitiser to generate 1O2 for tumour 
suppression. The supramolecular architecture was used to prevent π-stacking of the 
porphyrins and enhance their activity. In order to render them more suitable for in vivo 
application, the cage was embedded with nanoparticles comprised of two amphiphilic 
diblock polymers. These nanoparticles were found to have long blood circulation time and 
good accumulation within tumours, and to be more effective than separate treatment with 





Figure 1.4.5: (a) Depiction of cages incorporated into nanoparticles for use as anticancer 
(C11a), PET (C11b) and MRI (C11c) agents. (b) In vivo T1-weighted axial MRI images (7T) of 
the mice pre-injection and post-injection of C11c-loaded nanoparticles. (White circle denotes 
the tumour site). Figure adapted from reference 31. 
14 
 
The porphyrins can also be utilised as binding sites for the functional metals, 64Cu (C11b) or 
manganese (C11c). C11b allows monitoring of the cage in vivo through PET imaging of the 
positron emitting 64Cu or MRI detection of the paramagnetic manganese. These techniques, 
combined with near infrared fluorescence imaging, allowed the distribution of the cage to be 
detected and monitored in vivo, providing direct evidence for high concentrations of the 
nanoparticles being maintained in mouse tumours for more than 24 hours after 
administration.31  
With the vast array of approaches available for synthesising metallosupramolecular cages, a 
cage which possesses intrinsic solubility should theoretically be accessible without the need 
to embed within a stabilising matrix.  
 
 
1.5 Stabilisation of Supramolecular Assemblies 
As aqueous and biological systems are particularly challenging for supramolecular 
coordination complexes, those intended for biomedical applications will often require 
specific design to render them suitably robust to resist degradation or rearrangement. 
Generally, this requires stronger interactions between the components of the assembly, 
which conflicts with the requirement for reversible interactions to allow for error-correction. 
Therefore, many approaches to “locking” the architectures after assembly have been 
explored.  
A common approach to the problem has been to use assemblies with stronger interactions, 
producing species which are kinetically trapped. As the literature shows, one approach for 
this is to use third row transitions metals, which are considerably more coordinatively inert 
than the first and second row.32,33 These inert metals require labilisation in order to undergo 
self-assembly. This is commonly done by heating,34 the addition of strongly coordinating 





Figure 1.5.1: Fujita and co-workers have employed different assembly conditions to promote 
the formation of kinetically trapped metallosupramolecular systems: (a) To form the 
kinetically inert M6L4 system containing Pt cations (C12a), the system required extensive 
heating. (b) An alternative approach used light to labilise the Pd-N bonds to form C12b. (c) 
Trifluoroethanol (TFE) and DMSO were used as strongly coordinating solvents to displace the 
L12c ligand to help error-correct the system to form C12c. Figures (a), (b), and (c) were adapted 
from references 34, 35, and 36, respectively.  
These approaches are held back by limited applicability. For instance, the use of high 
temperatures is not always suitable, as this will influence the equilibrium when speciation is 
associated with a change in entropy. For instance, two molecules of M2L3 helicates are 
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entropically more favoured than a single M4L6 tetrahedron, meaning the helicate is favoured 
at elevated temperatures (Fig. 1.5.2).37 
 
Figure 1.5.2: Using heat in the self-assembly of these species can lead to the formation of 
disfavoured products, for example, M2L3 helicates will be entropically favoured at higher 
temperatures over M4L6 tetrahedra. Figure adapted from reference 37.  
This problem was encountered by Lindoy and co-workers when they attempted to produce 
ruthenium analogues of a previously developed iron cage. After extensive heating at 225 °C, 
only a 36% yield of the helicate could be isolated after silica gel chromatography of the 
product mixture, with no tetrahedron detected.38 
Restriction of the coordination sphere of the metal through auxiliary capping ligands can 
reduce the possible arrangements of a system and increase the viability of thermal activation. 
Thomas and co-workers were able to use [9]aneS3 to occupy three fac coordination sites in 
a ruthenium complex, allowing only three fac sites for monodentate pyridine ligands to 
coordinate to form a M8L12 cube (C13, Fig. 1.5.3).39 Similarly, half sandwich complexes of inert 
metal have been used extensively by Therrien and co-workers to allow the sequential 










Figure 1.5.3: Chemical structure of a Ru8L12 cube C13. Figure adapted from reference 39. 
With more labile metal-based assemblies, post assembly modification can be utilised to 
“lock” the architectures once assembled. An example of this was shown by Lindoy and co-
workers when they used reductive amination to covalently bridge the ligands at the vertices 
of an iron tetrahedron and helicate to prevent their interconversion.38 
Rather than covalent alterations, redox changes at the metal centres of an assembly can also 
be exploited to alter the lability of the metal centre. An early example of this was the 
oxidation of cobalt (II) helicates by the addition of bromine. This oxidised the labile cobalt (II) 
metal centres to the inert cobalt (III), for which the higher charge, lack of Jahn-Teller 
distortion and low spin d6 electron configuration rendered the helicates stable enough to 
purify by chromatography.41,42 
The Lusby group have continued this route to chemical robustness with an “assembly-
followed-by-fixing” procedure (Fig. 1.5.4).43 This method also exploits the redox couple of 
cobalt (II/III) to allow the facile formation of cages with labile cobalt (II), before chemical 






Figure 1.5.4: General procedure for “assembly-follow-by-fixing” method. The cobalt (II) 
species are in equilibrium between tetrahedron and helicate. Upon addition of an oxidising 
agent, this equilibrium is locked by the kinetically inert cobalt (III). Figure adapted from 
reference 43.  
Initially, this approach was developed with a pyridine-triazole system (L14). This was utilised 
due to ease of ligand synthesis and functionalisation; in this case, a short PEG chain for 
solubility (Fig. 1.5.5). This tetrahedron (C14) was found to be highly water soluble but not 
entirely water stable.  
 
Figure 1.5.5: Scheme showing the formation followed by fixing synthesis of water-soluble 
nitrate tetrahedra C14. 
Solutions of C14 were found to have native pH values of 2.98 in a 2.5 mM solution. Ward and 
co-workers made a similar observation with a cobalt (II), Co8L12 16+ cube.44 As acidic 
conditions are not biologically compatible, C14 was tested at various pH; adjustment of the 
pH through use of phosphate buffer showed that the cage had limited stability above pH 5. 
Additionally, as shown in Figure 1.5.6, simple dilution of C14 solutions led to an accelerated 
loss of NMR signals and precipitation of the ligand and attempted dissolution in cell media 




Figure 1.5.6: (Left): The pyridine-triazole system (C14) is unstable to non-acidic conditions 
leading to rapid disassembly and precipitation of ligand from solution. (Right): (a) C14 in D2O. 
C14 in phosphate buffer at (b) pH 6, (c) pH 7, (d) pH 8. Figure adapted from reference 43. 
This degradation was hypothesised to be due to nucleophilic attack of hydroxide ions on the 
cobalt metal centres.45 It was suggested that this process is exacerbated by the cages 
experiencing a higher local pH than the bulk solution. This is ascribed to the macro-cationic 
cage binding hydroxide ions and decreasing the relative concentration in comparison to 
protons in the bulk solution, thereby leading to the decrease in pH.44 The binding of 
hydroxide ions bound to the cationic cage would be expected to increase the local 
concentration of nucleophiles around the cage, accelerating degradation.  
In order to overcome this instability, ligands with different coordination motifs, L15 and L16 
(Fig. 1.5.7), where developed and investigated. The tetrahedra derived from these ligands 
were found to be far more stable at higher pH values, retaining their structure for multiple 
days in pH 7 phosphate buffer solutions.37  
 
Figure 1.5.7: Ligand L15 and L16 which formed more stable Co (III) assemblies than L14. 
1.6 Summary 
Overall, supramolecular coordination complexes have been investigated for a variety of 
biomedical applications. The majority of systems have applications as anti-cancer agents, 
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potentially due to the toxicity of the third-row transition metals. However, it is worth noting 
that some examples do exist of the supramolecular architecture of the assemblies being the 
cause of activity within cells.  
Additionally, many of the systems have required some form of functionalisation or further 
formulation in order to render them suitable for aqueous biological environments. This often 
involved the requirement for the use of inert third row transition metals or post-assembly 
modification to increase stability. In the case of many of the assemblies employed in vivo, the 
assemblies were incorporated into nanoparticles. This allows the exploitation of the 
supramolecular properties of the assemblies while avoiding issues of solubility, stability and 
pharmacokinetics. 
In contrast, the Lusby group have developed a family of cages that are kinetically locked post-
assembly to give stable cobalt (III) tetrahedra. These cages have the advantages of high 
solubility and stability without the requirement for expensive and toxic third row transition 
metals. This may give them significantly different biological activity to the majority of 
capsules that have been explored in vivo. They hold potential as delivery agents for 
therapeutic or diagnostic compounds, and offer a platform for further functionalisation and 
conjugation. This could further increase their stability, allow bioconjugation for targeting, or 
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Chapter 2: Kinetically Robust CoIII4L6 
Tetrahedra for In Vivo Anion Binding 





Metallosupramolecular capsules are of great interest for a large number of applications including 
catalysis,1 storage,2 and biomedical use (see Chapter 1). This is because self-assembly is a powerful 
tool to synthesise well-defined complex three-dimensional structures; however, many 
implementations of self-assembled species are limited by their instability. Therefore, a means to use 
the power of self-assembly to produce capsules possessing high kinetic stability would be very 
desirable. 
Metallosupramolecular capsules are designed using rigid ligands and metals with well-defined 
coordination spheres with the aim of making the desired architecture the thermodynamic product. 
This is designed to be species with all coordination sites occupied, minimised strain and maximised 
favourable interactions. Selective synthesis of a desired architecture utilises reversible bonds that 
allow effective exploration of the energy landscape to find the desired thermodynamic product. 
However, sometimes the system design, and thereby the global energy difference, can be insufficient 
to drive the quantitative synthesis of a single species. Entropy will favour the smallest assembly, 
meaning that small amounts of flexibility in the ligand can lead to smaller assemblies being favoured 
over large species. Byproducts can also become kinetically trapped if the energy barriers to rearrange 
are too high, locking some of the material into local energy minima. 
Such an example of mixed speciation challenges was encountered when the Lusby group first 
developed the “assembly-followed-by fixing” method (Scheme 2.1.1). While the assemblies could be 
accessed in excellent yield, this did require careful control of reaction conditions. In particular, the 
assembly of the M4L6 tetrahedron encountered the common problem of competing M2L3 helicate 
formation. A number of factors were found to play important roles in the speciation of the products. 






Scheme 2.1.1: Protocol for “assembly-followed-by-fixing” cage assembly with L14. 
While these effects were useful for biasing the system towards the tetrahedron, further studies found 
that the equilibrium of the cobalt (II) species could not be induced to selectively give the tetrahedra, 
with small quantities of helicate remaining. The oxidation itself was found to be crucial for quantitative 
tetrahedron formation. Specifically, it was found that slow addition of oxidant led exclusively to the 
tetrahedron, while in contrast rapid addition led to a mixture of species. This is believed to be a result 
of the higher preference of cobalt (III) for ideal octahedral geometry. During slow addition of oxidant, 
the reaction mixture will contain cobalt centres in both the (II) and (III) oxidation states. This will lead 
to assemblies which contain metal centres of both oxidation states. It was theorised that in these 
species, the cobalt (III) centres will cause more strain in the distorted helicates than in the tetrahedron. 
This strain would induce the more labile cobalt (II) centres present to rearrange to tetrahedra before 
being oxidised, resulting in pure tetrahedra.3 
These studies were initially carried out with organic soluble salts of C14, utilising classic hydrophobic, 
non-coordinating anions (ClO4, PF6 and BF4) in acetonitrile. For biological applications cages must be 
both water soluble and stable. Cages usually use high charge and hydrophilic anions to infer water 
solubility,4,5 although functionalisation of the ligand with water solubilising groups is sometimes 
employed.6 Previous studies in the Lusby group using hydrophilic cobalt (II) salts,  most commonly 
Co(NO3)2.6H2O, found that mixtures of water and acetonitrile were required to effectively solvate both 
the ligand and the metal salt and allow coordination. The ratio of solvents was found to have a 
significant effect on speciation; mixtures of greater than 50% water were found to preferentially form 
tetraheda, while mixtures less than 50% showed preference for the helicate. As discussed in Chapter 
1, water can be a challenging environment for metallosupramolecular assemblies, and 
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Co4(L14)6(NO3)12 was found to have limited stability in neutral pH aqueous solutions (see Chapter 1). 
Therefore, L15 and L16 were developed and found to give more stable cobalt (III) tetrahedra and 
helicates (Fig. 2.1.2).  
The assemblies based on ligands L15 and L16 were found to be less labile in the cobalt (II) state than 
the previous triazole system (Fig. 2.1.1). Rearrangement between the helicate and tetrahedron upon 
change in concentration or temperature was found to be far slower. By extension, the slow addition 
of oxidant was also found to have a far less pronounced effect on the speciation of the final locked 
products. Nonetheless, pure tetrahedra and helicates could be obtained by careful optimisation of 
procedures.  
 
Figure 2.1.2: Ligands L15 and L16. 
Electrochemical investigation of the hexafluorophosphate salts of the triazole, benzimidazole and 
bipyridine cages were undertaken. Interestingly, reduction potentials did not fall in line with 
experimental stability tests as C14 and C16 had more negative reduction potentials than C15. This 
implies that the reduction potential does not directly correlate to cobalt (II) kinetic stability and is 
affected by factors such as octahedral distortion, bite angle, and π-back bonding character.  
2.1.1 Aims and Previously Developed Cages 
With the Lusby group having identified a method for generating cages with what was anticipated to 
be the prerequisite robustness for biological investigations, studies towards identifying suitable 
applications were undertaken. Furthermore, the project did not just pursue cages with inherent 
biological properties but also aimed to utilise their host-guest chemistry. In many ways, this presents 
an even greater challenge than constructing robust cages. Indeed, it is a common misconception, or 
is not acknowledged, that almost all guests are not trapped within a host’s cavity. In fact, many exhibit 
fast exchange on the NMR timescale, which suggests a very low energy barrier to ingress-egress. 
Nonetheless, the group started investigations with possible guests, which would at least show a 
thermodynamic binding preference that would allow preliminary biological investigations to be 
pursued.   
Previously, the three “robust” tetrahedra previously prepared in the group using L15, L16 and L14 
were found to bind a variety of organic guests. However, this binding was judged to be too weak (Ka < 
103 M-1) to carry forward for further study. The poor binding of organic molecules was postulated to 
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be a consequence of the high charge; while this is good for ensuring “unfunctionalised” cages are 
water soluble, it is very likely that their cavities do not possess the necessary hydrophobic properties 
to bind apolar species in water. Instead, the group’s focus shifted to binding anions, anticipating that 
the high charge on the cage could be exploited to coulombically attract an oppositely charged species.  
Anion binding is of interest for a number of biological applications and has been well explored by the 
supramolecular community.7 Due to their charge, cationic metallosupramolecular cages are well 
suited to binding anions in non-aqueous media, or mixed aqueous/organic solvent systems. In addition 
to size-shape complementarity,8 additional electrostatic interactions and ion pairing can lead to far 
stronger binding of charged species which are poorly solvated in less polar solvents.9 
More challenging, and far more applicable for biological applications, is the binding of anions in water. 
Water is a polar, highly competitive solvent, able to both accept and donate hydrogen bonds and 
effectively solvate charged species. This prevents the exploitation of the hydrophobic effect, or at least 
minimal apolar contributions, which is often a major component of neutral guest binding within 
metallosupramolecular cages in water.10 
Despite these challenges, some examples of aqueous anion binding in coordination cages are known. 
This includes the binding of numerous anions within an azaphosphatrane based Fe4L4 tetrahedra (C17, 
Fig. 2.1.2a).11 The binding in this cage was ascribed to hydrogen bonding interactions, electrostatic 
interactions and high structural flexibility. In this instance, the less hydrophilic anions such as 
bistriflamide and perrhenate bind more strongly than hydrophilic anions such as nitrate. Indeed, the 
preferential binding of “hydrophobic” anions has been a common theme to emerge. Ward and co-
workers have found that their Co8L12 cube (C18) binds hydroxide, halogens and phenolates in the 
portals of their cages rather than the cavity (Fig. 2.1.2b), and again, the strength of binding was found 




Figure 2.1.3: (a) The azaphosphatrane-based Fe4L4 tetrahedra (C17) using hydrogen bonding and 
electrostatic interactions coupled with high structure flexibility to bind a variety of anions. (b) The 
Co8L12 cube (C18) binds anions in the portals of the cage rather than in the cavity. Figures (a) and (b) 
have been adapted from references 11 and 4, respectively.  
Within the Lusby group, it was found that the smaller tetrahedron Co4(L19)6(NO3)12 was a suitable size 
for binding common anions (Fig. 2.1.3).8 Specifically, C19 was shown to bind a number of anions in 
water with association constants in the range of 10-105 M-1 (Table 2.1.1). The strength of binding is 
dependent upon a number of factors such as charge, hydrophobicity and shape-volume 
complementarity with the cavity of the cage. The cavity volume of C19 was estimated from the crystal 
structures to be 134 Å3 and the larger anions appeared to have larger binding constants, though SiF6- 
and SbF6- were found to not bind, implying that the optimal size lies between these and PF6-.12 
 






Table 2.1.1: Volumes and binding constants of anions in C19. Binding constant experiment errors 
estimated to be ±50%. Data collected by Michael Burke. 
 
The less hydrophilic anions bind more strongly, with the very hydrophilic sulfate anion binding less 
strongly than the similarly sized perchlorate. This is likely due to solvation effects, where there is a 
significant thermodynamic penalty for the binding of the 2− anion.  The lack of strong interaction with 
phosphate, presumably due to similar reasons, was also considered promising from a biological 
application perspective due to its prevalence in vivo. The suggestion that this common biological anion 
will not interfere with the binding of other guests is a large advantage for biomedical applications. The 
binding of perrhenate and the fluoroanions is significant for nuclear medicine applications. 
Hypothetically, the fluoroanions could be substituted with 18F,13,14 which is commonly used in PET 
imaging. 188Re is used a therapeutic agent and rhenium is commonly used as a cold analogue of 99mTc,15 
the most widely used diagnostic agent in nuclear medicine.16 
2.1.2 Radiochemistry and Molecular Imaging 
Nuclear medicine is concerned with the diagnostic and therapeutic use of radioactive elements. 
Imaging techniques such as positron-emission tomography (PET) and single-photon emission 
computerised tomography (SPECT) are often combined with radiotherapeutic treatments. The use of 
an internalised radio-source is very powerful in both applications but comes with associated risks in 
exposing the patient to radiation. 
To this end, radionuclides with short half-lives are selected, so that the patient’s exposure is as limited 
as possible. The imaging agent is also required to be selective in order to reduce the overall dose 
required to get a necessary quality image. Therefore, radionuclides are usually reacted with a 
“radioligand” which is able to coordinate the nuclide and imbue the required properties and tissue 
selectivity. As the half-lives of the radionuclides are so short, they often have to be generated at the 
point of use, meaning that procedures to formulate the imaging agent must be as straight forward as 
possible so that they may be carried out by non-expert operators. 
Anion Ka / M-1 Volume Å3 
SO42- 100 60 
BF4- 500 56 
ClO4- 7100 61 
ReO4- 61000 64 
PF6- 91000 78 
HPO42- - 75 
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99mTc is a γ-emitter with an half-life of six hours and is eluted from a 99Mo generator as a saline solution 
of [99mTc]TcO4-. This oxoanion had been assumed not be suitable for ligation without further reaction. 
It is commonly reduced using harsh reducing agents, such as SnCl2, to allow coordination by 
conventional chelating ligands. However, this reduction procedure represents a portion of the 
nuclide’s half-life and must be performed by an operator, increasing their exposure to radiation. The 
fact that C19 had been shown to bind the isostructural ReO4- and ClO4- anions suggested that it could 
potentially act as a ligand for [99mTc]TcO4-. The binding of the pertechnetate anion has been identified 
as desirable goal,17 and cages make attractive radioligands due to their well-defined three-dimensional 
structure, solubility, and the speed and ease of host-guest interactions.   
In the case of pertechnetate, common radiopharmaceuticals do not target specific sites and have not 
even been fully structurally characterised. Instead they rely on physiochemical properties such as 
hydrophilicity, charge and size to alter tissue uptake through means that are not fully understood.18,19 
This means that any perturbation of pertechnetate’s uptake, for instance by encapsulation within a 
large 12+ cation such as C19, would be of significant interest. 
When using a cage as a supramolecular radioligand, the interaction between host and guest would 
ideally be as stable as possible to simplify the monitoring of uptake, distribution and elimination. This 
would require not only the capsule to be particularly stable in vivo, but also its corresponding host-












2.2 Results and Discussion 
2.2.1 Co4(L19)6(NO3)12 as a Radioligand for [99mTc]TcO4 
With a potential host for [99mTc]TcO4-, a collaboration with the Archibald group in the University of 
Hull was begun to explore the cage’s potential as a radioimaging ligand. Due to the limitations of 
working with radioactive material, the cage was assessed for binding [99mTc]TcO4- through 
chromatographic methods as depicted by Figure 2.2.1. When [99mTc]TcO4- is deposited onto a silica 
plate, and then eluted with H2O, it moves with the solvent front. C19 is not eluted by water when 
deposited onto a silica plate and is effectively immobilised, therefore [99mTc]TcO4- bound within the 
cage will remain on the baseline within the immobilised cage. [99mTc]TcO4- can be detected by its γ-
emittance and comparison of radiation at the baseline and the solvent front can be used to calculate 
the radiochemical yield of the [99mTc]TcO4- as a measure of the cage’s affinity for the anion. 
 
 
Figure 2.2.1: Cartoon depiction of [99mTc]TcO4- binding assay. [99mTc]TcO4- (red), C19 (blue), mixtures 
of two depicted by fractions of circles. Equation for calculation of radiochemical yield. 
Initial results of these tests showed that the cage was able to bind the [99mTc]TcO4- anion. The 
concentration of cage required to bind half the activity in 1 MBq of [99mTc]TcO4- was found to be 13.8 
µM, while 126 µM was required for 95% retention (Fig. 2.2.2).  
 
 
Elution with water 





Figure 2.2.2: Radiochemical yield for [99mTc]TcO4-  encapsulation C19  as a function of concentration. 
[99mTc]TcO4-  (1 µL, 1 MBq) was added to cage solution (100 µL), incubated at five minutes at room 
temperature, before assessment by chromatography. Experiment performed in triplicate by Benjamin 
Burke. 
Incubating the solutions of C19 and [99mTc]TcO4- for different periods of time (one minute to thirty 
minutes) prior to deposition on silica was found to have no effect on retention of the anion. This 
confirmed that the encapsulation equilibrium is reached in less than a minute and that host-guest 
chemistry could allow the formulation of an effective radiopharmaceutical by simply mixing solutions 
of the cage and radionuclide, without the need for any covalent chemistry. To verify that [99mTc]TcO4-  
binds within the cavity in the same manner as ReO4-, binding studies were carried out in the presence 
of high concentrations of ReO4-. The binding of [99mTc]TcO4- decreased in the presence of an ReO4- (Fig. 
2.2.3), showing that the two anions bind in a competitive manner within the cavity of the cage rather 




Figure 2.2.3: Radiochemical yield of [99mTc]TcO4- by encapsulation within C19 in the presence of 
different equivalents (Eq.) of  ReO4- with respect to C19. [99mTc]TcO4-  (1 µL, 1 MBq) was added to 
KReO4 solution (50  µL, concentration 0/0.1/0.5 of C19) before addition to cage solution (100 µL, 
42.9/14.3/4.29 µM), incubated at five minutes at room temperature, before assessment by 
chromatography. Experiment performed by Benjamin Burke. 
To further prove that the binding of [99mTc]TcO4-  is a host-guest interaction with the cavity of the cage 
rather than non-specific ion pairing, binding studies were carried out with assemblies of different 
sizes. For a larger cavity, C15 (Table 2.2.1), was used, while for a smaller cavity it was proposed that a 
helicate was used. The helicate of L19 could not be isolated due to the increased steric strain in the 
smaller ligand. Instead, the helicate of L15 was identified as a reasonable substitute, as it also has 
negligible cavity and shares the same metal coordination motif as C19 (Table 2.2.1). The structure 
obviously differs in the overall size (Table 2.2.1) and possesses a phenylene “linker” that would not be 
present in the smaller helicate. However, it was theorised that this was a useful control representing 





Table 2.2.1: Representations of the assemblies trialled for [99mTc]TcO4- binding and estimates of their 
metal-metal distances and cavity volumes. Estimated measurements acquired using Spartan 10’ 






Structure C19 C15 H15 
Co-Co 
distance / Å 
9.3 13.2 11.4 
Cavity 
volume / Å3 
134 302 N/A 
When these assemblies were utilised in the same binding experiments as C19, neither showed any 
retention of [99mTc]TcO4-, even at concentrations exceeding the C95 of C19. The fact that these 
differently sized assemblies show no binding of [99mTc]TcO4- provides strong evidence that the binding 
in C19 is due to the strong size and shape complementarity with the cavity. This suggests that the 
interaction is likely to be more selective than ion pairing and that the bound guest will be effectively 
“partitioned” within the cavity of the cage.   
To investigate the resilience of the binding of [99mTc]TcO4- within C19 to a range of different chemical 
environments, the encapsulation studies were repeated in a number of different solutions. This 
included salts of strongly binding anions, weakly binding anions and biologically relevant solutions to 




Figure 2.2.4: Radiochemical yield of [99mTc]TcO4- (1 MBq) in C19 (132 µM) in various solutions (100 µM) 
over time. [99mTc]TcO4-  (1 µL, 1 MBq) and salt solution (50 µL, 0.1mM) were added to cage solution 
(100 µL), incubated for stated time at room temperature, before assessment by chromatography. 
Experiment performed in triplicate by Benjamin Burke. 
As predicted, an excess of the strong guests, perchlorate and hexafluorophosphate, was able to almost 
completely prevent the binding of [99mTc]TcO4-. Less predictably, the hydrophilic anions, chloride, 
nitrate and phosphate also lowered [99mTc]TcO4- binding. These anions would be expected to be poor 
guests due to their affinity for aqueous solution and poor spatial fit for the cavity of C19 but it appears 
that some (weak) interaction is occurring. 
C19 retained a significant amount of radiochemical yield in phosphate buffered saline; however, in 
pure serum the yield was observed to decline over a period of 24 hours. All other yields remained 
relatively constant over the same time frame, as would be expected from guest binding equilibria. This 
decrease in binding over time was therefore attributed to degradation of the cage, decreasing the 





Scheme 2.2.1: Depiction of reductive degradation of C19 to release bound guest. 
Both phosphate buffered saline and serum are commonly used biological models, representing 
analogues of biological environments. Serum is a close biological model and is present in most cell 
media. Hence, the degradation of C19 by serum implied that the cage would not be stable in vivo and 
was therefore not suitable as a radioligand. Therefore, the aim of the project going forward was to 
develop a suitable robust capsule for use a as radioligand for [99mTc]TcO4-. It was proposed that this 
would be best performed by gaining greater insight into the process of this degradation. This insight 
would then hopefully allow a countermeasure for the degradation to be proposed and implemented.   
2.2.2 Biological Reductant Degradation of C19  
To continue the project, the nature of this instability was explored. Serum is a direct in vivo analogue 
as it is an extract of calf blood with only the clotting agents removed. It is therefore a complex mixture 
of the lipids, sugars, amino acids, hormones, biological growth factors and proteins (largely albumin) 
found in the blood of living organisms. These species possess a variety of chemistries which could be 
expected to degrade cages in a number of different ways.  
Serum contains a number of molecules which could act as competing ligands for the metal centres, 
such as chloride, histidine and cysteine which have been shown to disassemble a number of cage 
structures.20 Serum also contains a number of biological redox agents, such as glutathione and 
ascorbic acid (Scheme 2.2.2). Often referred to as antioxidants, these compounds are present in living 




Scheme 2.2.2: Common biological redox agents. 
These biomolecules could be expected to reduce the cobalt centres of the C19 to labile cobalt (II), 
effectively “unlocking” the kinetically “locked” system, making it susceptible to degradation by 
nucleophiles and competing ligands present in solution (Scheme 2.2.3). Glutathione has been shown 
to trigger the disassembly of palladium capsules,22 and both compounds have been oxidised by a 




Scheme 2.2.3: Proposed route of degradation of C19 by reduction by biomolecules and subsequent 
disassembly of the cobalt (II) cage. 
To test this proposed degradation mechanism of C19, the cage was exposed to phosphate buffered 
saline and an excess of glutathione. Solutions of C19 in phosphate buffered saline without glutathione 
showed no loss of cage concentration over time when monitored by 1H NMR, concurring with the 
[99mTc][TcO4]- binding studies. However, when ten equivalents of glutathione were added, C19 was 





Figure 2.2.5: Partial 1H NMR (600 MHz, D2O, 1 M PBS) of C19 (0.1 mM)  in deuterated PBS in presence 
of 10 equivalents glutathione over time (descending: 0 h, 0.5 h, 5 h, 10 h, 22 h, 26 h, 30 h, 52 h, 70 h). 
C19 (dark blue), glutathione (yellow), glutathione disulphide (orange). 
The 1H NMR signals of the cage were rapidly lost from the spectra within the first hour, implying a 
significant decrease in concentration of the cobalt (III) species. The cage signals were almost entirely 
gone after twenty-four hours (Fig. 2.2.6). A precipitate was also observed in the NMR sample, implying 
the disassembly of the cage and precipitation of the ligand. A number of paramagnetic signals also 
developed in the 10–20 ppm range, the nature of this species could not be identified but they 








Figure 2.2.6: Concentrations of glutathione disulphide (glutahthioneDS) and C19 (1 mM), when C19 
exposed to 10 equivalents of glutathione in pH 7.4 phosphate buffered saline. 
Interestingly, as shown in Figure 2.2.6, the oxidation of glutathione continues after the complete 
consumption of cage, which may indicate that the cobalt species remaining in solution are able to 
continue the oxidation. Oxidation of glutathione by cobalt (III) complexes and other transitions metals 
has been reported and is likely the case here.24–26  
This rapid depletion of C19’s 1H NMR signals and the precipitation of the ligand indicate that 
glutathione is able to reduce the cage complex, leading to its disassembly. This confirms our 
hypothesis that reduction by “antioxidants” is one of the likely routes to degradation of C19 by 
biological conditions.  
2.2.3 Development of a Functionalised Ligand for Stabilised Cages 
With the knowledge that the “locked” cage was unstable to representative biological conditions, 
further stabilisation of the tetrahedra was proposed. Substitution of an amine group para to the 
coordinating nitrogen of the outer pyridine groups was proposed to increase the σ-donor strength of 
the ligand (Fig. 2.2.7). The increased donor strength was expected to stabilise the cobalt (III) oxidation 
state and decrease the cage’s susceptibility to reduction, providing resistance to biological 
degradation. It was also proposed that the stronger interactions would slow the rate of ligand 





Figure 2.2.7: Left to right. L19, proposed amine functionalised ligand L20 and potential functionalised 
amine ligand. 
The amine also provides a potential functionalisation handle for appending groups to the cage in order 
to alter properties such as solubility and biological targeting.27 A similar approach was reported by 
Crowley and co-workers, who added amine groups to the coordinating pyridine in Pd2L4 paddlewheel 
cages (C21b,c, Fig. 2.2.8). C21b and C21c showed much greater kinetic stability and longer lifetimes in 
the presence of nucleophiles such as cysteine and chloride than C21a.28 
 
Figure 2.2.8: Parent (C21a) and functionalised cages (C21b,c) in order of stability to nucleophiles.  
For the synthesis of this new ligand, Stille couplings were proposed as the most dependable coupling 
reaction to form the substituted 2,2’-bipyridine building blocks. Direct reaction of N4 with N1 would 
have been ideal (Scheme 2.2.4).29 However, this was unsuccessful, potentially due the electron rich 
nature of the amine-containing substrate.  
Instead, nitro groups were identified as an amine precursor that might be more compatible with the 
Stille coupling conditions (Scheme 2.2.4). Indeed, N3 was successfully reacted with N2 to give the 
compound N5. The N-oxide protected N3 was selected as it was readily available. Initial yields of the 




the solvent from dimethyl formamide to toluene significantly increased yields, though side products 
persisted.  
 
Scheme 2.2.4: Synthesis of L20 ligand. 
One of the side products was identified to be the reduced form of N5, N7 (Scheme 2.2.5). The 
reduction was hypothesised to have been caused by the triphenylphosphine present in the catalyst. 
As N5 is still a viable intermediate of the desired ligand, the Stille coupling was then repeated with the 
unprotected 2.7 (Scheme 2.2.6). This reaction successfully gave N7 but without a significantly 
increased yield.  
 















Scheme 2.2.6: Alternative synthesis of N6 from different starting material N8. 
The previously utilised Ullman-type homocoupling was found to be ineffective with N7, likely due to 
reaction of the stoichiometric metals with the redox active nitro groups. The nitro compound(s) were 
therefore reduced to give the amine N6 (Scheme 2.2.6). This was found to be suitable for the homo-
coupling and the product was successfully synthesised in a good yield of 80%. 
L20 displayed significantly lower solubility than L19 and the 1H NMR showed a similar spectrum that 
was far more shielded, especially the electron rich functionalised pyridine ring (Fig. 2.2.9).   
 














R = NH2 
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2.2.4 Attempted Direct Formation of Co4(L20)6(NO3)12 Tetrahedron 
Initial attempts at cage formation with L20 using the conditions developed for the previous L19 ligand 
systems (Scheme 2.2.7) were found to not produce pure C20. 1H NMR of the crude product showed 
peaks consistent with the desired tetrahedron but also other peaks and a broad, raised baseline (Fig. 
2.2.10). An almost exact repetition of the reaction with slight variation in conditions gave similar 
complex spectra but with a slightly different range of peaks. 
 
Figure 2.2.10: Partial 1H NMR (500 MHz, D2O) of the products of cage formation with L20 using 
standard cage formation conditions. C20 peaks highlighted in light blue. 
The well-defined impurity peaks are likely to be alternate assemblies and the broad baseline to be 
oligomeric material. This mixture of products could be caused by the stronger coordinating properties 
of L20 reducing reversibility in the cobalt (II) state. The Co4(L19)6(NO3)12 system has previously been 
shown to be more sluggish to rearrange in the cobalt (II) oxidation state than Co4(LTZPEG)6(NO3)12, 
indicating higher kinetic stability. Further stabilisation of these assemblies could increase these energy 






Scheme 2.2.7: Attempted synthesis of C20. 
Similar issues have been reported when attempting to form species with inert third row transition 
metals, which required extended heating in order to access a low yield of desired product.30 It was 
therefore hoped that higher temperatures would overcome the energy barriers of dissociation, 
allowing these intermediates to rearrange to the tetrahedron. Higher temperatures might be 
expected to increase the preference for the entropically favoured helicate but it was hoped that it 
would prevent the formation of oligomeric material. Therefore, the reaction was repeated at a variety 
of temperatures including 60, 70, 80 and 90 °C, but all give similar mixtures of products. Additionally, 
at 90 °C the material was found to be very difficult to re-dissolve, potentially due to presence of 
oligomeric material which degraded upon removal of solvent. 
 
Scheme 2.2.8: Depiction of lack of dissociation of L20 and cobalt (II) ions, leading to impure 
tetrahedron. 
Investigation of the cobalt (II) speciation by paramagnetic NMR was precluded by the apparent lower 
solubility of system. Upon heating, the ligand would enter solution but a precipitate would form over 
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time. The cause for this could not be identified but it prevented the accurate study of the species in 
solution.  
The M2L3 helicate H20 (Figure 1.5.2) is the most likely discrete byproduct of the reaction; it is the 
smallest assembly which fully satisfies all coordination sites and would represent an energy minimum. 
Indeed, a recurring impurity in the product mixture, which exhibited the same symmetry as the cage, 
and was found to have a smaller hydrodynamic radius (Fig. 2.2.11, 7.99 Å), was theorised to be the 
helicate. 
 
Figure 2.2.11: Partial DOSY NMR (500 MHz, D2O) of C20 (blue) and H20 (red). 
After finding it challenging to directly synthesise pure C20, separation of the product from the impure 
mixtures was attempted. Crystallisation and selective precipitations were attempted with a variety of 
solvents and solvent mixtures. The assemblies were found to have high solubility in water/acetonitrile 
mixtures but could be precipitated with addition of acetone or methanol. The slow diffusion of 
acetone into water/acetonitrile mixtures caused mixtures of orange block, needle and hexagonal 
crystals to form, in addition to precipitated powder. Unfortunately, these proved too small to 
effectively collect by filtration and re-dissolution did not provide any significant increase in purity.   
Alternatively, Lindoy and co-workers were able to separate iron tetrahedron from helicate using 
chromatography on silica gel.31 However, attempts at chromatography on both standard and reverse 
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phase silica proved ineffective - the nitrate assemblies could not be eluted with water, sodium nitrate 
solutions, acetonitrile, DMF or mixtures of the previous.   
Size exclusion chromatography was also trialled as a means of purification of the cage. It was predicted 
that C20, H20 and oligomeric species would be considerably different sizes, allowing separation by 
this method. While the technique initially did yield a small quantity of pure material, it remained 
problematic. In particular, the separation of the tetrahedron from other discrete species proved 
unreliable, with the helicate frequently co-eluting with the tetrahedron (Fig. 2.2.12). This separation 
was found to vary from batch to batch of cage, giving poor and unreliable yields.  
 
Figure 2.1.12: Partial 1H NMR (500 MHz, D2O) of size exclusion fractions of cage formation reaction. 
From top: (a) Crude product, (b) Fraction 1-3, (b) Fraction 4-5, (d) Fraction 6-7, (e) Fraction 8, (f) 
Fraction 9-12. C20 highlighted in blue, H20 highlighted in red. 
2.2.5 Investigation of Alternative Conditions for Co4(L20)6(NO3)12 Formation 
With previously utilised cage formation conditions only partly successful in the selective formation of 
the C20, it was proposed that a wider range of conditions be trialled. It was suggested that changes in 
the solvation of the components and/or intermediates may affect the equilibrium. 
Unfortunately, as Figure 2.2.13 shows, none of the solvent systems offered clear improvement, with 









particularly good solubility and thus was revisited as mixed co-solvent with acetonitrile. While this 
offered an improvement on the pure acetone reaction, the product still left much to be desired. 
 
Figure 2.2.13: Partial 1H NMR (500 MHz, D2O) of attempted C20 formations in various co-solvent. (a) 
acetone/acetonitrile, (b) acetone, (c) tetrahydrofuran, (d) ethanol, (e) trifluoroethanol, (f) methanol.  
C20 signals highlighted in blue.  
Since common solvents proved ineffective at improving the selectivity of the reaction, strongly 
coordinating solvents were suggested. It was hoped that strongly coordinating solvents such as 
dimethylformamide, dimethylsulfoxide and pyridine would coordinate the metal centres and better 
solvate the ligands to thereby stabilise the uncoordinated metals and ligands. The strongly 
coordinating solvents, may also act as nucleophiles to displace the L20 ligands coordinated to metal 
centres to “unlock” kinetically “locked” structures. The use of DMSO as co-solvent was not completely 











Figure 2.2.14: Partial 1H NMR (500 MHz, D2O) of product of C20 formation reaction with DMSO as a 
co-solvent. (a) 80 °C, (b) 60 °C. C20 peaks picked out in blue.  
DMF showed a similar trend, though the product of the reaction at 80 °C precipitated in two batches 
(Fig. 2.2.15a and b), one appearing to largely contain a single impurity (Fig. 2.2.15b). This impurity was 
observed in many product mixtures and could not be identified as it did not have high enough 
solubility to be analysed by DOSY but appeared to have lower symmetry than homochiral tetrahedra, 







Figure 2.2.15: Partial 1H NMR (500 MHz, D2O) of products of C20 formations with DMF co-solvent. (a) 
80 °C first product, (b) 80 °C second product, (c) 60°C. C20 signals highlighted in blue. 
Reactions in which pyridine was used as co-solvent led to poorly soluble products which could not be 
redissolved once the solvent was removed, preventing further investigation. Another approach to 
attempt to increase the reversibility of the metal-ligand bonds was to decrease the pH of the reaction 
mixture. It was suggested that decreasing the pH would increase the protonation of L20, which should 
disfavour the coordination of the ligand to the metals (Scheme 2.2.9).  
 







Therefore, cage assembly reactions were attempted utilising 5 M, 1 M, 10 mM, 1 mM, 0.1 mM 
concentrations of nitric acid in the place of water (Fig. 2.2.7). The two most acidic reactions showed 
no change after heating at 50 °C for 12 hours and then 80 °C for a further 2 hours, with no colour 
change or dissolution of the ligand observed. The three other reactions did exhibit coordination and 
were investigated further. None of the reactions gave pure products and none of the observed species 
had the shifts prescribed to C20. The dominant species in the reactions appeared to possess similar 
symmetry to C20 (green, Fig. 2.2.16) but could not be identified. An entirely different set of assemblies 
seemed unlikely and it was theorised the peaks may be shifted by excess nitrate salts or acetate from 





Figure 2.2.16: Partial 1H NMR (600 MHz, D2O) of products of C20 formations using nitric acid in place 







2.2.6 Electron-Withdrawing Protecting Groups   
After being unable to identify conditions that would formation of pure C20, it was proposed that 
modification of the ligand might be required. It was proposed that substituting a tert-butyloxycarbonyl 
(BOC) protecting group onto the amine would reduce its electron donation to the pyridine ring, 
decreasing the σ-donor strength of the ligand and reduce the kinetic stability of byproducts. This 
protecting group could then be removed post-assembly – not least as the cobalt (III) cages had shown 




Figure 2.2.17: Proposed route to C20 via protection of the ligand, tetrahedral formation followed by 
deprotection. 
It was also suggested that a tert-Butyloxycarbonyl protected amine could serve as an alternative to 
the nitro group as an amine precursor and give a better route to the ligand (Scheme 2.2.10). The tert-
Butyloxycarbonyl pyridine monomer N9 was synthesised according to a literature procedure but was 
found to not undergo Stille coupling using the previously developed conditions. Therefore N6 was 
reacted directly with tert-Butyloxycarbonyl to give the protected bipyridine N10, which was then 
homo-coupled to give L22 (Scheme 2.2.10), though both reactions had poor yields, possibly due to the 







Scheme 2.2.10: Synthesis of L22. 
When L22 was utilised in a cage formation reaction, it dissolved less readily than L20 but otherwise 
behaved in a similar manner. However, when the product was analysed by NMR, it appeared to be an 
impure sample of C20 rather than the expected cage (Fig. 2.2.18).  
 
Figure 2.2.18: Partial 1H NMR (600 MHz, D2O) comparison of (a) product of cage formation using L22, 









The main species in the spectra was consistent with C20 and there was no evidence of the tert-butyl 
group. It appeared that the protecting group had been cleaved in the reaction, leading to a similar 
product mixture as reactions with L20.  
It appeared that the cage formation conditions were harsh enough to be able to cleave the acid labile 
protecting group, possibly because the cage formation conditions have a similar acidity to cage 
solutions. Whether the groups were cleaved before or after coordination cannot be said without 
further investigation.   
As the protected ligand offered limited improvement in the selectivity of the cage formation and 
posed a greater synthetic workload, this approach was abandoned. It is possible that a more robust 
protecting group, such as acyl, may withstand the formation conditions and allow for facile cage 
formation.  
Another possible approach would be the use of a template to favour the formation of the tetrahedron. 
Templating is a powerful tool in the synthesis of three-dimensional assemblies, though removal of the 
template post-assembly can be challenging.32 This means that although common anions such as 
tetrafluoroborate, hexafluorophosphate and triflate may template the formation of the tetrahedron, 
they would likely then occupy the cavity and reduce its ability to bind other guests such as 
[99mTc]TcO4.33 However, there are examples of careful anion selection allowing anion templated cages 
to bind guests, and it is possible that the weak binding of the sulfate anion might make it suitable to 












2.2.7 C20 Synthesis by Ligand Exchange 
Due to continued difficulty in synthesising C20, a less common synthesis approach was suggested. In 
this strategy, the idea was to use a template tetrahedra with less strongly bound ligands that would 
undergo sequential displacement by L20 (Fig. 2.2.19). It was hypothesised that the negligible 
concentration of free cobalt ions would prevent the formation of intermediates species.  
 
Figure 2.2.19: Proposed route to synthesis of pure C20 tetrahedron by ligand exchange. 
Ligand exchange and the substitution of ligands into existing assemblies has been reported a few 
times. An example was reported by Hardie in which two analogous ligands appeared to form cages of 
significantly different stabilities.34 This leads to the preferred formation of one cage over the other 
and the sequestering of the metal ions by the uncoordinated stronger ligand. Michl and co-workers 
used prearrangement to access a challenging kinetically locked structure. In their method, they use 
reversible pyridine-Pt interactions (facilitated by strong trans-directing phosphine capping groups) to 
generate square (M23a) in high yield. They then substituted these neutral “weak” ligands for strongly 




Figure 2.2.20: Synthesis of fully covalent square assembly M23b through initial formation of M23a with 
L23a followed by substitution with L23b.  
These examples lead us to propose the possibility of exchanging the ligands in an assembled L19 
tetrahedron with L20. The cooperativity of the cage could be expected to maintain the integrity of 
cage, thus allowing stepwise substitution of the ligands, effectively using the existing tetrahedra as a 
template. L19 was considered an effective sacrificial ligand as it will have a weaker interaction with 
the metal, making ligand exchange is thermodynamically favoured. This equilibrium could be further 
biased with an excess of L20, and it was also possible that the kinetic stability of the coordinated L20 
would lead to formation of L20 through an irreversible pathway.  
Initially it was suggested that the cobalt (II) tetrahedron of L19 would be suitable for this substitution, 
as the lability of the system would allow the fast and facile incorporation of the ligand into the 
assembly. However, as discussed previously, it has been shown that it was very difficult to 
quantitatively form the cobalt (II) tetrahedron in solution. While paramagnetic 1H NMR had been a 
powerful tool when working with cage systems in acetonitrile, attempts at investigation of cobalt (II) 

















and NMRs of the solutions obtained did not show high symmetry species. An attempt was made to 
isolate the Co4(L19)6(NO3)8 by crystallisation, which also proved ineffective due the high solubility of 
the cobalt (II) assemblies. 
 
Figure 2.2.21:  1H NMR (500 MHz, D2O/CD3CN 9:1) of mixed cobalt (II) assemblies of LBB. 
Substitution of the cobalt (III) tetrahedron was proposed as an alternative approach, as shown in 
Figure 2.2.22. Though these cobalt (III) species have been targeted as kinetically “locked” assemblies, 
the previous triazole based C14 and C24 was shown to undergo ligand scrambling when two cages 
composed of different ligands were mixed. H14 was shown to rearrange to the C14 upon heating and 
the two tetrahedra were shown to scramble ligands after extended heating. Though the L19 system 
has been demonstrated to be considerably less labile than the L14, it was still anticipated that it could 
exhibit some lability. In particular, it was suggested that scrambling by adding an uncoordinated ligand 
would substantially speed up this process. Indeed, it has previously been shown that ligand scrambling 
with intact cages gives an artificially high assessment of their stabilities due to the very low steady 




Figure 2.2.22: Proposed substitution of functionalised ligands into C19. 
Therefore, a sample of the C19 was dissolved in a 9:1 mixture of D2O/CD3CN and nine equivalents of 
L20 were added as a solid. The mixture was sealed, heated to 75 °C and monitored by NMR (Fig. 
2.2.23). The yellow colour of the C19 solution quickly changed to the orange colour of C20 and the 
NMR showed the rapid loss of C19 peaks in favour of ones consistent with C20. Continued heating 

























Figure 2.2.23: Partial 1H NMR (600 MHz, 9:1 D2O/CD3CN) of C19 with 9 equivalents of L20. (a) Before 
addition of L20, then after heat at 75 °C for (b) 0 h, (c) 1 h, (d) 12 h, (e) 36 h, (f) 50 h, (g) 71 h. C19 
highlighted in dark blue and C20 in light blue. 
The other species present are likely to be heteroleptic species with mixed ligands (Figure 2.2.24). 
These heteroleptic cages would be expected to represent a complex mixture of species with different 












Figure 2.2.24: Depictions of nine potential substitution patterns of heteroleptic tetrahedra formed in 
the reaction. Ligands depicted in black and blue. (*Possess additional chirality) 
While these heteroleptic cages might be of interest due to their lowered symmetry and intermediate 
properties, they threatened to make isolation of pure cage difficult. The persistence of these 
intermediates implied that the excess of L20 was too small to effectively out-compete L19 in the 
exchange equilibrium. Therefore, the reaction was repeated with twelve equivalents of L20, making 
the total L20/L19 ratio two to one. This reaction appeared to show a smaller number of other species 
in the NMR spectra even after 13 days. Unfortunately, the solid ligand present in solution caused bad 





Figure 2.2.25: Partial 1H NMR (600 MHz, 9:1 D2O/CD3CN) of C19 with 12 equivalents of L20. (a) Before 
addition of L20, then after heating at 75 °C for: (b) 0 h, (c) 48 h, (d) 13 days. C19 highlighted in dark 
blue and C20 in light blue. 
It was hypothesised that these persistent impurities may be caused by metastable intermediates. 
Higher temperatures may overcome this problem but could also lead to a rearrangement to the 
helicate over extended periods of time. Therefore, it was proposed that energy barrier to ligand 
exchange be lowered by exploiting the redox activity of cobalt.  
It was hypothesised that the inclusion of a catalytic amount of cobalt (II) into the system would 
facilitate exchange. Under an inert atmosphere, these cobalt (II) centres could propagate through the 
system by electron transfer between complexes. These reduced sites would be expected to be far 
more labile, increasing the overall rate of substitution without destabilising the cage. This is a similar 
concept to the slow oxidation of the system, which exploits rearrangement of the mixed oxidation 
state species. While L20 cobalt (II) assemblies appeared to be slow to rearrange, it was hypothesised 
exchange may be more effective with uncoordinated ligand.  
Addition of cobalt (II) nitrate was proposed as the most practical means of introducing cobalt (II) into 







mol% Co(NO3)2.6H2O (with respect to cage) before degassing and sealing of the reaction vessel prior 
to heating. 
 
Figure 2.2.26: Partial 1H NMR (600 MHz, 9:1 D2O/CD3CN) of C19 with 12 equivalents of L20 and 0.23 
mol% (CoNO3)2.6H2O. After heating at 75 °C for: (a 0 h, (b) 24 h, (c) 4 days, (d) 5 days, (e) 6 days. C19 
highlighted in dark blue and C20 in light blue. 
The results of this cobalt (II) “catalysed” reaction (Fig. 2.2.26) appeared to show a large reduction in 
the impurities, with only a single broad set of other signals. DOSY investigation of these peaks 
appeared to show that they had a smaller hydrodynamic radius than the tetrahedron, though the 
broadness of the peaks might imply a dynamic or cobalt (II) species. Encouraged by this improvement, 
the reaction was filtered and the product dried and isolated. Size exclusion chromatography was 
trialled on the product mixture and found to be effective at isolating the pure cage from these 
impurities. Whether this separation was caused by the DOSY-implied size difference, or some chemical 
differentiation by the saccharide-silicone gel could not be determined, but the cage was isolated in a 
respectable 70% yield. 
The reaction was repeated on a preparative scale and found to be reproducible, consistently giving 
pure C20 with greater than 50% yields (Scheme 2.2.11). While this synthesis may be considered 










Scheme 2.2.11: Successful route to C20 via the formation of C19 and substitution with L20 ligands. 
The reaction is less resource intensive than it may first appear, as the excess ligand and the byproducts 
are recoverable. The excess ligands are collected by filtration during the work up and are easily 
separated according to their different solubilities. The impure byproducts can also be disassembled 
through demetallation with EDTA to recover the ligands in a similar manner. 
While the reaction was found to be effective, greater understanding may allow its improvement. 
Identification of the intermediates, byproducts and impurities of the reaction might give insight into 
the kinetic and thermodynamic factors in the exchange and allow optimisation.  
The rapid progress of the reaction implies that the temperature of the reaction could be lowered to 
allow closer monitoring of the intermediate stages of the reaction. It may also prevent any possible 
rearrangement to helicate occurring during the reaction. Temperature variation may also provide 
more information about the role of the cobalt (II) additive in the reaction. The inverse reaction, 
attempting to exchange of an excess of L19 into C20, would also be a poignant experiment, 







2.2.8 Properties of C20 
Once isolated, C20 was characterised; The proton NMR of the cage showed that the shielding observed 




Figure 2.2.27: Partial 1H NMR (500 MHz, D2O) of C19 (top, R = H, dark blue) and C20 (bottom, R = 
NH2, light blue), NH2 signals not observed due to deuterium exchange. 
As C20 does not differ in size or charge in comparison with C19, it was predicted that it would have 
very similar guest binding properties. A number of guest binding studies with C20 were performed; 
perchlorate and perrhenate were both found to bind within C20 to a similar extent as C19 (Table 
2.2.2). Perrhenate with a binding constant of 46000 M-1 and perchlorate with a binding constant of 



















Table 2.2.2: Binding constants of perchlorate and perrhenate in C19 and C20. Experimental error 
estimated to be ±50%. Binding constants for C19 collected by Michael Burke. 
 
Additionally, a crystal structure of [ReO4⊂C20] was obtained by the slow diffusion of acetone into a 
solution of the cage saturated with [NMe4][ReO4], shown in Figure 2.2.28. Though the angle of 
diffraction was insufficient for in-depth measurements and analysis, it provides further proof of both 
the connectivity of the capsule and the binding of the guest within its cavity. Interestingly the anion 
was only bound within the cavity of the cage with a 50% occupancy in this crystal structure, though 
the reason for this remains unclear. 
 
Figure 2.2.28: Partial crystal structure of [ReO4⊂C20]. Protons, solvent molecules, and anions have 
been omitted for clarity.  
 Ka M-1 
Anion C19 C20 
ClO4- 7100 21000 
ReO4- 61000 46000 
67 
 
C20 was characterised and found to retain the desirable qualities of C19 regarding solubility, structure 
and guest binding of “cold” anions.  In order to assess the stability of the new cage, the glutathione 
assay previously utilised with C19 was repeated. As expected, C20 was found to be stable in pH 7.4 
phosphate buffered saline with negligible loss of 1H NMR signals over several weeks (Figure 2.2.29). 
 
Figure 2.2.29: Partial 1H NMR (600 MHz, D2O, 1 M PBS) of C20 (0.1mM) in presence of 10 equivalents 
of glutathione over time (descending: 0 h, 0.5 h, 1 h, 2 h, 2.5 h, 3 h, 3.5 h, 4 h, 4.5 h, 5 h, 5.5 h, 6 h, 6.5 
h, 7 h, 7.5 h, 8 h, 8.5 h, 9 h, 9.5 h, 10 h, 10.5 h, 11 h, 24 h, 36h, 42 h). C20 (blue), glutathione (yellow), 
glutathione disulphide (orange).  
Following the addition of 10 equivalents of glutathione to a PBS solution of C20, it appeared to exhibit 
better stability than C19. The 1H NMR signals of the cage are present for far longer; in fact, the signals 
of the cage appear to still be present after 40 hours, whereas C19 had been almost completely 








Figure 2.2.30: Concentration of C20 and glutathione disulfide (GlutathioneDS), when C20 (1 mM) 
exposed to 10 equivalents glutathione in pH 7.4 phosphate buffered saline. 
Analysis of the concentration of the cage and glutathione disulfide showed that the concentration of 
the cage did not fall below half of the initial concentration during the experiment. The concentration 
of glutathione could not be accurately monitored due to overlap with the water peak; however, it was 
apparent that all ten equivalents of glutathione were consumed, even after the concentration of the 
C20 had stabilised. One explanation for the consumption of glutathione in the absence of consumption 
of C20 could be other reactions. The previous experiments have shown that degraded C19 appeared 
to catalyse the oxidation of glutathione. It is possible that this also occurring in this instance before 
the complete consumption of C20. However, continued consumption of C20 might be expected in this 
were the case. 
Another possibility is that the cage concentration is being regenerated. It is possible that the cobalt 
(II) form of C20 may be sufficiently stable to remain in solution and react with atmospheric oxygen to 
regenerate the cobalt (III) species. This would allow C20 to effectively catalyse the oxidation of 
glutathione by atmospheric oxygen. Though, as the C20 concentration remains stable rather than 
increasing or decreasing, it implies that the system had reached some form of equilibrium. That this 
was observed with C20 and not C19 could be explained by the greater stability of the cobalt (II) or 
mixed valent assemblies of C20. L20-cobalt (II) assemblies were shown to be stable by the apparent 
perseverance of kinetically trapped byproducts. This observed stability could imply that the cobalt (II) 
assemblies of L20 are kinetically stable enough to survive in phosphate buffered saline long enough 
to be re-oxidised.  
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The mechanism of the reaction cannot be known without further study and is likely to be complex. 
Many reported glutathione oxidations include the coordination of the glutathione to the metal centres 
and the supramolecular nature of our system provides many interactions that may be significant to 
the reaction. Cage solutions in buffer represent a complex mixture of chemical species and 
environments. The cage’s counterions, cavity, portals, exterior surface and coordination sphere all 
represent different chemical micro-environments. Additionally, the buffer also contains a large 
number of ions, including various phosphate, chloride and nitrate. Therefore, the complexity of the 
system may make identification of the reaction mechanism difficult. 
At pH 7.4, glutathione would be expected to possess two anionic carboxylic acid groups, one 
protonated amine and the thiol group, all of which will be expected to interact with the cage and 
solution ions. By 1H NMR the peaks of glutathione and C20 in PBS only shift marginally when combined, 
suggesting there is little non-covalent interaction (Figure 2.2.31). 
 
Figure 2.2.31: Partial 1H NMR (600 MHz, D2O, 0.1 M PBS) of solutions of (a) glutathione, (b) C20, (c) 
glutathione and C20. 
The peaks of the cage do not shift, though its concentration has dropped considerably upon the 
addition of glutathione, implying that the glutathione is interacting with some form of degraded or 






In an attempt to gain more insight into this interaction between glutathione and C20 the reaction was 
repeated in D2O rather than phosphate buffered saline. This was expected to simplify the system by 
reducing the number of ions in solution, allowing the cage to decrease the pH. Treating the cage with 
glutathione in D2O was found to degrade the cage at a slower rate. Unexpectedly, a second set of 
peaks appeared (Figure 2.2.32, purple peaks) and these peaks increase in intensity as the peaks of C20 
decrease (Figure 2.2.32, blue peaks). These peaks possess the same symmetry as the cage and appear 
to be diamagnetic but also migrate over time.  
 
Figure 2.2.32: Partial 1H NMR (600 MHz, 600 MHz, D2O, 1 M PBS) of C20 and Glutathione over time 
(descending). C20 (blue), C20* (purple), glutathione (yellow, select peaks), GlutathioneDS (orange, 
select peaks).  
The properties of this species imply that is either an entirely different cobalt (III) L20 assembly of the 
same symmetry or the original cage shifted by an exchange process that is slow on the NMR timescale. 
The movement of the second cage species over time implies either a fast exchange process or a 
response to a change in solution, potentially pH changes. The slower rate of overall degradation could 
be explained by the lower pH either reducing interactions between the cage and glutathione or the 








2.2.9 [99mTc]TcO4- binding in C20 
With this new, more stable cage, the pertechnetate binding studies were revisited. When the binding 
studies were carried out with C20, it was found to also bind the radiotracer better than C19 (Fig. 
2.2.33).  
 
Figure 2.2.33: Radiochemical yield for [99mTc]TcO4- encapsulation against concentration of C19 (black) 
and C20 (red). [99mTc]TcO4-  (1 µL, 1 MBq) were added to cage solutions (100 µL), incubated for stated 
time at room temperature, before assessment by chromatography. Experiment performed in triplicate 
by Benjamin Burke. 
C20 appears to be 50 times more effective than C19 at binding [99mTc]TcO4. This result is surprising as 
it is not reflected in the results of the NMR studies with “cold” anions, which showed very similar 
binding of perrhenate in the two cages. C20 being a better host than C19 for [99mTc]TcO4- is difficult to 
rationalise as the cages are believed to be largely isostructural. The discrepancy between the results 
of the two techniques could either be caused by difference in the anion or the techniques. 
Perrhenate is commonly used as a cold model for pertechnetate but some differences are apparent 
in their properties and interactions with hosts.16 It is possible that these differences allow C20 to 




















between the techniques. The chromatographic analysis differs from the NMR studies as it does not 
monitor the interaction in solution but rather deposited on silica.  
Deposition onto silica is regarded as a harsh procedure, known to degrade sensitive chemical groups. 
It is possible that C19 is degraded by this deposition while the more stable C20 is not, thereby 
artificially lowering the effective concentration of C19. However, the cages have been shown to be 
stable to both silanols and acid conditions which are the main chemical features of silica.3  
Encapsulation of [99mTc]TcO4- by C20 was investigated in a number of different solutions (Fig. 2.2.34). 
These experiments showed similar results to those for C19, though the improved affinity of C20 for 
[99mTc]TcO4- was reflected by increased radiochemical yields. This implies that C20 is actually more 
selective towards TcO4- but could still be explained by a higher concentration of undegraded cage. 
Again, this did not reflect the NMR analysis, which showed C20 being slightly better than C19 at 
binding perchlorate.  
 
Figure 2.2.34: Radiochemical yield of [99mTc]TcO4- (1 MBq) in C20 (132 µM) in various solutions over 
time. [99mTc]TcO4-  (1 µL, 1 MBq) and salt solution (50 µL, 0.1mM) were added to cage solutions (100 
µL), incubated for stated time at room temperature, before assessment by chromatography. 






Most importantly, the presence of serum did not cause C20 to show a reduction of [99mTc]TcO4- 
retention over time. No significant drop of radiochemical yield was observed over a 24 hour period 
indicating that the cage remains intact and able to bind the [99mTc]TcO4- under these conditions.  
These results, in combination with the glutathione studies, indicate that the functionalisation of the 
cage was effective at stabilising the cage against biological breakdown while retaining its ability to 
bind [99mTc]TcO4-. These properties suggested that C20 may be suitable to act as radioligand for 
[99mTc]TcO4- and so investigations turned to SPECT imaging. 
2.2.10 In vivo SPECT imaging with [99mTc]TcO4-[TcO4⊂C20] 
With evidence that C20 is able to bind [99mTc]TcO4- under biological conditions, the cages were also 
assessed for cytotoxicity to get an idea of whether they could be safely administered to animals. This 
work, alongside imaging studies, was carried out by David Roberts, Isaline Renard, Rebecca 
Hargreaves, Christopher Cawthorne and Benjamin P. Burke at the University of Hull. 
MTT assays found that the two cages possessed low cytotoxicity towards HeLa cells, with EC50 values 
of 31.4 µM for C19 and 10.6 µM for C20. The toxicity values of the cages are low, especially in the 
context of the concentrations at which radioimaging agents are administered. However, a greater 
understanding of their biological activity and fate would be desirable. 
With C20 exhibiting good biological stability and low cytotoxicity, in vivo studies were initiated. Naïve 
anaesthetised mice were dosed with either [99mTc]TcO4- or [99mTc]TcO4-[TcO4⊂C20] prior to a 
combined CT/SPECT acquisition. The biological uptake of pertechnetate is well understood, it is known 
to be taken up by sodium-iodide symporter (NIS). This receptor is mostly present in the thyroid but 
also the stomach and salivary and lacrimal glands, making these tissues the main location of 
pertechnetate uptake.17 
The mice treated with unbound [99mTc]TcO4- showed the expected uptake in the thyroid and stomach 
(Fig. 2.2.35, left). However, the mouse administered a solution of [99mTc][TcO4⊂C20] showed a marked 
difference in uptake with considerable activity present in the liver in addition to the stomach and 





Figure 2.2.35: (Left) Naïve mice dosed with free [99mTc]TcO4- solution (25-35 MBq), uptake apparent in 
thyroid and stomach. (Right) Naïve mice dosed with [99mTc]TcO4-[TcO4⊂C20] (7-20 MBq), uptake 
apparent in liver as well stomach and thyroid . Animals dosed 20 minutes before 100-minute SPECT 
acquisition. Th = Thyroid, S = Stomach, L = Liver. Experiment performed by Benjamin Burke and 
Christopher Cawthorne. 
To further explore this difference of uptake, another three animals were dosed, killed and their organs 
collected and assessed for radioactivity (Fig. 2.2.36). These results confirm the host-guest complex 
showed considerable uptake in the liver.   
 
Figure 2.2.36: Biodistribution of [99mTc][TcO4⊂C20]11+ in selected tissues from CD1-IGS mice 120 
minutes after injection with [99mTc][TcO4⊂C20]11+ (6-8 MBq). All radioactivity values converted into 
%ID/g. Data are mean ± SD of 3 animals. Experiment performed by Benjamin Burke and Christopher 
Cawthorne. 
To assess the fate of pertechnetate in the liver, an aqueous extract of the dosed mouse’s livers was 
taken, purified by centrifugation and investigated by TLC. When eluted with water, this extract 
exhibited 30% retention on the baseline, while elution with acetonitrile led to no retention. These 
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results are consistent with the extract containing [99mTc][TcO4⊂C20]11+, indicating that this is the 
species which was taken up by the liver.  
The continued uptake in the thyroid and stomach likely represents dissociation of the anion from the 
cage. This is not unexpected and is likely due to the high dilution and prevalence of competing 
biological anions in vivo. This would lead to “bleeding” of free anion into the biological environment 
which will follow the standard uptake mechanism.  
These results show that: 
• The functionalised cage remains stable enough in vivo to retain a cavity fit to bind the guest 
• The guest remains largely bound within the cavity of the cage in vivo during the experiment  
• The host-cage complex exhibits significantly different uptake to the free anion 
These results prove the potential for these cage systems as a radioligand capable of directly “ligating” 
the pertechnetate anion without the requirement for conventional chemistry. Bioconjugation of the 
cage prior to encapsulation would allow the synthesis of directed radioimaging agents by the simple 
addition of [99mTc]TcO4- solution from the generator to these pre-formulated cages.  
The results also provide evidence for the potential of this cage system for other biological applications. 
Examples of discrete cages that are stable in vivo are very rare and could have a huge number of 





The previously developed Co4(L19)6(NO3)12 system was found to be promising as a radioligand for 
[99mTc]TcO4-, the precursor to all 99mTc based radioimaging agents. This suggested that the cage could 
be used as a supramolecular ligand for the radionuclide to provide a new and promising means of 
synthesising radiopharmaceuticals. However, further investigation found that Co4(L19)6(NO3)12 was 
susceptible to reduction by glutathione, making it insufficiently stable for in vivo use.  
In order to counteract this instability a functionalised ligand (L20) was developed, which was 
substituted with an amine group to increase the strength of interaction with the metal centres and to 
improve the overall stability of the cage. Attempts at the direct formation of the tetrahedron through 
previously established methods were hindered by kinetic trapping of the byproducts due to the lack 
of reversibility in the strengthened coordination bonds. 
A range of attempts made to facilitate the direct formation of the cage included elevated 
temperatures, strongly coordinating solvents, lowered pH, and protection of the amine group with an 
electron withdrawing group. Unfortunately, none of these measures were successful and purification 
of product mixtures was found to give very poor yields. 
An effective means of synthesising the cage was found by substituting L20 directly into 
Co4(L19)6(NO3)12. This allowed the exploitation of the prearrangement of the existing tetrahedra to 
prevent the formation of alternate assemblies. Co4(L20)6(NO3)12 was found to retain many of the 
properties of the previous cage and was found to be an even better host for [99mTc]TcO4-. The cage 
was also shown to be considerably more stable to biological conditions, resisting degradation by 
glutathione and retaining its binding of [99mTc]TcO4- in serum.  
After determining that the cage had low cytotoxicity, in vivo radioimaging experiments were able to 
demonstrate [99mTc][TcO4⊂C20]11+ had different biological uptake to free [99mTc]TcO4- and that the 
host-guest complex could be recovered from the liver of dosed animals. This proves that C20 is able 
to bind a medicinally significant guest in vivo, and that similar metallosupramolecular cages may be 







General Information  
Unless otherwise stated, all reagents and solvents were purchased from Alfa Aesar, Fluorochem, VWR 
or Sigma Aldrich and used without further purification. Anhydrous solvents: anhydrous DMF was 
obtained from Sigma Aldrich, other solvents were dried using a solvent purification system 
manufactured by Inert. Column Chromatography. Column chromatography was carried out using 
Geduran Si60 (40-63 µm), as the stationary phase. TLC was performed using pre-coated ALUGRAM 
plates, (0.2 mm, UV254) and observed under UV irradiation. Alumina chromatography was performed 
using Aluminium oxide, neutral, 50-200 microns, as the stationary phase. Size exclusion 
chromatography was performed using Sephadex LH-20 pre-swollen in the stated solvent. All reactions 
were carried out under N2 atmosphere unless otherwise stated. Degassing of solvents was carried out 
by sparging with N2 for a minimum of ten minutes.  
Abbreviations used in this text:  
DMSO   Dimethylsulfoxide 
DMF                     N,N-dimethylformamide 
THF   Tetrahydrofuran  
DCM   Dichloromethane 
NMR   Nuclear Magnetic Resonance  
COSY   Correlation Spectroscopy  
DOSY   Diffusion ordered spectroscopy  
NOESY   Nuclear Overhauser Effect Spectroscopy  
HSQC   Heteronuclear Single Quantum Coherence  
RT   Room Temperature  
EDTA                   Ethylenediaminetetraacetic acid 
Na4EDTA  Ethylenediaminetetraacetic acid tetrasodium salt  
MS   Mass Spectrometry 
pi                          Penetration Index 
MBq                     Megabecquerel 
MTT                     3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
All 1H NMR spectra were recorded on either a 500 MHz Bruker AV III equipped with a DCH cryo-probe 
(Ava500) a 600 MHz Bruker AV IIIHD equipped with a TCL cryoprobe (Ava600) or a 400 MHz Bruker AV 
III equipped with a BBFO+ probe (Ava400). All 13C NMR spectra were recorded on the Ava500. All 
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spectra recorded at a constant temperature of 300 K. All DOSY experiments were performed on either 
the Ava500 or Ava600 using bipolar gradient pulses for diffusion with two spoil gradients 
(ledbpg2s.compensated) pulse sequence. The sequence was carried out under automated conditions 
where the duration was 100 ms. Typically, in each PFG NMR experiment a series of 16 spectra on 32 
K data points were collected and eddy current delay was set to 5 min in all experiments. The pulse 
gradients were incremented from 2 to 95% of the maximum gradient strength in a linear ramp. The 
temperature was set and controlled at 300 K with an air flow of 400 Lh-1 in order to avoid any 
temperature fluctuations due to sample heating during the magnetic field pulse gradients. The Stokes-
Einstein equation was used to convert diffusion coefficient to hydrodynamic radius. The NMR data 
was processed using Topspin 2.1 and MestreLab Research MestReNova 11.0.0. Chemical shifts are 
reported in parts per million from low to high field and were referenced against values for the residual 
solvent peaks. Coupling constants (J) are reported as observed in Hz. Standard abbreviations indicating 
multiplicity were used as follows: m = multiplet, t = triplet, d = doublet, s = singlet, br(s/d) = broad 
(singlet/doublet etc.), appt = apparent triplet etc. Mass spectrometry of organic compounds was 
carried out on a high resolution Bruker ToF instrument, mass spectrometry (ESI-MS) of complexes was 
carried out using a Waters SYNAPT G2 instrument. 
Synthesis of ligands 
Safety Notice: Alkyltin compounds are all highly toxic and should be handled with great caution. 
Tributyltin chloride is highly toxic, readily absorbed through the skin, and relatively volatile; it and 
other tributyltin derivatives should be only be handled within a fume cupboard, and extreme vigilance 
is recommended in handling the viscous oil in the reaction to make N2. Tributyltin chloride is 
regenerated in Stille cross coupling reactions, meaning that the Stille couplings to make N5 and N7 
should be carried out and worked up with the same caution. All glassware that has been in contact 
with tin compounds should be thoroughly washed into a clearly marked and sealable “tin waste” for 
proper disposal. Glassware should preferably be washed with bleach before being returned to general 
use. 
Fragments 5-bromo-2,2’-bipyridine (N22) ,36 5-bromo-2-(tributylstannyl)pyridine (N2),29 and tert‐










A solution of NiCl (0.174 g, 1.34 mmol) and PPh3 (1.34 g, 5.10 mmol) in DMF (12.0 mL) was heated at 
50 °C for 0.5 h under N2. The resulting blue suspension was treated with Zn (powder, 90.3 mg, 1.38 
mmol) to produce a red brown suspension after 0.5 h, to which N22 (0.299 g, 1.27 mmol) in DMF (6.0 
mL) was added and the mixture stirred at RT for 3 days. To this, Na4EDTA (0.25 M, 60 mL, 15.0 mmol) 
was added and the aqueous layer washed with dichloromethane (5 × 100 mL) and brine added (20 
mL). The combined organic layers were dried over MgSO4, the solvent removed in vacuo and purified 
by silica flash column (dichloromethane, 1% trimethylamine, 1% methanol). This was crystallised in 
hot acetonitrile to give white plate crystals. Yield = 0.126 g (64%).  
M.p. 233-235 °C, 1H NMR (600 MHz, CDCl3): δ 9.03 (dd, J = 2.4, 0.8 Hz, 2H, HG), 8.75 (d, J = 4.8 Hz, 2H, 
HA), 8.58 (dd, J = 8.3, 0.8 Hz, 2H, HE), 8.50 (d, J = 8.0 Hz, 2H, HD), 8.13 (dd, J = 8.3, 2.4 Hz, 2H, HF), 7.89 
(t, J = 7.6 Hz, 2H, HC), 7.38 (dd, J = 7.6, 4.8 Hz, 2H, HB). 13C NMR (151 MHz, CDCl3): δ 155.8, 155.6, 
149.3, 147.5, 137.0, 135.2, 133.1, 124.0, 121.2, 121.2. HR-ESI: m/z 311.12890 (predicted [M+H]+ = 
311.12912), 333.11180 (predicted [M+Na]+ = 333.11107). 
N5 
 
N3 (4.039 g, 18.4 mmol), Pd(PPh3)4(1.04 g, 0.901 mmol) and N2 (8.29g, 18.5 mmol) were combined in 
toluene (80 mL) and heated at 100 °C for 24 h under N2. The mixture was allowed to cool to room 
temperature, diluted with dichloromethane (30 mL) and filtered. The solvent was removed from 
filtrate in vacuo. The crude product was crystallised from hot ethanol and then purified by silica flash 
column (gradient: dichloromethane to dichloromethane, 4% diethyl ether) to give a colourless 
powder. Yield = 3.07 g (57%).  
1H NMR (500 MHz, Chloroform-d) δ 9.19 (d, J = 3.3 Hz, 1H, HF), 8.90 (dd, J = 8.6, 0.7 Hz, 1H, HA), 8.84 
(dd, J = 2.4, 0.7 Hz, 1H, HC), 8.35 (d, J = 7.2 Hz, 1H, HD), 8.08 (dd, J = 7.2, 3.3 Hz, 1H, HE), 8.01 (dd, J = 
8.6, 2.4 4 Hz, 1H, HB). 13C NMR (126 MHz, Chloroform-d) δ 151.1, 147.56, 146.0, 142.7, 142.3, 139.5, 
126.2, 122.9, 122.5, 119.2. HR-ESI: m/z 295.96780 (predicted [M+H]+ = 295.96653), 317.9480 







N8 (1.0008g, 4.9300 mmol), Pd(PPh3)4 (282 mg, 0.1811 mmol) and N1 (2.268g, 5.073 mmol) were 
combined in toluene (25 mL) and heated at 110 °C for 48 h under N2. The mixture was allowed to cool 
to room temperature, diluted with toluene (30 mL) and filtered. The solvent was removed from filtrate 
in vacuo. The crude product was purified by silica flash column (gradient: dichloromethane to 
dichloromethane, 2% diethyl ether) and then recrystallized from acetonitrile to give colourless 
needles. Yield = 660 mg, (48%). 
1H NMR (500 MHz, Chloroform-d) δ 9.12 (dd, J = 2.2, 0.7 Hz, 1H, Hc), 8.94 (dd, J = 5.3, 0.7 Hz, 1H, HA), 
8.78 (dd, J = 2.3, 0.8 Hz, 1H, HF), 8.38 (dd, J = 8.5, 0.7 Hz, 1H, HD), 8.03 (dd, J = 5.3, 2.2 Hz, 1H, HB), 8.00 
(dd, J = 8.5, 2.3 Hz, 1H, HE). 13C NMR (126 MHz, Chloroform-d) δ 158.7, 155.2, 152.6, 151.5, 150.8, 






N5 (1.66g, 5.60 mmol) and Fe (fillings, 1.67g, 29.9 mmol) were combined in acetic acid (50 mL) and 
heated at 100 °C for 3 h under N2. The mixture was allowed to cool to room temperature and a solution 
of NaOH (10.54 g, 0.27 mol), EDTA (17.564g, 60.1 mmol) in water (50 mL) and ammonium hydroxide 
(30 %, 100 mL) was added slowly. The mixture was then extracted with chloroform (3 x 150 mL) and 
the combined organic phases were dried over MgSO4. The solvent was removed in vacuo and the 
crude product was crystallised from hot toluene to give pale yellow needle crystals. Yield = 1.03 g 
(74%). 
1H NMR (600 MHz, Chloroform-d) δ 8.68 (d, J = 2.4 Hz, 1H, HF), 8.32 – 8.25 (m, 2H, HA,D), 7.91 (dd, J = 
8.5, 2.4 Hz, 1H, HE), 7.64 (d, J = 2.5, 0.5 Hz, 1H, HC), 6.57 (dd, J = 5.5, 2.4 Hz, 1H, HB), 4.24 (s, 2H, HG). 
13C NMR (126 MHz, Chloroform-d) δ 156.0, 155.0, 153.7, 150.1, 139.6, 122.6, 121.1, 110.0, 106.9. HR-
ESI: m/z 249.99910 (predicted [M+H]+ = 249.99744). 
1H NMR (601 MHz, DMSO-d6) δ 8.74 (dd, J = 2.4, 0.7 Hz, 1H, HF), 8.25 (dd, J = 8.5, 0.7 Hz, 1H, HD), 8.12 
(dd, J = 8.5, 2.4 Hz, 1H, HE), 8.09 (d, J = 5.5 Hz, 1H, HA), 7.57 (d, J = 2.3 Hz, 1H, HC), 6.53 (dd, J = 5.5, 2.3 
Hz, 1H, HB), 6.23 (s, 2H, HG). 
L20 
 
NiCl2 (779.5 mg, 6.01 mmol) and PPh3 (638.5 mg, 2.43 mmol) were combined in DMF (50 mL) and 
heated at 50 °C for 24 h under N2. The mixture turned an intense blue with some yellow material 
visible. Zn (powder, 375.6 mg, 5.74 mmol) was added causing an immediate colour change to red and 
then black. The mixture was left stirring for 1 h before a solution of N6 (1.272 g, 0.51 mmol) in DMF 
(5 mL) was added and then left stirring for 48 h. The solvent was removed in vacuo and a Na4EDTA 
solution was added to the residue and then refluxed for 72 h. A beige suspension was collected by 
filtration and then extracted with 2 × 100 mL chloroform/methanol (1:1, 100 mL) and 2 × 100 mL THF. 
The solvent was removed from the extractants in vacuo. The residue was heated in acetonitrile (100 
mL), allowed to cool and collected by filtration to give a beige solid. Yield = 695 mg (80%). 
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M.p. 342 °C decomposition. 1H NMR (500 MHz, DMSO-d6) δ 9.09 (dd, J =2.4, 0.8 Hz, 1H, HF), 8.45 (dd, 
J = 8.3, 0.8 Hz, 1H, HD), 8.33 (dd, J = 8.3, 2.4 HZ, 1H, HE), 8.15 (d, J = 5.5 Hz, 1H, HA), 7.70 (d, J = 2.3 Hz, 
1H, HC) 6.56 (dd, J = 5.5, 2.3 Hz, 1H, HB), 6.21 (s, 2H, HG). 13C NMR (126 MHz, DMSO-d) δ 155.7, 155.2, 
154.8, 149.4, 147.0, 134.8, 132.0, 120.4, 109.1, 105.6. HR-ESI: m/z 341.15240 (predicted [M+H]+ = 
341.15092), 363.1339 (predicted [M+Na]+ = 363.1334). 
1H NMR (500 MHz, Methanol-d4) δ 9.03 (dd, J = 2.3, 1.0 Hz, 1H), 8.34 – 8.28 (m, 2H), 8.16 (d, J = 5.8 Hz, 
1H), 7.59 (d, J = 2.3 Hz, 1H), 6.69 (dd, J = 5.8, 2.4 Hz, 1H).  
N10 
 
N6 (303.2 mg, 1.21 mmol) and di-tert-butylcarbonate (326.1 mg, 1.13 mmol) were placed in a 2-5 mL 
sealed vial with septum under N2. Dichloromethane (5 mL) and trimethylamine (0.5 mL) were added 
and the mixture sparged with N2 for five minutes and heated at 50 °C for 48 h. The solvent was 
removed in vacuo and the crude product purified by silica gel chromatography (19:1 
dichloromethane/diethylether) to give an off-white solid. Yield= 69 mg (17%). 
1H NMR (601 MHz, Chloroform-d) δ 8.72 (d, J = 2.3 Hz, 1H, HF), 8.53 (d, J = 5.5 Hz, 1H, HA), 8.32 (d, J = 
8.5 Hz, 1H, HD), 8.22 (d, J = 2.2 Hz, 1H, HC), 7.95 (dd, J = 8.5, 2.3 Hz, 1H, HE), 7.58 (dd, J = 5.5, 2.2 Hz, 
1H, HB), 6.76 (s, 1H, HG), 1.57 (s, 9H, HH). 13C NMR (126 MHZ, Chloroform-d) δ 150.5, 150.3, 139.7, 
122.6, 112.7, 109.8, 28.5. Only HC of the quaternary carbons could not be detected. 
L22 
 
NiCl2 (162.3 mg, 0.48 mmol) and PPh3 (52.4 mg, 0.20 mmol) were combined in in DMF (2 mL) and 
heated at 50 °C for 1 h under N2. The resulting blue suspension was treated with Zn (powder, 35.7 mg, 
0.55 mmol) to produce a red brown suspension after 0.5 h, to which N10 (168.6 mg, 0.48 mmol) in 
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DMF (2 mL) was added and the mixture stirred at RT for 3 d. A solution of EDTA (703.4 mg, 2.41 mmol) 
and NaOH (385.0 mg, 9.63 mmol) in ammonium hydroxide solution (30%, 20 mL) was added to the 
mixture and the mixture stirred for 24 h. The colourless precipitate was collected by filtration, 
extracted with THF (50 mL) and the solvent removed in vacuo. The crude product was crystallised from 
hot acetonitrile to give a colourless powder. Yield = 39 mg (30%). 
1H NMR (601 MHz, DMSO-d6) δ 10.00 (s, 2H, HG), 9.16 (dd, J = 2.4, 0.8 Hz, 2H, HF), 8.67 (d, J = 2.2 Hz, 
2H, H, HC), 8.49 (d, J = 5.5 Hz, 2H, HA), 8.49 (d, J = 8.3 Hz, 2H, HD), 8.38 (dd, J = 8.3, 2.4 Hz, 2H, HE), 7.48 
(dd, J = 5.5, 2.2 Hz, 2H, HB), 1.52 (s, 18H, HH). 13C NMR (126 MHz, DMSO-d6) δ 193.2, 192.6, 190.1, 
187.6, 185.2, 185.0, 172.8, 170.03, 158.2, 150.3, 146.7, 117.8, 65.6. HR-ESI: m/z 541.2582 (predicted 
[M+H]+ = 541.2558), 563.2395 (predicted [M+Na]+ = 563.2377). 
Synthesis of capsules 
C19 synthesised according to previous procedure.38  
General procedure for attempted C20 Synthesis 
 
 
Co(NO3)2.6(H2O) (1 equivalent, approximately 50 µ) and L20 (1.5 equivalents) were suspended in a 
mixture of degassed water and co-solvent (9:1, approx. 22.1 mM with respect to L20) under N2. The 
reaction was heated at the stated temperature for 2-12 hours and allowed to cool. (NH₄)₂Ce(NO₃)₆ 
(1.5 equivalents) in acetonitrile (approx. 22.85 mM) and was added to the reaction mixture. Dilution 
with acetonitrile induced an orange precipitate which was isolated by filtration on celite and washed 
with acetonitrile. The retentate was eluted with water and freeze-dried to give the crude product. 
Example 
Co(NO3)2.6(H2O) (17.2 mg, 59.1 µmol) and L20 (30.1 mg, 88.4 µmol) were suspended in a mixture of 
degassed water-acetonitrile (9:1, 4mL) and heated in a microwave reactor for 2 h at 80 °C. The reaction 
was cooled to room temperature before (NH₄)₂Ce(NO₃)₆ (501 mg, 91.4 µmol) in acetonitrile (4 mL) 
was added via syringe pump (4.2 µL min-1). Dilution with acetonitrile (40 mL) induced precipitation, 
this was isolated by filtration onto celite and washed with acetonitrile. The retentate was eluted with 
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water and freeze-dried to give an orange solid. It was then purified by size exclusion chromatography 
on sephadex LH-20 gel in water and freeze-dried to give an orange solid. Yield = 11 mg (26%).  
1H NMR (600 MHz, D2O) δ 8.55 (d, J = 8.4 Hz, 12H, HD), 7.92 (d, J = 2.7 Hz, 12H, HC), 7.78 (dd, J = 8.4, 
1.8 Hz, 12H, HE), 7.31 (d, J = 1.8 Hz, 12H, HF), 6.99 (d, J = 7.0 Hz, 12H, HA) 6.81 (dd, J = 7.0, 2.7 Hz, 12H, 
HB). 13C NMR (126 MHz, D2O) δ 158.4, 156.5, 153.4, 148.5, 143.2, 137.3, 124.6, 114.7, 112.0, 110.0.. 
1H DOSY NMR (500 MHz, D2O): D 22 = 2.14 x 10-6 cm2 s -1 ; calculated hydrodynamic radius = 11.5 Å. 
ESI-MS ESI-MS (m/z): 369.5 (7+), 315.6 (8+). 
Suspected helicate H20 
1H NMR (601 MHz, Deuterium Oxide) δ 8.56 – 8.49 (m, 24H), 7.77 (d, J = 2.7 Hz, 12H), 7.35 (d, J = 1.9 
Hz, 12H), 6.85 (dd, J = 7.1, 2.7 Hz, 12H), 6.61 (d, J = 7.1 Hz, 12H). 1H DOSY NMR (500 MHz, D2O): D 22 
= 2.84 x 10-6 cm2 s -1 ; calculated hydrodynamic radius = 8.6 Å. 
Ligand exchange reactions 
NMR trial  
C19 (5 mg, 1.759 µM) was dissolved in D2O (1170 µL,) and CD3CN (130 µL) in an NMR tube. A “zero 
time point” 1H NMR was acquired. L20 (9 or 12 equivalents) was added and the mixture was sonicated 
for five minutes. The reaction was sealed and heated at 75 °C and the mixture periodically allowed to 
cool before 1H NMR acquired. 
NMR trial with Co(NO3)2.6H2O 
C19 (5mg, 1.76 µmol) was dissolved in D2O (854 µL) and CH3CN (98 µL) in a NMR tube, L20 (7.2 mg, 
21.2 µmol, 12 equivalents) was added and the mixture sparged with argon. An aqueous solution of 
Co(NO3)2.6H2O (2 mM, 23 µL) was added the mixture sparged again. The reaction was sealed and 
heated at 75 °C and the mixture periodically allowed to cool and 1H NMR acquired. 
After the reaction was finished the reaction mixture was filtered onto celite and the retentate washed 
with water. The filtrate was freeze-dried to give the crude product. This was purified by size exclusion 
chromatography on sephadex LH-20 gel in water under gravity. 1 mL fractions were collected of all 
coloured material and the purity assessed by 1H NMR. Pure C20 fractions were combined and freeze-
dried to yield the product as an orange powder. Yield = 5 mg (71%). 
Preparative scale Ligand exchange 
L20 (28.4 mg, 83.4 µmol) was suspended in a solution of C19 (20.2mg, 7.04 µmol) in degassed 
acetonitrile (9:1, 3.9 mL), an aqueous solution of Co(NO3)2.6(H2O) (2 mM, 141 µL) was added, the 
mixture sparged with N2 and heated at 75 °C in a sealed vial. The mixture was allowed to cool, filtered 
through celite and the retentate washed with water (5 mL). The filtrate was freeze-dried, dissolved in 
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water (2 mL), purified by size exclusion chromatography on sephadex LH-20 gel (see above) and 
freeze-dried to give an orange solid. Yield = 12 mg, 56%). 
1H NMR (600 MHz, D2O) δ 8.55 (d, J = 8.4 Hz, 12H, HD), 7.92 (d, J = 2.7 Hz, 12H, HC), 7.78 (dd, J = 8.3, 
1.8 Hz, 12H, HE), 7.31 (d, J = 1.8 Hz, 12H, HF), 6.99 (d, J = 7.0 Hz, 12H, HA) 6.81 (dd, J = 7.0, 2.7 Hz, 12H, 
HB). 13C NMR (126 MHz, D2O) δ 158.3, 156.4, 153.3, 148.4, 143.1, 137.2, 124.5, 114.6, 111.9, 109.9. 1H 
DOSY NMR (500 MHz, D2O): D 22 = 2.14 x 10-6 cm2 s -1; calculated hydrodynamic radius = 11.5 Å. ESI-




NMR Guest Binding Studies 
Ka for cage and guest combinations determined through 1H NMR titration in unbuffered D2O. A 
solution of compounds cage with a guest compound was titrated into a solution of cage, thereby 
maintaining a constant concentration of cage. With anion guests, addition of more than approximately 
two equivalents led to precipitation, preventing further data acquisition. Where possible, different 
cage peaks were plotted separately before using a global fitting technique. Some peaks omitted due 
to overlap with other peaks. 
Fast exchange determination 
All observable shifts in the 1H NMR spectra had their peak position plotted against concentration of 
guest. A global non-linear curve fitting function was then applied to the combined plots using the 1:1 
binding model given by:  
𝑦 = 𝑦0 + ∆𝑦 
(
 






𝑦0 = 𝑝𝑒𝑎𝑘 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑤𝑖ℎ𝑡 𝑛𝑜 𝑔𝑢𝑒𝑠𝑡 
∆𝑦 = 𝑝𝑒𝑎𝑘 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 100% 𝑏𝑜𝑢𝑛𝑑 
𝑥 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑢𝑒𝑠𝑡 
𝑃 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑎𝑔𝑒 
















NMe4ClO4 in C19 
 
Figure 2.4.1: Fitted curves for change in peak positions for NMe4ClO4 in C19.  
 
Slow exchange determination 
Concentration of guest⊂cage was calculated from 1H NMR integrals and plotted against guest 
concentration. A non-linear curve fitting function was then applied to the plot using the 1:1 binding 
model given by:  
𝑦 =
(𝑥 + 𝑃 + (
1
𝐾𝑎








𝑥 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑢𝑒𝑠𝑡 
𝑦 = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 ℎ𝑜𝑠𝑡 𝑔𝑢𝑒𝑠𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑥 
𝑃 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 ℎ𝑜𝑠𝑡 








K4ReO4 in C19  
 
Figure 2.4.2: Fitted curve for concentration (independent peaks plotted separately) of host+guest 




KReO4 in C20 
 
Figure 2.4.3: Fitted curve for concentration of host+guest complex for K4ReO4 in C20. 
 
  




























MTT Studies  
Benjamin Burke  
HeLa cells were plated onto a 96-well plate in Dulbecco’s Modified Eagle Medium (DMEM) (10% in 
PBS) (100 µL) at approximately 8000 cells/mL. The plate was incubated for 20 h. The DMEM was 
removed and replaced with a solution of the stated compound in DMEM (100 µL); each concentration 
was added to seven wells. The plate was incubated for another 20 h before the removal of DMEM and 
washing of the cells with PBS. A 1.2 mM solution 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2H 
tetrazolium bromide (5 mg) in media/PBS (7/3, 10 mL) was prepared and 100 µL added to each well. 
This was incubated for 3 h, at which point crystals were apparent. A solubilising solution (prepared: 5 
mL Triton-X 100, 45 mL Isopropanol, 1 drop HCl (12M)) (100 µL) was added and the plate shaken on a 
plate shaker overnight to ensure complete dissolution of crystals. UV-visible absorbance 
measurements were carried out at 490 nm. For each concentration of the added compound the 
absorbances were averaged (discarding those more than two standard deviations from the mean). 
The absorbances were then normalised against those of untreated cells.  
 









Pertechnetate Binding Studies, 
Benjamin Burke 
[99mTc]TcO4 ‒ was eluted from a 2.15 GBq Ultra-TechneKow™ DTE 99Mo/99mTc generator (Mallinckrodt, 
UK) in 4 mL 0.9% saline solution. [99mTc]TcO4 ‒ (1 µL, 1 MBq) was then added to C19 or C20 solutions 
(100 µl) and incubated at room temperature for 5 minutes. Pertechnetate encapsulation was assessed 
by silica gel thin layer chromatography, wherein eluting with DI water separates free [99mTc]TcO4‒, 
which runs with the solvent front, while bound [99mTc]TcO4‒ complex remains on the baseline. The 
proportion of bound and free [99mTc]TcO4‒ was determined by cutting the eluted TLCs into 10 mm 
strips and independently analysing using a Wallac 1480 Wizard 3” automatic-gamma-counter (Perkin 
Elmer, USA). All reactions were carried out in DI water. [99mTc][TcO4⊂cage]11+ was spin filtered using a 
10 kDa MWCO centrifuge filter (12,000 g, 5 minutes), during which 79% ± 1.6 of the activity passes 
through the filter. TLC analysis demonstrated [99mTc][TcO4⊂cage]11+ remained >99% stable in the 
filtrate. 
Pertechnetate Binding Controls 
See table 2.2.1 for assembly structures 
 







Deuterated phosphate buffered saline (pH 7.4, 1 M) was prepared using D2O with 1 mM tBuOH as an 
internal standard. 
Stock solutions of cages were prepared to a concentration of approximately 0.3 mM in deuterated 
PBS or D2O (with 1 M tBuOH internal standard). 0.45 mL of these solutions were placed in NMR tubes. 
Solutions of glutathione (25 mM, 10 equivalents) were added to samples and the samples monitored 
by 1H NMR (600 MHz).  
Characterisation of glutathione and glutathione disulphide 
Glutathione 
 
1H NMR (601 MHz, Deuterium Oxide) δ 4.61 (dd, J = 6.8, 5.4 Hz, 1H, HF), 4.01 (s, 2H, HG/H), 3.87 – 3.83 
(m, 1H, HA), 3.02 – 2.95 (m, 2H, H, HI/J), 2.59 (apthept, J = 7.8 Hz, 2H, HD/E), 2.21 (aptq, J = 8.4, 7.8 Hz, 
2H, HB/C). 
1H NMR (601 MHz, Deuterium Oxide 1M PBS) δ 4.62 (d, J = 6.2 Hz, 1H, HF), 3.82 (s, 2H, HG/H), 3.82 (t, J 
= 6.3 Hz, 1H, HA), 3.02 (dd, J = 13.4, 4.7 Hz, 1H, HI/J), 2.98 (dd, J = 14.2, 6.9 Hz, 1H, HI/J), 2.68 – 2.55 (m, 




1H NMR (500 MHz, Deuterium Oxide) δ 4.00 (s, 4H, HG/H), 3.85 (d, J = 6.3 Hz, 2H, HA), 3.32 (dd, J = 14.5, 
4.7 Hz, 2H, HF), 3.02 (dd, J = 14.3, 9.3 Hz, 2H, HI), 2.56 (apthept, J = 7.6 Hz, 4H, HD/E), 2.20 (aptq, J = 7.3 
Hz, 4H, HB/C). HJ covered by water peak 
1H NMR (601 MHz, Deuterium Oxide 1M PBS) δ 3.93 (s, 4H, HG/H), 3.84 (t, J = 6.3 Hz, 2H, HA), 3.34 (dd, 
J = 14.3, 4.6 Hz, 2H, HF), 3.03 (dd, J = 14.3, 9.4 Hz, 2H, HI), 2.65 – 2.52 (m, 4H, HD/E), 2.21 (td, J = 7.7, 6.3 





In vivo Studies 
Benjamin Burke, Christopher Cawthorne 
Mice were injected i.v. with 25-35 MBq of [99mTc]TcO4− and 7-20 MBq of caged (C20) [99mTc]TcO4‒ under 
anaesthesia before being transferred to a temperature-controlled imaging bed and attached to an 
anaesthetic facemask (Minerve, France).  
[99mTc]TcO4‒ SPECT images were acquired at ~40 minutes pi for 30 minutes under anaesthesia, 
[99mTc][TcO4⊂C-2]11+ SPECT images were acquired at 20 minutes pi for 100 min. In both cases SPECT 
was followed by CT scan (240 projections with 1 s exposure to 55 kVp X-rays). SPECT and CT images 
were reconstructed with an iterative algorithm (HiSPECT, Scivis GmbH, Germany) and with exact cone 
beam Filtered Back Projection (VivoQuant, inviCRO LLC, USA), respectively. 
Ex vivo biodistribution  
Benjamin Burke, Christopher Cawthorne 
Naïve female CD1-IGS mice (30-50 g) were obtained from Charles River. Animals were injected 
intravenously with 6-8 MBq of radiotracer and euthanised 2 h post-injection. Blood, liver, stomach and 
other selected organs were harvested and the radioactivity present measure by an Automated 
Gamma Counter. The biodistribution was then performed as describe above. All values were 
normalised and are quoted as percent injected dose per gram of tissue (%ID/g). 
Liver samples were analysed to investigate the identity of technetium-99m. Liver samples (ca. 200 mg) 
from three animals were extracted with water (200 µL) for five minutes an ultrasonic bath followed 
by centrifugation at 12,000 g for five minutes. TLC analysis of the supernatant showed 29.7% ± 2.4 of 
the radioactivity remained on the baseline in a manner consistent with [99mTc][TcO4⊂C20]11+ and the 
remaining radioactivity was present at the solvent front, consistent with free TcO4-.  
Extraction of the silica plate by ultrasonication in acetonitrile (200 µL) followed by centrifugation at 












1 V. Martí-Centelles, A. L. Lawrence and P. J. Lusby, J. Am. Chem. Soc., 2018, 140, 2862–2868. 
2 C. T. Mcternan, T. K. Ronson and J. R. Nitschke, J. Am. Chem. Soc., 2019, 141, 6837–6842. 
3 M. J. Burke, G. S. Nichol and P. J. Lusby, J. Am. Chem. Soc., 2016, 138, 9308–9315. 
4 W. Cullen, A. J. Metherell, A. B. Wragg, C. G. P. Taylor, N. H. Williams and M. D. Ward, J. Am. 
Chem. Soc., 2018, 140, 2821–2828. 
5 J. L. Bolliger, T. K. Ronson, M. Ogawa and J. R. Nitschke, J. Am. Chem. Soc., 2014, 136, 14545–
14553. 
6 M. Whitehead, S. Turega, A. Stephenson, C. A. Hunter and M. D. Ward, Chem. Sci., 2013, 4, 
2744-2751. 
7 N. Busschaert, C. Caltagirone, W. Van Rossom and P. A. Gale, Chem. Rev., 2015, 115, 8038–
8155. 
8 C. R. K. Glasson, G. V. Meehan, J. K. Clegg, L. F. Lindoy, P. Turner, M. B. Duriska and R. Willis, 
Chem. Commun., 2008, 1190–1192. 
9 C. R. K. Glasson, J. K. Clegg, J. C. McMurtrie, G. V. Meehan, L. F. Lindoy, C. A. Motti, B. 
Moubaraki, K. S. Murray and J. D. Cashion, Chem. Sci., 2011, 2, 540–543. 
10 A. J. Metherell, W. Cullen, N. H. Williams and M. D. Ward, Chem. Eur. J., 2018, 24, 1554–1560. 
11 D. Zhang, T. K. Ronson, J. Mosquera, A. Martinez, L. Guy and J. R. Nitschke, J. Am. Chem. Soc., 
2017, 139, 6574–6577. 
12 N. R. Voss and M. Gerstein, Nucleic Acids Res., 2010, 38, 555–562. 
13 H. Jiang and T. R. DeGrado, Theranostics, 2018, 8, 3918–3931. 
14 H. Jiang, A. Bansal, R. Goyal, K.-W. Peng, S. J. Russell and T. R. DeGrado, Bioorg. Med. Chem., 
2018, 26, 225–231. 
15 A. Boschi, L. Uccelli, M. Pasquali, A. Duatti, A. Taibi, G. Pupillo and J. Esposito, J. Chem., 2014, 
2014, 1–14. 
16 E. A. Katayev, G. V. Kolesnikov and J. L. Sessler, Chem. Soc. Rev., 2009, 38, 1572–1586. 
17 H. Stephan, R. Berger, H. Spies, B. Johannsen and F. P. Schmidtchen, J. Radioanal. Nucl. Chem., 
1999, 242, 399–403. 
18 S. Jürgens, W. A. Herrmann and F. E. Kühn, J. Organomet. Chem., 2014, 751, 83–89. 
19 S. Vallabhajosula, R. Zimmerman, M. Picard, P. Stritzke, I. Mena, R. S Hellman, R. S Tikofsky, M. 
G Stabin, R. A Morgan and S. Goldsmith, J. Nucl. Med., 1989, 30, 599–604. 
20 S. M. McNeill, D. Preston, J. E. M. Lewis, A. Robert, K. Knerr-Rupp, D. O. Graham, J. R. Wright, 
G. I. Giles and J. D. Crowley, Dalton Trans., 2015, 44, 11129–11136. 
21 A. Meister and M. E. Anderson, Annu. Rev. Biochem., 1983, 52, 711–760. 
22 A. Ahmedova, R. Mihaylova, D. Momekova, P. Shestakova, S. Stoykova, J. Zaharieva, M. 
Yamashina, G. Momekov, M. Akita and M. Yoshizawa, Dalton Trans., 2016, 45, 13214–13221. 
95 
 
23 L. E. H. Paul, B. Therrien and J. Furrer, Inorg. Chem., 2012, 51, 1057–1067. 
24 S. Nayak, K. V. Reddy and A. C. Dash, Transit. Met. Chem., 2014, 39, 177–187. 
25 A. A. Campanali, T. D. Kwiecien, L. Hryhorczuk and J. J. Kodanko, Inorg. Chem., 2010, 49, 4759–
4761. 
26 D. R. Frasca and M. J. Clarke, J. Am. Chem. Soc., 1999, 121, 8523–8532. 
27 A. Schmidt, M. Hollering, M. Drees, A. Casini and F. E. Kühn, Dalton Trans., 2016, 45, 8556–
8565. 
28 D. Preston, S. M. McNeill, J. E. M. Lewis, G. I. Giles and J. D. Crowley, Dalton Trans., 2016, 45, 
8050–8060. 
29 Y. A. Getmanenko and R. J. Twieg, J. Org. Chem., 2008, 73, 830–839. 
30 G. I. Pascu, A. C. G. Hotze, C. Sanchez-Cano, B. M. Kariuki and M. J. Hannon, Angew. Chem. Int. 
Ed., 2007, 46, 4374–4378. 
31 C. R. K. Glasson, G. V. Meehan, C. A. Motti, J. K. Clegg, P. Turner, P. Jensen and L. F. Lindoy, 
Dalton Trans., 2011, 40, 10481–10490. 
32 R. L. Paul, Z. R. Bell, J. C. Jeffery, J. A. McCleverty and M. D. Ward, Proc. Natl. Acad. Sci. U. S. A., 
2002, 99, 4883–4888. 
33 D. P. August, G. S. Nichol and P. J. Lusby, Angew. Chem. Int. Ed., 2016, 55, 15022–15026. 
34 J. J. Henkelis, J. Fisher, S. L. Warriner and M. J. Hardie, Chem. Eur. J., 2014, 20, 4117–4125. 
35 A. G. L. Olive, K. Parkan, C. Givelet and J. Michl, J. Am. Chem. Soc., 2011, 133, 20108–20111. 
36 J. Chen, M. Kuss-Petermann and O. S. Wenger, Chem. Eur. J., 2014, 20, 4098–4104. 
37 J. M. Cross, N. Gallagher, J. H. Gill, M. Jain, A. W. McNeillis, K. L. Rockley, F. H. Tscherny, N. J. 
Wirszycz, D. S. Yufit and J. W. Walton, Dalton Trans., 2016, 45, 12807–12813. 










Chapter 3: Functionalisation and 





New detection methods for different disease states remain an ongoing endeavour. Having shown that 
the host-guest complexes of a robust Co4L612+ cage can be utilised for in vivo imaging, our attention 
turned to biological targeting through derivatisation of the cage exterior.   
The behaviour of synthetic cages in vivo has had limited exploration, and their pharmacokinetics are 
likely to be dominated by high charge.1 Our experiments have indicated that the C20 macro-cation is 
taken up by the liver, potentially due to binding by albumin and macrophages.2,3 Control of cage 
pharmacokinetics, and overcoming the inherent biological fate of the “naked” cage structure would 
promote a far greater scope of biomedical applications. 
There are several strategies for derivatisation of the cage periphery. Theoretically, the conjugation 
could be carried out before or after assembly, both approaches possessing advantages and challenges. 
Post-assembly modification requires that a functionalisation handle be incorporated into the ligand, 
so that the assembled cage can be readily modified. This approach requires careful consideration of 
chemoselectivity: the cage assembly procedure must be tolerant of the chemical handle and vice 
versa. Furthermore, the post-assembly modification of the cage must occur without degradation of 
the cage and the bio-conjugation must not be hindered by the macromolecular structure. In contrast, 
pre-assembly functionalisation has the advantage that the cage is not required to be stable to any 
conjugation reaction conditions. However, pre-functionalised ligands must assemble into the desired 
assembly despite additional chemical groups, which may pose chemical or steric barriers.   
Both approaches can be effective, and both have been explored. The Lusby group have previously 
encountered issues with the pre-assembly functionalisation method, wherein it was found that a 
ligand containing an iridium complex could not be used to form a tetrahedron. In contrast, the Lusby 
group previously developed a ligand precursor (N9, Scheme 3.1.1) with intrinsic functionalisation 
handles to allow customisation using copper catalysed azide-alkyne Huisgen cycloaddition (CuAAC) 
reactions, which allow different constituents (N11 and N12) to be externally affixed (Scheme 3.1.1). 
This method further utilised the triazole group as a coordinating alternative to bipyridine, facilitating 
the ready inclusion of a polyethylene glycol group into the ligand to improve aqueous solubility.4 The 
triazole-pyridine chelating moiety, however, were found to be poorly suited to in vivo environments 




Figure 3.1.1: Simultaneous “click” synthesis and functionalisation of triazole ligands L14 and L24 from 
ligand precursor N9. 
A similar approach was taken by Crowley and co-workers, who developed a ligand with a pendant 
azide (L25a) to allow facile functionalisation of their ditopic ligands through CuAAC reactions with 
fluorescent, redox active and biologically relevant groups (L25b-j, Fig. 3.1.2).5 All of these ligands were 
successfully assembled into Pd2L4 lantern capsules, though protecting groups were required for the 








































Casini and co-workers took an alternative route in conjugating proteins to similar Pd2L4 systems. They 
successfully synthesised a number of cages with four pendant proteins using an amide coupling 
reaction. Interestingly, attempts at post-assembly conjugation of the proteins onto the assembled 
cages resulted in poor yields, variable numbers of couplings, and side reactions.6  
While these two groups found success in pre-assembly conjugation, it should be noted that Pd2L4 are 
well suited to the approach and are widely studied due to their relative synthetic accessibility. The 
cages form readily when the components are mixed in appropriate solvents with limited potential 
side-products. The assemblies are also conveniently shaped with little ligand overlap, causing 
conjugated groups to point away from each other to avoid steric clash. In comparison, tetrahedral 
systems are more complex structures with more entwined ligands. They also sometimes require 
multiple steps in the assembly process further complicating “chemical orthogonality”.  
An example of pre-assembly ligand conjugation was reported by Fujita and co-workers, who showed 
that a Pd12L24 macroscopic cage could be assembled around a ubiquitin protein covalently affixed to a 
single ligand of the assembly (L26b, Fig. 3.1.3). This attachment was achieved by reacting a cysteine 
residue from the protein to L26b using a maleimide Michael “click” reaction. Mixing the correct ratio 
of L26a and L26b with palladium salts in a water-acetonitrile mixture gave the desired cage-protein 
complex C26c. While a remarkable achievement, conjugation of a cage interior is significantly different 
to the exterior, due to templating effects and the blocking of the cavity.7  
 
Figure 3.1.3: Fujita and co-workers pre-functionalised the ligand L26b with ubiquitin, such that when 
combined in a 1:23 ratio with the unfunctionalised ligand L26a and a palladium salt, they assembled 
to give Pd12L24 C26c. Figure adapted from reference 7.  
Post-assembly conjugation has also been reported in the literature.8 These reactions have largely been 
carried out using “click” reactions exploiting highly tolerant functional groups and mild reaction 
conditions. The very popular “click” reaction, CuAAC, has had some success. For example, Zhao and 
co-workers were able to able conjugate a number of polyethylene glycol groups to their copper (II) 










utilised copper (I) catalysts rather than exposing their system to the reducing agents required for the 
more common copper salts.9  
 
Figure 3.1.4: CuAAC was used to attach solubilising and stabilising polyethylene glycol groups to 
alkyne-functionalised copper (II) cuboctahedra C27a to give water soluble C27b. Figure adapted from 
reference 9. 
Many groups have also found ways to avoid the use of redox active copper catalysts, which can prove 
incompatible with many coordination assemblies. One method of avoiding copper is to use electron 
deficient alkynes that are able to undergo cycloaddition without the need for a catalyst (Fig. 3.1.5a).10 
This allowed for the effective “click” functionalisation of a copper paddlewheel structure (M27a), 
though a zinc analogue (M28a) was still incompatible with these mild conditions (Fig. 3.1.5b).11,12 
Strain-promoted alkyne-azide cycloadditions have also been used by Stang and co-workers to attach 








Figure 3.1.5: Copper free post-assembly azide-alkyne cyclo additions. (a) Successful “click” reaction of 
copper paddlewheel (M27a) with electron deficient alkyne (b) Unsuccessful “click” reaction of zinc 
metallocycle (M28a) with electron deficient alkyne, (c) Strain promoted “click” reaction of platinum 
metallocycle (M29a). 
The popularity of the alkyne-azide cycloaddition as a means of post-assembly modification is due to 
the low polarity of these functional groups, which prevents unwanted side reactions. However, Stang 
and co-workers have reported nucleophilic conjugation reactions that possess ligand based amine 
nucleophiles (C30a) and maleimide electrophiles (C30a), which could be expected to disrupt many 
coordination assemblies (Fig. 3.1.6).15 The success of this bio-conjugation reaction to give C30c,d,e was 





















Figure 3.1.6: Post-assembly modification of amine (C30a) and maleimide (C30b) appended hexagonal 
prisms. Figure adapted from reference 15. 
In a similar manner, Nitschke and co-workers were able to acetylate primary amines present in a meta-
stable iron helicate H31a using reactive anhydrides and carboxylic acids activated with HATU to 
funtionalised the helicate with range of groups (H31b,c,d,e, Fig. 3.1.7).16  
  
Figure 3.1.7: Post-assembly covalent functionalisation iron helicate H31a through acylation. (b) R2 = 2-
pyridine, (c) R2 = 3-pyridine, (d) R2 = 4-pyridine, (e) R2 = 4-pyridylphenyl. Figure adapted from reference 
16.  
In summary, the literature shows that that there are several possible approaches for the conjugation 
of metallosupramolecular capsules. The key is finding suitable key intermediates, either pre-
functionalised ligands or a cage, which can allow access to a library of conjugated targets such as 






















complexity of our cage assembly reaction, point to post-assembly modification being desirable. 
However, pre-functionalisation is a valid alternative that could be explored from similar building 
blocks. The key is therefore to identify “click” functionalisation handles that will display the necessary 
chemical orthogonality to ensure compatibility with our system. This chapter will describe the 
synthesis of ligand and cage precursors with functionalisation handles appropriate for either pre- or 
post-assembly modification. 
 








3.2 Results and Discussion 
3.2.1 Direct Functionalisation of L20 
The external amines of L20 might appear to be ideal groups from which to functionalise C20. Primary 
amines can undergo a plethora of high-yielding organic reactions. Unfortunately, the strong electron 
withdrawing properties of the pyridine ring means that the amine groups of L20 are poor nucleophiles, 
especially after coordination to metal centres. While this makes post-assembly reactions of these 
amines highly unlikely, it was suggested that the amine groups could be functionalised pre-assembly 
to improve the properties of the ligands and/or to install other functional groups for post-assembly 
modification. In short, the incorporation of a spacer between the pyridine amine and some 
functionalisable group were thought to represent the most obvious chance of success. 
Alkynes and esters were identified as suitable groups for this purpose, the former using CuAAC “click” 
chemistry and the latter using classic carbonyl chemistry. Trial reactions of N6 (see Chapter 2) with 
propargyl bromide were unsuccessful in making N13 but treatment with ethylbromoacetate afforded 
product (N14, Scheme 3.2.1). However, the direct reaction with the full L20 ligand was found to not 
progress to L32, potentially due to the lower solubility of L20 (Scheme 3.2.2).  
 
Scheme 3.2.1: Trialled nucleophilic reactions of N6 with alkyne and ester containing compounds. 
Dimethylacetamide was adopted as the solvent, and sodium carbonate, sodium hydroxide or Et3N 
were trialled as bases. However, in all instances the reactions were found to be slow and very poor 







Scheme 3.2.2: Unsuccessful reaction of L20 with ethyl bromoacetate. Base = Et3N, K2CO3 or KOH. 
Solvent = THF and/or dimethylacetamide. 
It was also suggested that the electron deficient amine, while a poor nucleophile, could instead be 
exploited as a pro-nucleophile activated by deprotonation. To explore this strategy, the electron 
withdrawing o-Nitrobenzenesulfony (Nosyl) group was identified as an activating moiety to increase 
pro-nucleophile acidity. This group could then be easily cleaved by reaction with soft nucleophiles via 
a Meisenheimer complex.17 
Reaction of N6 with o-nitrobenzenesulfonyl chloride led to the precipitation of a crystalline solid. 
However, the characterised solid was not consistent with the desired product N15, and N6 was 
recovered when it was exposed to base, implying the reaction had yielded a salt (Scheme 3.2.3). 
Repeating the experiment using multiple solvents and bases yielded the same result and this approach 
was abandoned. The tert-Butyloxycarbonyl groups reported in the previous chapter could be a valid 
pro-nucleophile alternative; however, time constraints hindered further exploration. 
 
Scheme 3.2.3: Unsuccessful reaction of N6 with nosyl chloride. Base = K2CO3 and Et3N. Solvent = THF, 
toluene, CHCl3 and/or DMF. 
3.2.2 Development of Ligand Precursor 
As the direct functionalisation of the pendent amine proved challenging, it was proposed that 






3.2.3 Nucleophilic functionalisation 
Literature reports of amines substituting the nitro groups by SNAr are common. Unfortunately, many 
of these reactions require high temperatures that are not always compatible with the reactants.18 As 
N5 was a key intermediate in the synthesis of L20, this compound was reacted with several different 
amines under a range of conditions (Scheme 3.2.4). In almost all instances, significant decomposition 
was observed. Even when products were detected, purification issues were encountered due to the 
presence of high boiling point amines and the products being too polar for silica gel chromatography. 
 
Scheme 3.2.4: Failed SNAr substitutions of N5. Solvent = none, toluene, THF and/or CH3CN. Amine = 
diethanolamine, ethanolamine. 
3.2.4 Sandmeyer reaction of L20 
After encountering issues with the nucleophilic substitution of the nitro groups, another ligand 
functionalisation route was sought. A Sandmeyer reaction of L20 would allow the substitution of the 
amine groups with chlorines or other halogens, opening up a range of different derivatisation 
reactions. Due to the poor solubility of L20 and concerns over diazonium salts, a procedure utilising 
concentrated hydrochloric acid as both the solvent and source of chloride nucleophiles was selected 
and was found to give L33 in good yield, as shown in Scheme 3.2.5. 
 
Scheme 3.2.5: Sandmeyer reaction of L20 to give L33. 
L33 could be considered a ligand in its own right, it is also a precursor that can be functionalised by a 
number of routes. While not synthetically trivial (requiring five synthetic steps from commercial 
materials), it does have the properties of a versatile ligand precursor. Furthermore, the compound 





groups for SNAr reactions with either alcohol or amine nucleophiles and could also be used in 
palladium cross-coupling transformations, such as the Buchwald-Hartwig reaction.  
SNAr reactions were initially considered as a simple means to substitute L33. However, these reactions 
gave similarly poor results to that observed with N5, leading to slow reaction times and decomposition 
of the starting material. The reaction was attempted with the corresponding lithium salt, by initially 
treating a protected propargylamine with nBuLi, before reaction with L33. This reaction yielded only 
starting material and the reason for this lack of reaction could not be determined. 
 
Scheme 3.2.6: Failed reaction of L33 with lithium amide of 3.12. 
There are reports of Lewis acid catalysts being used to activate chloro-pyridine rings to nucleophilic 
attack by amines, which could be an effective means of allowing substitution of the ligand.19 It was 
proposed that assembly of L33 to give a cobalt (III) tetrahedra might activate the chlorine groups in a 
similar manner. Unfortunately, exposing the ligand to standard cage formation conditions was 
completely ineffective (Scheme 3.2.7). The ligand remained completely undissolved under the 
standard reaction conditions. This may be caused by both the reduced aqueous solubility of the less 
polar ligand and the reduced strength of the interaction with the metal. 
 
Scheme 3.2.7: Failed cage assembly with L33. 
N16 L34 L33 
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3.2.5 Buchwald-Hartwig coupling of L33 
Buchwald-Hartwig reactions were trialled as an alternative to the problematic SNAr functionalisation 
of the ligand. These Pd cross-coupling reactions have been shown to be an effective means of coupling 
amines to aryl halides.20 Conditions adapted from a literature procedure were successful in coupling 
the protected propargylamine with L33 to give L34 in a reasonable yield of 58%.21 Deprotection of L34 
could be achieved with tetrabutyl ammonium fluoride to give the desired terminal alkyne ligand, L35 
(Scheme 3.2.8). This ligand is suitable for CuAAc “click” conjugation, which could allow the conjugation 
with many azide-containing biological compound groups under very mild conditions.  
 
Scheme 3.2.8: Successful synthesis of L35. 
3.2.6 “Click” Reactions 
Polyethylene glycol (PEG) chains were identified as a group which could be conjugated to the ligand 
in order to modify the properties of the ligand and cage. They were also considered of interest as they 
could “mask” the cationic structure and thereby alter the biological behaviour of the cage.9 Initial 
attempts at “click” conjugation with a PEG azide (N11, Fig.3.2.9), previously prepared by Dr Michael 
Burke, using standard copper (II) salts and ascorbic acid as a reducing agent, were met with limited 
success.22 Challenges in the isolation of the product were encountered wherein the increased aqueous 
solubility of the product made demetallation and recovery difficult. To avoid this issue, a copper on 
carbon catalyst was used to prevent copper leaching.4 While this was more successful, the product 
could still only be isolated in very low yield. Despite initial challenges, optimisation of the reaction and 
workup conditions could provide a universal method of ligand conjugation.  




Scheme 3.2.9: Partially successful CuAAC conjugation of L35 with PEG azide N17. 
3.2.7 Maleimide Reactions 
The Buchwald-Hartwig reaction itself represents a branching point for functionalisation of the ligand. 
Theoretically, this reaction would allow the coupling of a large range of amines directly onto the ligand, 
including other “click” handles. One group identified as a promising alternative were maleimides. 
These undergo Michael-“click” reactions with thiols under very mild aqueous conditions as 
demonstrated by Fujita and co-workers.23 Therefore, the protected amine maleimide precursor N11 
was synthesised according to a literature procedure and the coupling reaction with L33 was attempted 
(Scheme 3.2.10).24 Unfortunately, the compound was found to be incompatible with the reaction 
conditions, which resulted in the retro-Diels-Alder reaction, thereby removing the furan protecting 
group and the polymerisation of the unprotected maleimide.25 




Scheme 3.2.10: Failed Buchwald-Hartwig coupling of L33 and N18. 
Alternative conditions could be used for the coupling which may not remove the protecting group.26 
Alternatively, a range of different groups could be introduced including other “click” handles such as 
carboxylic acids or cyclooctynes.  
3.2.8 SNAr Derived Ether Functionalised Ligands 
While functionalisation of the ligand with an amine proved successful at stabilising the cages in vivo, 
it did lead to some synthetic challenges. Therefore, other electron donating groups that could imbue 
favourable cage-stability properties whilst providing a chemical ligation handle were considered. As 
such, methyl ether groups were identified as stable, strongly electron donating groups which might 
be suitable for cage functionalisation (Fig. 3.2.1). Methyl ether groups have a Hammett constant of -
0.37, in comparison to the -0.66 amine groups and it was hoped that this intermediate electron 
donation would allow straightforward cage synthesis, while imparting some measure of biological 
stability.  
 






In contrast to the SNAr reactions with amine and lithium amide nucleophiles, the nitro-containing 
intermediates N5 and N7 underwent ready substitution with methoxide, giving compounds N19 and 
N20 in excellent yield (Scheme 3.2.11).27 
 
Scheme 3.2.11: Synthesis of methyl ether ligand precursors N19 and N20. 
Compound N20 was then taken forward to homo-coupling procedures, using both nickel and Stille 
conditions, but neither reaction was successful (Scheme 3.2.12). Therefore, the reaction was repeated 
with N19, which successfully gave the quarter-pyridine ligand precursor N21 in a reasonable yield of 
66% (Scheme 3.2.13). With this in hand, only a reduction of the N-oxide was required to access L38. 
 
Scheme 3.2.12: Failed homocoupling reactions of N20 to give L38. 
 
Scheme 3.2.13: Successful Stille homocoupling of N19. 
3.2.9 Reduction of N-oxides 
While N-oxides can aid the synthesis of pyridine species, their installation and removal represent 
additional synthetic steps which can prove non-trivial. A range of conditions have been reported for 









Previously, N5 had been refluxed in acetic acid with iron (0) in order to simultaneously reduce the 
nitro group and N-oxide group. While effective, these conditions require tricky workups in order to 
remove iron salts from the multidentate ligating product. The conditions were found to be effective 
for the reduction of N19 (Scheme 3.2.14), but it was suggested that identification of milder conditions 
would be advantageous.    
 
Scheme 3.2.14: Successful methods of N-oxide reduction in N19.  
Triphenyl phosphine is a common, mild, reducing agent for N-oxides, with the strength of the formed 
O=P bond the driving force of the reaction. However, the triphenylphosphine oxide byproduct can be 
non-trivial to separate from polar products. Additionally, 4-nitro-pyridine has been noted to be a 
particularly challenging substrate for reduction.29 Experimentation on an NMR scale showed that 
triphenyl phosphine reacts with N5 very slowly, taking over a week to fully consume the starting 
material and appearing to lead to partial decomposition. 
Another set of mild conditions were found that utilise bis(pinacolato)diboron (BPin), with the boron 
atom’s affinity for oxygen driving the reaction. The reaction required only mild conditions and 
produced easily separable byproducts.30 These conditions were then used to reduce N21 to give L38, 
though with a relatively low yield of 54% (Scheme 3.2.15). This was unexpected given the mild nature 
of the reaction and was judged likely be due to the small scale of the reaction, with the hope that 
repetition of the reaction on a larger scale would give better results. 
  





3.2.10 Synthesis of Methylether Functionalised Tetrahedron 
With L38 now synthesised, the formation of its respective tetrahedron was attempted. It was hoped 
that the lower σ-donor strength in comparison to L20 would allow the formation of the 
Co4(L38)6(NO3)12 (C38) quantitatively without kinetic byproducts. 
Unfortunately, the use of standard tetrahedron formation conditions (i.e. direct reaction of ligand with 
Co(NO3)2.6H2O followed by oxidation with cerium ammonium nitrate (see Chapter 2) failed to give 
pure tetrahedron (Scheme 3.2.16). As Figure 3.2.2 shows, a high symmetry species that likely 
corresponded to C38 was present in the crude 1H NMR spectrum along with a broad baseline peak 
indicative of polymeric material. Additionally, a large amount of insoluble material was obtained that 
could not be re-dissolved in water, presenting further evidence that large amounts of polymeric or 
oligomeric material was being produced in the reaction. 
 





Figure 3.2.2: Partial 1H NMR (600 MHz, D2O) of crude product of attempted direct Co4(L38)6(NO3)12 
formation. 
Size exclusion chromatography allowed a very small amount of cage to be isolated (yield = 6%), proving 
the presence of the tetrahedron (Fig. 3.2.3). Due to limited material, the properties of this new cage 
could not be investigated in depth but it was possible to demonstrate that the cage was able to bind 




Figure 3.2.3: Partial 1H NMR (600 MHz, D2O) of Co4(L38)6(NO3)12 synthesised by direct cage formation. 
In light of the ligand encountering similar cage formation challenges as L20, synthesis by ligand 
exchange was attempted, with an excess of the ligand added to a solution of C19 in a water-




Figure 3.2.4: Partial 1H NMR (600 MHz, 9:1 D2O/CD3CN) of ligand exchange of L38 into C19. (a) C19, 
(b) After addition of L38, sampled then heated at 75 °C for (c) 1 hour, (d) 1 day, (e) 4 days, (f) 12 days, 
(g) 13 days, (h) 15 days. C19 peaks highlighted in blue. C38 highlighted in red. 
This ligand exchange appeared successful, with peaks consistent with C38 becoming dominant after 
12 days at 75 °C (Fig. 3.2.5). As could be expected, the intermediate stages of the ligand exchange 
showed very broad signals, likely caused by the solid in solution leading to poor shimming. The greater 
solubility of L38 allowed the easy workup of the reaction by extraction of the excess ligands with 
chloroform. The resulting solution also appears to contain several other well-defined species with 
apparent high symmetry, implying that they are heteroleptic species. Unfortunately, time constraints 
did not allow the confirmation of the nature of these species or attempts at their separation, but 












Figure 3.2.5 Partial 1H NMR (600 MHz, D2O): Unpurified Co4(L38)6(NO3)12 and heteroleptic impurities.   
 The properties of C38 in comparison to both C19 and C20 would be of great interest. The stability 
offered by the ether groups should be assessed in order to ascertain whether the functionalisation 
imparts the necessary stability for biological applications. This could be assessed through both 
[99mTc]TcO4- binding studies and glutathione assays as with the previous systems. The development of 
a second isostructural ligand to L19 presents the possibility of a greater exploration of ligand exchange 
reactions, as the hypothesised intermediate ligation strength of L38 may provide information on the 
kinetic and thermodynamic details of the reaction.  
The success of the methyl ether functionalised ligand suggests that the use of alkoxide nucleophiles 
could be a promising means of functionalising ligands with a variety of other groups. These groups 
could be reacted with N19 in a parallel synthesis to L38. However, reaction with L33 may be more 
lucrative, allowing the direct synthesis of functionalised ligands without the need for further 
homocoupling and reduction.  
3.2.11 Ligand Exchange using Functionalised Ligands  
The ligand exchange reaction described in Chapter 2 is a promising means of post-assembly 
modification, which may allow the substitution of conjugated ligands into cages without the need for 
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additional reagents. Theoretically, this exchange could be made either partial or complete, by using 
different stoichiometries. 
Full exchange would be more effective for groups which seek to change the general properties of the 
cage, while partial exchange would be more desirable for conjugation to a single targeting group. 
Intermediate exchange could be useful for accessing polyvalent targeting, e.g. protein-protein 
interactions. Therefore, developing a synthetic procedure for either Co4(L35)6(NO3)12 or 
Co4(L20)5(L35)1(NO3)12 would be a proof of concept for general cage functionalisation. The cages could 
theoretically be formed in different manners: the homoleptic cage is most logically synthesised by 
substitution of L35 into Co4(L19)6(NO3)12 in exactly the same manner as Co4(L20)6(NO3)12. However, 
Co4(L20)5(L35)1(NO3)12 would theoretically be best synthesised by starting with Co4(L20)6(NO3)12 and 
substituting with L35. Substitution into Co4(L20)6(NO3)12 should be feasible as the previous ligand 
exchange experiments with Co4(L19)6(NO3)12 and L20 appeared to be under thermodynamic control. 
Therefore, addition of an appropriate amount of L35 added to an exchange reaction should lead to 
the system being driven to a majority of Co4(L20)5(L35)1(NO3)12. 
An initial experiment appeared to show evidence of the exchange occurring by 1H NMR; however, the 
significant loss of symmetry of caused by the substitution of single ligand makes NMR analysis a limited 
means of monitoring the reaction. Unfortunately, time constraints precluded the use of other 





A means of generating functionalised variants of the L20 was explored. Direct functionalisation of the 
amine groups was found to be ineffective due to their extremely electron poor nature. Substitution of 
nitro groups by different amines using SNAr chemistry also proved ineffective. Instead, L20 was utilised 
as a precursor itself and substituted to give the chlorine functionalised L33. This ligand successfully 
underwent Buchwald-Hartwig coupling to yield a ligand with pendant propargyl amine suitable for 
CuAAC reactions. Furthermore, it was shown that this ligand could be “clicked” with a PEG chain using 
a heterogenous Cu-C catalyst.  
A ligand functionalised with methyl ether groups in the place of amines (L38) was also successfully 
synthesised using a combination of SNAr and Stille reactions. The tetrahedron was synthesised in poor 
yield due to similar kinetic trapping of byproducts as observed in C20. 
While many of the synthetic routes reported in this chapter have proved problematic, they will 
nonetheless allow the continuation of the project in multiple possible directions. Whether 
Co4(L38)6(NO3)12 shares the robustness of C20 will be of interest to inform us as to whether it is a viable 






As described in Chapter 2. 
Abbreviations used in this text:  
DMSO   Dimethylsulfoxide  
DMF                    N,N-dimethylformamide 
THF   Tetrahydrofuran  
DCM   Dichloromethane 
NMR   Nuclear Magnetic Resonance  
DOSY   Diffusion ordered spectroscopy  
RT   Room temperature  
EDTA                   Ethylenediaminetetraacetic acid 
Na4EDTA  Ethylenediaminetetraacetic acid tetrasodium salt  
MS   Mass Spectrometry 
DCE  Dichloroethane 
BPin  Bis(pinacolato) diboron 
BINAP  2,2′-Bis(diphenylphosphino)-1,1′-binaphthyl 
DBA  Dibenzylideneacetone 
Direct functionalisation of L20 
Ethylbromoacetate 
 
N6 (106.4 mg, 0.424 mmol), Et3N (30 µL, 21.7 mg, 0.214 mmol), ethylbromoacetate (110 µL, 165.6 mg, 
0.992 mmol) were dissolved in THF (10 mL) and stirred under N2 for 72 h. The solvent was removed in 
vacuo and the crude product was crystallised from hot acetonitrile to give product as colourless 
crystalline material. Yield = 27 mg (19 %). 
1H NMR (500 MHz, DMSO-d6) δ 8.85 (d, J = 2.4 Hz, 1H, HF), 8.40 (dd, J = 8.3, 2.4 Hz, 1H, HE), 8.26 (d, J = 
7.3 Hz, 1H, HA), 7.80 (d, J = 8.3 Hz, 1H, HD), 7.01 (d, J = 2.7 Hz, 1H, HC), 6.98 (dd, J = 7.3, 2.7 Hz, 1H, HB), 
5.07 (s, 2H, HH), 4.16 (q, J = 7.1 Hz, 2H, HI), 1.18 (t, J = 7.1 Hz, 3H, HJ). 
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Synthesis and reactions of L33  
L33 
 
Finely ground L20 (504.8 mg, 1.48 mmol) was added to hydrochloric acid (40% in water, 20 mL) and 
sonicated for 15 minutes. Additional hydrochloric acid (580 mL) was added and the mixture stirred 
vigorously for 30 minutes under gentle warming (beware corrosive gas evolution) and then sonicated 
for a further five minutes to attain complete dissolution. The mixture was cooled to 0 °C and a solution 
of sodium nitrite (1.0 mg, 0.02 mmol, 15 mL) was added dropwise resulting in a yellow solution. The 
reaction was stirred at 0 °C for 6 h then at room temperature for 24 h. Hydrochloric acid (20%, 100 
mL) was added to dissolve the colourless precipitate. NaOH solution (240 g, 1 L) was added slowly, 
while the temperature was maintained below 20 °C. Then solid sodium carbonate was added until the 
pH = 8 and the mixture was extracted with CHCl3 (3 × 400 mL). The combined organic phases were 
dried over MgSO4 and the solvent removed in vacuo to give the product as a pale-yellow powder. Yield 
= 436 mg (78%). 
1H NMR (400 MHz, Chloroform-d) δ 8.99 (dd, J = 2.4, 0.8 Hz, 1H, HF), 8.61 (dd, J = 5.3, 0.7 Hz, 1H, HA), 
8.55 (dd, J = 8.3, 0.8 Hz, 1H, HD), 8.53 (dd, J = 2.1, 0.6 Hz, 1H, HC), 8.11 (dd, J = 8.3, 2.4 Hz, 1H, HE), 7.36 
(dd, J = 5.3, 2.1 Hz, 1H, HB).13C NMR (126 MHz, Chloroform-d) δ 157.2, 154.8, 150.3, 147.7, 145.5, 
135.5, 133.7, 124.3, 121.8, 121.7. HR-ESI-MS: m/z 379.0473 (predicted [M+H]+ = 379.0512) 
Protected propargyl amine N16 synthesis 
 
 




Buchwald-Hartwig coupling of L33 
 
L33 (146.9 mg, 0.39 mmol), tBuONa (112.8 mg, 1.17 mmol), BINAP (435.0 mg, 0.70 mmol) and 
Pd2(DBA)3 (31.9 mg, 0.035) were suspended in toluene (20 mL) in a sealed vial under N2. N16 (0.4 mL, 
0.86 g mL-1, 0.47 mmol) was added via syringe and the mixture was heated at 100 °C for 48 h. The 
mixture was diluted with water (100 mL) and extracted with chloroform (3 × 200 mL). The organic 
phases were combined and dried over MgSO4. The solvent was removed in vacuo and the crude 
product was crystallised from hot acetonitrile. Yield = 163 mg (58%). 
1H NMR (601 MHz, Chloroform-d) δ 8.94 (d, J = 2.4 Hz, 2H, HF), 8.51 (d, J = 8.2 Hz, 2H, HD), 8.37 (d, J = 
5.6 Hz, 2H, HA), 8.06 (dd, J = 8.2, 2.4 Hz, 2H, HE), 7.77 (d, J = 2.5 Hz, 2H, HC), 6.61 (dd, J = 5.6, 2.5 Hz, 
2H, HB), 4.49 (t, J = 5.7 Hz, 2H, HG), 4.12 (d, J = 5.7 Hz, 4H, HH), 1.03 – 1.02 (m, 24H, HI,J). HR-ESI-MS: 
m/z 365.2265 (predicted [M+2H]+ = 365.2282), 729.4466 (predicted [M+H]+ = 729.4491). 
L35 Synthesis: TIPS Deprotection 
 
L34 (75.4 mg, 0.10 mmol) was dissolved in THF (6 mL) in a sealed microwave vial under N2. Tetrabutyl 
ammonium fluoride (1 M in THF, 0.25 mL) was added dropwise. The reaction was stirred for 2 h. The 
reaction was diluted with water (10 mL) and the precipitate was collected by filtration. The residue 
was then extracted with THF (200 mL) and the solvent removed in vacuo. The crude product was 
heated in acetonitrile before being allowed to cool and filtered. The retentate was washed with 
acetonitrile and isopropanol and dried to give an off-white solid. Yield = 26 mg (61 %). 
1H NMR (601 MHz, Chloroform-d) δ 8.96 (d, J = 2.4 Hz, 2H, HF), 8.51 (d, J = 8.2 Hz, 2H, HD), 8.39 (d, J = 
5.6 Hz, 2H, HA), 8.07 (dd, J = 8.2, 2.4 Hz, 2H, HE), 7.75 (d, J = 2.5 Hz, 2H, HC), 6.60 (dd, J = 5.6, 2.5 Hz, 
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2H, HB), 4.50 (s, 2H, HG), 4.10 (dd, J = 5.8, 2.5 Hz, 4H, HH), 2.30 (t, J = 2.5 Hz, 2H, HI). HR-ESI-MS: m/z 
209.0948 (predicted [M+2H]+ = 209.0947), 417.1831 (predicted [M+H]+ = 317.1822).  
1H NMR (601 MHz, DMSO-d6) δ 9.12 (dd, J = 2.4, 0.9 Hz, 2H, HF), 8.46 (dd, J = 8.3, 0.9 Hz, 2H, HD), 8.34 
(dd, J = 8.3, 2.4 Hz, 2H, HE), 8.25 (d, J = 5.6 Hz, 2H, HA), 7.75 (d, J = 2.4 Hz, 2H, HC), 7.10 (t, J = 5.9 Hz, 
2H, HG), 6.66 (dd, J = 5.6, 2.4 Hz, 2H, HB), 4.03 (dd, J = 6.0, 2.4 Hz, 4H, HH), 3.17 (t, J = 2.4 Hz, 2H, HI). 
Synthesis of L36 
CuAAC reaction 
 
L33 was suspended in DCE (10 mL). Cu/C (81.4 mg) and trimethylamine (20 µL, dried over NaOH) were 
added. The mixture was sparged with N2 and heated at 60 °C for 72 h. The mixture was allowed to 
cool and filtered onto celite. The retentate was extracted with DMF and the solvent removed in vacuo. 
The residue was washed with methanol and collected as an off-white powder. Detected by not 
isolated.  
1H NMR (601 MHz, DMSO-d6) δ 9.09 (d, J = 2.4 Hz, 2H, HF), 8.44 (d, J = 8.3, 2H, HD), 8.31 (dd, J = 8.3, 2.4 
Hz, 1H, HE), 8.20 (d, J = 5.6 Hz, 1H, HA), 7.75 (d, J = 2.4 Hz, 1H, HC), 7.22 (t, J = 5.8 Hz, 1H, HI?), 6.67 (dd, 
J = 5.7, 2.4 Hz, 1H. HB). HR-ESI-MS: m/z 472.2419 (predicted [M+2H]+ = 427.2429). Not isolated in 




Synthesis of L38 
Synthesis of N19 by SNAr 
 
N5 (1.01 g, 3.40 mmol) and NaOH (1.16 g, 29.06 mmol) were dissolved in methanol (200 mL). The 
reaction mixture was heated at 75 °C for 3 h. The reaction was allowed to cool to room temperature 
and diluted with a DCM/water mixture (550 mL:300 mL). The aqueous layer extracted with DCM (3 x 
250 mL) and the solvent removed from combined organic fractions in vacuo. Water (150 mL) was 
added to the residue and the mixture extracted with DCM (5 x 150 mL),  the combined organic 
fractions were dried over MgSO4 and the solvent in vacuo to give an off-white solid. Yield = 0.86 g 
(91%). 
1H NMR (400 MHz, DMSO-d6) δ 8.92 (d, J = 8.6 Hz, 1H, HD), 8.87 (d, J = 2.5 Hz, 1H, HF), 8.31 – 8.26 (m, 
1H, HA), 8.21 (dd, J = 8.6, 2.5 Hz, 1H, HE), 7.66 (d, J = 3.6 Hz, 1H, HC), 7.14 (dd, J = 7.3, 3.7 Hz, 1H, HB), 
3.89 (s, 3H, HG). 13C NMR (126 MHz, Chloroform-d) δ 157.7, 150.5, 148.1, 146.9, 141.9, 139.2, 126.9, 
121.9, 113.5, 111.1, 56.4. HR-ESI-MS: m/z 280.9920 (predicted [M+H]+ = 280.9920) 
Synthesis of N20 by SNAr 
 
N7 (0.103 g, 0.37 mmol) and NaOH (0.166 g, 4.14 mmol) dissolved in methanol (50 mL). and was 
heated at 75 °C for 1 h. The reaction was allowed to cool to room temperature. The mixture was 
diluted with DCM/water mixture (25 mL: 25 mL) and the aqueous layer extracted with DCM (3 x 100 
mL). The combined organic fractions were washed with water (50 mL) and dried over MgSO4 and the 
solvent removed in vacuo to give an off-white solid. Yield = 88 mg (90%). 
1H NMR (500 MHz, Chloroform-d) δ 8.71 (d, J = 2.4 Hz, 1H, HF), 8.47 (d, J = 5.6 Hz, 1H, HA), 8.32 (d, J = 
8.5 Hz, 1H, HD), 7.94 (d, J = 2.7 Hz, 1H, HC), 7.93 (dd, J = 8.5, 2.4 Hz, 1H, HE), 6.86 (dd, J = 5.6, 2.7 Hz, 
1H, HB), 3.95 (s, 3H, HG). 13C NMR (126 MHz, Chloroform-d) δ 166.9, 157.2, 154.6, 150.5, 150.2, 139.6, 





N19 (0.502 g, 1.79 mmol), Pd(PPh3)4 (0.102 g, 0.089 mmol) and (Bu3Sn)2 (0.50 mL, 1.09 mmol) were 
suspended in toluene (40 mL) and then sparged with N2. The reaction mixture was heated at 100 °C 
for 48 h. The reaction mixture was concentrated in vacuo and the crude product was purified via 
column chromatography (Eluent: 1% trimethylamine/ DCM) to give the off-white solid product. Yield 
= 0.238 g (66%). 
 
1H NMR (400 MHz, DMSO-d6) δ 9.24 (d, J = 2.4 Hz, 2H, HF), 9.11 (d, J = 8.4 Hz, 2H, HD), 8.42 (dd, J = 8.4, 
2.4 Hz, 2H, HE), 8.30 (d, J = 7.3 Hz, 2H, HA), 7.77 (d, J = 3.6 Hz, 2H, HC), 7.15 (dd, J = 7.3, 3.6 Hz, 2H, HB), 
3.92 (s, 6H, HG). 13C NMR (126 MHz, DMSO-d6) δ 156.3, 149.1, 147.4, 145.9, 141.6, 113.5, 111.2, 56.3, 
52.0, 27.7, 7.2. HR-ESI-MS: m/z 403.1363 (predicted [M+H]+ = 403.1401). 
N-oxide reductions 
 
N19 Reduction with Fe (0) 
N19 (0.25 g, 0.90 mmol) and Fe (fillings, 0.27 g, 4.84 mmol) were suspended in acetic acid (40 mL) and 
heated at 80 °C for 2 h under N2. The mixture was allowed to cool to room temperature and a solution 
of NaOH (1.35 g, 38.52 mmol), EDTA (2.80 g, 9.59 mmol) in water (40 mL) and ammonia (80 mL) was 
added slowly. The mixture was extracted with chloroform (3 x 150 mL) and the combined organic 
phases were dried over MgSO4. The solvent was removed in vacuo and the crude product was 
crystallised from hot toluene to give an off-white solid. Yield =0.193 g, (81%). Characterisation 
matched previous synthesis. (See above) 
 
N20 Reduction with BPin 
N19 (13.7 mg, 0.00487 mmol) and bis(pin)diboron (12.6 mg, 0.0049 mmol) were dissolved in CD3CN 
(0.5 mL) in a sealed NMR tube and heated at 70 °C for 1 h. Ethylenediamine (65 μL, 0.9747 mmol) was 
added and the reaction stirred for two hours. Water (0.5 mL) was added and the aqueous layer 
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extracted with dichloromethane (3 x 0.5 mL). The organic phases were combined, dried over MgSO4 
and concentrated in vacuo. Characterisation matched previous synthesis. (See above) 
L38  
 
N21 (0.24 g, 0.59 mmol) and bis(pinacolato)diboron (0.30 g, 1.19 mmol) were dissolved in acetonitrile 
(60 mL) and sparged with N2. The reaction mixture was heated at 70 °C for 4.5 h. The reaction was 
allowed to cool, ethylenediamine (1.6 mL, 23.93 mmol) was added and stirred for 1 h. Water (25 mL) 
was added to the reaction mixture and it was extracted using dichloromethane (3 x 25 mL). The organic 
fractions were combined, dried over MgSO4 and concentrated in vacuo. The crude product was 
purified using column chromatography (Gradient eluent: dichloromethane/trimethylamine/ 
methanol: 100:0:0 to 99:1:0 to 94:1:5) to give product as off-white solid. Yield = 0.12 g (54%). 
1H NMR (601 MHz, DMSO-d6) δ 9.16 (d, J = 2.1 Hz, 2H, HF), 8.55 (d, J = 5.6 Hz, 2H, HA), 8.52 (d,  J = 8.2 
Hz, 2H, HD), 8.40 (dd, J = 8.2, 2.1 Hz, 2H, HE), 8.00 (d, J = 2.2 Hz, 2H, HC), 7.08 (dd, J = 5.6, 2.2 Hz, 2H, 
HB), 3.95 (s, 6H, HG). 13C NMR (126 MHz, DMSO-d6) δ 166.3, 156.6, 154.6, 150.8, 147.4, 135.3, 132.6, 
110.8, 106.0, 73.5, 24.9. HR-ESI-MS: m/z 371.1496 (predicted [M+H]+ = 371.1503) 
Cage formations 
Co4(L38)6(NO3)12 (C38) by direct formation 
 
 
Co(NO3)2.6(H2O) (27.5 mg, 0.094 mmol) and L38 (50.5 mg, 0.14 mmol) were suspended in a mixture 
of degassed water/acetonitrile (9:1, 6 mL) and sparged with N2 and heated at 60 °C for 16 h. 
(NH₄)₂Ce(NO₃)₆  (79.6 mg, 0.145 mmol) dissolved in acetonitrile (6 mL) and added using a syringe pump 
at a rate of 6.0 μL/min. Acetonitrile (20 mL) was added to precipitate the product. The yellow product 
was isolated by filtration onto celite, washed with acetonitrile and then eluted with water (15 mL). 
The combined filtrates were concentrated in vacuo and loaded onto a size-exclusion column 
(Sephadex LH-20). The progress of the column was tracked from the appearance of a yellow band and 
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the product fractions identified by 1H NMR. The fractions containing product were combined and 
freeze-dried to give a pale solid. Yield = 4.6 mg (6%). 
1H NMR (500 MHz, D2O) δ 8.76 (d, J = 8.2 Hz, 1H, HD), 8.47 (d, J = 2.7 Hz, 1H, HC), 7.87 (d, J = 8.2 Hz, 1H, 
E), 7.45 (s, 1H, HF), 7.39 (d, J = 7.0 Hz, 1H, HA), 7.35 (dd, J = 7.0, 2.5 Hz, 1H, HB), 4.16 (s, 3H, HG). 13C NMR 
(126 MHz, D2O) δ 171.4, 155.8, 155.3, 151.6, 149.0, 144.1, 138.0, 125.9, 117.1, 115.1, 57.7. 1H DOSY 
NMR (500 MHz, D2O): D = 1.91 x 10-6 cm2 s-1; calculated hydrodynamic radius = 12.5 Å.  
 
Ligand exchange reactions 
C38 
C19 (5.1 mg, 1.8 µmol) was dissolved in a mixture of D2O (842 µL) and CD3CN (98 µL) in an NMR tube. 
A 1H NMR was collected and L38 (8.2 mg, 22 µmol) was added and another 1H NMR was taken. The 
reaction was then sealed and heated at 75 °C. It was periodically allowed to cool for 30 minutes, 
monitored by 1H NMR and returned to heating. 
Co4(L20)5(L35)(NO3)12 
C20 (3.0 mg, 1 µmol) was dissolved in a mixture of D2O (450 µL) and CD3CN (50 µL) in an NMR tube 
and a 1H NMR was collected. L35 (0.4 mg, 1 µmol) was added and another 1H NMR was taken. The 
reaction was then sealed and heated at 75 °C. It was periodically allowed to cool for 30 minutes, 
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Chapter 4: In Vitro Raman Spectroscopy of 

















4.1.1 In vivo Imaging of Capsules 
With the suitability of our cage systems for biological applications a greater understanding the 
behaviour of the cages in a biological setting was of great interest. Cellular imaging of the cages could 
give more insight into their behaviour within organisms. 
A number of groups have used fluorescence microscopy to the study biological behaviour of cages in 
a cellular environment. Though many ligands are fluorescent themselves, this is often quenched by 
coordination to the metal centres.1 This means that the cages can only be indirectly imaged through 
the fluorescence of guests or ligands after disassembly. 
The Yoshizawa group used the fluorescence of an anthracene-containing ligand to study the uptake 
and degradation of M2L4 cages C4a,b in cells (Fig. 4.1.1). This study implied the uptake of both the cages 
and free ligands, though this may have been partially aided by the inclusion of ethanol in the cell 
solution which would be expected to increase cell permeability.2 They observed that the less stable 
palladium cage C4a showed similar uptake to the free ligand, leading to fluorescence in the cytoplasm 
of the cell, while the platinum cage C4b caused fluorescence to be observed in the nucleus of the cell 
(Fig, 4.1.1, (c), ii-iv). These results suggest that the more stable C4b is able to penetrate the nucleus of 
the cell while the palladium variants were degraded in the cytoplasm. The fact that the more stable 
assembly has weaker fluorescence signal, demonstrates the limitation of fluorescence for imaging 
stable coordination species.3 
 
Figure 4.1.1: (a) M2L4 system (M = Pd, C4a or Pt, C4b, R = -OCH2CH2OCH3) used by Yoshizawa and co-
workers, containing fluorescent anthracene panels. (b) Selection of guest tested in fluorescence 














untreated vital HT-29 cells, and cells treated for 4 h with 10μM solutions of (ii) ligand, (iii)Pt2L4 , 
(iv)Pd2L4, (v)Pt2L4·(pyrene)2, and (vi) Pd2L4·(pyrene)2. The fluorescence images under green-light 
excitation of (ii–vi) the treated and (i) the untreated HT-29 cells stained with acridine orange (AO), and 
visualized with 40× objectives (in AO (40×) respectively). The unstained cells are visualized with the 40× 
objective; all the scale bars mark 30μm. Adapted from 3. 
Isaacs and co-workers were also able to indirectly image cellular behaviour by appending a fluorescent 
pro-drug onto the outside of a Pd12L24 cage using cucurbit[8]uril inclusion chemistry (C9b, Fig.1.4.4).4 
Similarly Zheng and co-workers bound a tethered fluorescein inside Fujita’s M6L4 truncated 
octahedron, which was then loaded into an anionic polymeric matrix to permit cellular imaging (C8, 
Fig. 1.4.3).  They also showed the release of cis-platin from a bound fluorescein-platinum (IV) prodrug.5  
In a similar manner, Therrien and co-workers were able to investigate their ruthenium trigonal prism 
(C7) through the release of a fluorescent pyrene guest in greater detail (Fig. 4.1.2).6 They were able to 
show that the fluorescence was far higher within the cells when the host-guest complex was 
administered, rather than just the guest. They were also able to quantify the uptake of the guest 
through use of flow cytometry to investigate the effect of relative concentrations of guest and cage. 
Their results showed that the uptake of the cage was not linear with either concentration of host-
guest complex or exposure time. Again, as fluorescence could only be observed by guest release, these 
results give limited information about the state of the cage and the nature of drug release.  
 
Figure 4.1.2: Therrien and co-workers’ triangular prism (C7) and fluorescent pyrene guest.  
In contrast, Stang and co-workers used assemblies based on ligands which show aggregation-induced 
emission and fluorescence, which is stronger when molecular rotation is restricted, either through 
aggregation or coordination. This permitted the active imaging of the assemblies within cells and even 




The Lusby group have previously explored a range of options that would permit the fluorescent 
imaging of our robust Co4(L)4(NO3)12 tetrahedra. The cages C15 and C14 (Fig. 4.1.3 (a)) were found to 
bind a number of organic fluorophores (Fig. 4.1.3 (b)) but none were found to have sufficiently high 
association constants to allow cellular imaging. Therefore, attempts were made to tether a 
fluorophore to a tightly bound triisopropylsilanol guest (Fig. 4.1.3 (c)) but this was ultimately 
ineffective due design and solubility limits. Additionally, the inclusion of a fluorescent iridium metal 
complex into the ligand L40 (Fig. 4.1.3, (d)) was trialled but the bulky groups were found to prevent 
cage formation due to their steric bulk. 
 
Figure 4.1.3: (a) C14 and C15, (b) Small fluorescent weakly binding guests of C14 and C15, (c) 
Fluorophores (blue) tethered to a strongly binding triisopropyl silyl group (yellow), (d) L40 containing 
fluorescent iridium complex.  
It is a commonly encountered problem in fluorescence microscopy that fluorophores are difficult to 
introduce into a molecule. Many common fluorophores, such as fluorescein and iridium complexes, 
have high molecular weights meaning that their incorporation is likely to significantly change the 





4.1.2 Raman Spectroscopy for Bioimaging 
Raman spectroscopy represents a very attractive alternative approach to other cellular imaging 
methods as it uses very small spectroscopic “handles” that can be incorporated with little perturbation 
of molecular properties. Raman spectroscopy is similar to IR spectroscopy and uses the interaction of 
photons molecular vibrations to analyse compounds. The technique detects inelastically scattered 
photons, which have had an interaction with vibrational modes of the substrate to change the 
wavelength of the scattered photons. Most photons are scattered in an elastic manner and will 
therefore have the same energy as the incident photons. However, a small number of photons will be 
scattered inelastically, when they induce a change in polarizability of the molecule which couple to a 
molecular vibration. These photons are scattered at a different energy to the incident photons and 
can be detected to give a Raman spectrum. 
Raman spectroscopy has other properties that make it an attractive imaging technique. It is largely 
non-destructive, using relatively low energy excitation and therefore allowing imaging of living cells. 
Cellular components can be visualised through detection of characteristic bands (Fig. 4.1.4); proteins 
can be detected by the peaks of amide carbonyl groups (1657 cm-1), CH of phenylaniline (1033 cm-1) 
and lipids can be detected by measuring the intensity of the CH3 groups (2880 cm-1). Importantly water 
has no signal and cells have a “silent region” in their Raman spectra between 1800-2800 cm-1, in which 
few cellular components have any Raman signal. This means that signals in this range are easily 
detected due to minimal “noise”.  
 












A number of chemical groups have active Raman vibrations in the “silent region”, including nitriles, 
azides, deuterium-carbon bonds and alkynes. Studies have shown that alkynes in general give the 
strongest signal out of these groups.8 These groups are also small a and apolar making them easier to 
incorporate into a species of interest than large fluorophores 
An alkyne tagged analogue of thymidine, originally developed for “click” labelling of cells with 
fluorescent groups,9 was found to be to be suitable for direct imaging with Raman spectroscopy. 
Analysis of the 5-ethynyl-2-deoxyuridine (EdU, Fig. 4.1.5) signal in combination with that of the lipids 
and cytochrome in the cell was able to provide evidence for the accumulation of the alkyne-labelled 
species within the nucleus of HeLa cells.10  
 
Figure 4.1.5: Structure of EdU, a common Raman spectroscopic alkyne standard. 
This Raman imaging approach has been developed for simultaneous imaging of two different 
compounds within cells. Live-cell imaging has led to the technique providing insight into the cellular 
distribution of alkyne labelled lead drug compounds.11  
Spontaneous Raman is the most common imaging variant, using a fixed wavelength laser which 
simultaneously stimulates all the Raman bands of the sample and giving a full spectrum. While this is 
effective for obtaining single spectra and has been used imaging cells,12 the technique is insensitive as 
only a fraction of photons are scattered inelastically. This means the techniques requires relatively 
high concentrations of analyte and extended acquisition times to capture images, approximately 30 
minutes for a single image, which can severely limit the suitability of the technique for imaging.13 
A newer technique, known as stimulated Raman scattering (SRS), was developed to overcome this low 
signal problem. This technique uses two aligned lasers, wherein the difference in wavelength between 
the two beams matches a molecular vibration.  When this vibration is stimulated it causes an intensity 
loss in one beam and an intensity gain in the other. Conversely, when no vibration is excited, then no 
change in the beam intensity occurs. Therefore, changes in beam intensity can be measured to detect 
the corresponding vibration. These measurements can be performed across a sample to give contrast 
images.14 This technique is more sensitive, able to detect species at far lower concentrations, and far 
quicker, greatly decreasing acquisition time. This has greatly increased the feasibility of time-lapse cell 
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imaging, with SRS images being able to be collected in a matter of minutes or even seconds.15 This 
allows real time imaging of living cells and tissue, allowing direct visualisation of drug uptake and 
metabolism.11  
It was theorised that this technique could be informative for imaging the uptake of the 
metallosupramolecular cages in cells. The rigid, linear nature of alkynes permits their incorporation 
into ligands used in supramolecular cage assembly. Specifically, it was envisaged that an alkyne spacer 
could be placed between the two bipyridine groups of L19 and/or L20  without interfering with 
tetrahedron formation (Fig. 4.1.6). Assuming this is successful, stimulated Raman microscopy 
promises the possibility of being able to directly image intact cages within cells. This could provide a 
far greater understanding of uptake, distribution, guest release and metabolism of the cages within 
cells. This could significantly inform ongoing research into the biomedical applications of cage 
compounds. 
 
Figure 4.1.6: Proposed structure of tetrahedra formed from Raman active alkyne containing ligands (n 





4.2 Results and Discussion 
4.2.1 Synthesis of Alkyne Containing Cobalt (III) Tetrahedra 
In order to closely match our existing cages, it was proposed that the alkynes could be used as central 
linkers in a M4L6 bis-bidentate ligand (Fig. 4.2.1). The bis-alkyne was proposed in order to attempt to 
have a more intense Raman signal. These would be close analogues of the previous M4L6 systems such 
as L15, hopefully meaning they would behave in a similar manner for formation, solubility and, more 
importantly, biological behaviour. 
 
Figure 4.2.1: Proposed alkyne containing ligands. 
Both ligands were synthesised by modified literature procedures, heavily relying on Sonagashira cross-
coupling methodology, as outlined in Scheme 4.2.1.16 However, the bis-alkyne ligand L42 was found 
to be far less stable than the mono-alkyne ligand, L41, decomposing at room temperature over several 
days. Multiple alkyne containing groups are prone to instability.17,18 While L42 might be stable at lower 
temperatures, this instability was less than desirable and pointed to further problems with the 
subsequent cage compound, C42 (Scheme 4.2.2, n = 2) and it was not further pursued. 
 
Scheme 4.2.1: Synthesis of alkyne containing ligands L41 and L42. 
L41 L42 





Both L41 and L42 underwent cage formation using the “assembly-followed-by-fixing” method,  giving 
single high symmetry species in excellent yields. Both compounds showed characterisation that was 
consistent with previous tetrahedra and is very similar to the parent, C19 cage (Fig. 4.2.2). 
 
Scheme 4.2.2: Synthesis of C41 (n = 1) and C42 (n = 2). 




Figure 4.2.2: (a) Depiction of Cage and partial 1H NMR (500 MHz, D2O) of (b) C19 (n = 0), (c) C41 (n = 
1), (d) C42 (n = 2). 
4.2.2 Guest binding Studies 
While the cages were not designed for guest binding, their host-guest properties were still considered 
worth investigating. They would be expected to have significantly different guest binding properties 
to C19 and C15. The alkyne central linkers will alter the size of the assemblies with the estimated 
average metal-metal distances are shown in Table 4.2.1. The tetrahedron of L41 is therefore of an 
intermediate size to C19 and C15, while that of L42 would be slightly larger. This size difference will 




















C19, n = 0 
C41, n = 1 
C42, n = 2 
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Table 4.2.1: Estimated cobalt-cobalt distances of various tetrahedra. Estimated using Spartan 10’ 
models of assemblies. 





The small surface area of the alkyne would be expected to lead to the cage less effectively demarcating 
the cavity and therefore reducing the hydrophobic driving force for guest binding. Preliminary guest 
screening of the C41 cage was assessed to see if the cage is still suitable for the binding of anions. The 
screening appeared to show binding of several anions in common with C19, including SiF62−, ReO4−, 
BF4− and ClO4− (Fig. 4.2.3). This common binding across different size assemblies implies that 
electrostatics are a large driving force for the binding of these anions. Though the lack of PF6− binding, 
which bound very strongly in C19, implying that other factors also have an influence. 
Figure 4.2.3: Partial 1H NMR (500 MHz, D2O): Binding studies of different anions with C41. 
Further exploration of these differences may be of interest and determination of the binding constants 












of organic guests, which would be more dependent on the hydrophobic effect, would allow 
exploration of the effect of porosity on the cage.  
4.2.3 Spontaneous Raman Spectroscopy Studies 
Solution phase Raman spectra of the cage were taken but comparison with the ligand proved difficult 
as there was no single solvent in which both species were soluble. The cage also was ill suited to Raman 
spectroscopy in the solid phase as it appeared to decompose under exposure to the laser and give a 
broad spectroscopic peak. L41 had limited solubility in water miscible solvents such as methanol, 
ethanol, water and DMSO. L41 was found to be soluble to 10 mM in 1M HCl but not HNO3, while C41 
was readily soluble in both 1 M DNO3 and DCl. Solutions of the ligand and cage were mixed. The peaks 
of the cage remained stationary while the ligand shifts changed dramatically. Addition of more L41 did 
not cause its 1H NMR peaks to shift further, so the change does not appear to be concentration 
dependant and the solution appeared to be stable over multiple days.  
 
Figure 4.2.4: Partial 1H NMR (500 MHz, 1 M DCl, D2O) of (a) L41, (b) C41, (c) L41 and C41. L41 (Brown), 
C41 (Orange). 
With a common solvent identified, C41 and L41 were analysed using spontaneous Raman 
spectroscopy in a number of different solutions. These results appear to show that the vibration of 






wavenumbers between organic solvents and aqueous acid. The acidic solutions  of L41 gave a signal 
at a marginally higher wavenumber than in organic solvent, which was found to not differ at 
concentrations of 1 mM and 5 mM or in pH 0 or 0.7 solutions. Estimation of the pKa of L41 predicts 
that it would largely exist as the doubly protonated form in this pH range and protonation might be 
expected to have an effect on the electron density of the alkyne group. Combining the acidic and 
organic solutions gave intermediate peak positions, implying some intermediate state. 
C41 was investigated in a smaller number of solutions due to limited material. The alkyne vibration in 
the cage was at a higher wavenumber than uncoordinated L41 and appeared to appear at a slightly 
wider variation of values. This increase in wavenumber from ligand to cage was also observed by 
Crowley and co-workers with a Pd2L4 paddlewheel system.19 The wavenumber of the vibration of C41 
also increases in wavenumber when in acidic solution (Fig. 4.2.5). It might be expected that the 
coordination of the ligand makes it less sensitive to changes in the polarity and pH of the solvent, so 
it would appear that other factors to consider. One such explanation is the change in counteranion, 
as in water, the counter anions are NO3−. While in the acidic solutions, there will be a large excess of 
Cl− anions. Interactions of these anions with the alkynes may affect their Raman signal especially with 
the proximity of the alkyne moieties to the central cavity. 
Table 4.2.2: Alkyne Raman signal maximum of L41 and C41 in various solvents. 
Solvent Alkyne peak maxima / cm-1 
Concentration L41 C41 
5 mM 1 mM    
1 mM HCl  2228 2253 
DMF  2220 - 
 H2O (Insoluble) 2239 
 DMSO 2221 2245 
 DMSO/EtOH 2221 - 
 1 mM HCL 2228 2253 
 0.2 mM HCl 2228 - 
 1:1 0.2 mM HCl/DMSO 2226 - 




Figure 4.2.5: Spontaneous Raman spectra (2100-2450 cm-1) of 1 mM L41 and C41 in 1 M HCl. 
This difference between vibrational wavenumber of C41 and L41 mean that Raman spectroscopy 
could potentially distinguish between the cage and free ligand. This could make it a powerful tool 
when imaging, as it may provide information on the state of cage, as well its localisation.  
Both C41 and L41 have complex peaks in the Raman spectra, both appearing to possess two signals in 
the expected region, with this second peak being far more pronounced in C41 (Fig. 4.2.5). The reason 
for these secondary peaks is uncertain as both species appeared pure and of high symmetry by 1H 
NMR studies (Fig. 4.2.2). 
Table 4.2.3: Alkyne Raman signals of of 1 mM L41 and C41 in 1 M HCl. 
Sample Main peak (cm-1) Secondary Peak (cm-1) 
L41 2228 2193 
C41 2249 2217 
One explanation is the far greater time resolution of Raman spectroscopy over NMR. NMR spectra are 
time averaged over a far longer time frame and it is possible that a dynamic process not apparent by 
NMR is being detected by Raman.20 It is also possible that these secondary peaks represent some form 
of conformation change in the species. Severe conformational changes have been proposed to occur 
in cages to allow ingress and egress of guests into cage cavities and could be expected to be occurring 
constantly in solution.21 It is possible that these dynamic conformational changes are differentiated 
by Raman while not being detected by NMR. 

























The cause of the two peaks cannot be discerned without further study. Model mono-nuclear 
complexes, such as those depicted in Figure 4.2.6, with appended alkynes could provide insight into 
effect of coordination to metals on the alkyne vibration. It would also allow exploration of whether 
these additional peaks are due to the symmetry or dynamics of the tetrahedron.  
 
Figure 4.2.6: Potential mono-nuclear complexes for investigation of coordination on alkyne Raman 
signals.  
Comparison of the cross-section of the vibration would also be of interest. The compound EdU (Fig. 
4.1.5) has been used as a standard alkyne Raman compound to which intensity of scattering can be 
compared.11 Assessment of the strength of the scattering would also aid in the optimisation of cell 
imaging as it would indicate limits of detection and could allow analysis of concentration. 
Quantification of the intensity of the Raman bands of the ligand and cage could also provide insight 
into the effect of coordination has on the polarizability of an alkyne in a ligand.  
4.2.4 Cellular uptake  
Initial cellular uptake studies were undertaken, and HeLa cells were dosed with C41, pelleted and 
assessed with spontaneous Raman spectroscopy. This cell pellet did show a Raman band in the cell 
silent region consistent with an alkyne. However, this Raman band had a wavenumber of 2219 cm-1 
(Fig. 4.2.7), which is more consistent with solid L41 rather than C41 in an aqueous solution (Table 
4.2.2). This, in combination with the observation of solid material appearing to precipitate onto the 




Figure 4.2.7: Spontaneous Raman spectra of solid L41 (black line) and cell pellet treated with C41 (100 
mM, cell media) for three hours (red line). 
Precipitated ligand could be caused by decomposition of the cage in media, as was observed with C19 
(see Chapter 2). C41 could suffer similar instability and the insoluble ligand could be precipitating onto 
surface of the cells, meaning the alkyne signal detected might not indicate cellular cage uptake. 
4.2.5 Stimulated Raman Spectroscopy Studies 
Stimulated Raman spectroscopy was identified as means to investigate the behaviour of the C41 in 
media and cells. The technique is able to image a sample quickly and would allow spatial analysis of 
sample to detect the difference between precipitated solid and the bulk solution. 
Solutions of C41 were assessed by spontaneous and stimulated Raman in order to check whether 
there was good agreement between the two techniques (Fig. 4.2.8). The two results gave marginally 
different results, with the highest peak in the stimulated Raman spectrum being 2449 cm−1 compared 
to 2245 cm−1 for the spontaneous equivalent. It is possible this small difference may be caused by the 
lower number data of points that can be collected when using stimulated Raman compared to 
spontaneous. It also possible that differences between the two techniques may lead to slight 
differences in temperature or light source when the data is collected.  

























Figure 4.2.8: Stimulated (red line) and spontaneous (black line) Raman spectra of C41 (1 mM) in water. 
As it had been indicated that cage and ligand could be differentiated by the wavenumber of their 
alkyne peak, media solutions of C41 were analysed by stimulated Raman spectroscopy. Comparison 
of solutions of C41 in water and media found that they have similar alkyne vibrations with the highest 
signal at 2248 cm-1 (Fig. 4.2.9). However, continued observations of the solutions led to no change in 
pure aqueous solution, while solid precipitated from the media solution within an hour.  
 
Figure 4.2.9: Stimulated Raman scattering image of C41 (1 mM) in water (left) and cell media (right). 
Image shows Intensity of Raman signal at 2248 cm-1, Blue (low) to high (red). 
Stimulated Raman spectroscopy allows the separate analysis of the solution and precipitate. This 
showed that the alkyne vibration of the bulk solution was consistent with C41. In contrast, the solid 
precipitate had a different Raman vibration, with maximum signal at 2223 cm-1, a wavenumber very 




























similar to that of free L41 (Fig. 4.2.10). Furthermore, the precipitation of the poorly soluble material 
is likely to suggest free ligand, which is not water soluble. When the mixture was extracted with 
deuterated chloroform, 1H NMR showed the presence of free L41, confirming cage decomposition.  
 
 
Figure 4.2.10: Stimulated Raman Spectra of solution and precipitate of C41 in DMEM eagle media (0.1 

































4.2.6 Investigation of the Stability of C41 
As previously discussed, the most likely pathway for cage degradation in biological media is by 
reduction of the metal centres followed disassembly of the cage (see Chapter 2). Therefore, the 
glutathione assay previously described in Chapter 2 was repeated with C41 to assess if it is degraded 
in a similar manner. 
 
Figure 4.2.11: Partial 1H NMR (600 MHz, D2O, 1 M PBS) of C41 in presence of 10 equivalents of 
glutathione over time (descending). a) 0 h, b) 3 h, c) 7 h, d) 10 h, e) 12 h, f) 16 h, g) 38 h. 
C41 was found to be stable in phosphate buffered saline (PBS) and upon the addition of the 
glutathione was observed to degrade. Interestingly, C41 appears to decompose slower than C19, 
remaining detectable in solution after 15 hours, though it had entirely decomposed after 20 hours. 
Limited precipitation was observed in the sample, implying that the reduced species remained soluble, 











Figure 4.2.12: Concentration of C41 and Glutathione disulfide (glutathioneDS), when C41 exposed to 
10 equivalents of glutathione in pH 7.4 phosphate buffered saline. 
These results imply C41 has an intermediate stability between C19 and C20. The alkyne containing 
ligand would also be expected to more flexible than the ligands without central linkers, which might 
be expected to decrease the overall stability of the assembly by reduction of preorganization and 
cooperativity. However, this could also reduce steric strain on the assembly which may explain the 
apparent greater stability. 
4.2.7 Stimulated Raman Cell Imaging 
Despite the stability concerns of, it was proposed that C41 be investigated for its cellular uptake 
through stimulated Raman microscopy. This would allow determination of whether the cage is truly 
taken up by cells or if the positive cell pellet result was in fact due to ligand precipitation.  
Therefore, HeLa cells were dosed with a 100 µM solution of C41 (the higher end of the expected 
concentrations of analyte)22 for two hours before they were washed, fixed and investigated by SRS. 
The precipitation of the solid proved problematic as it formed crystals on the surface of the cells, 
leading to image saturation and sample damage. The crystals appeared most concentrated around 
the cells, most likely as the cells present the best nucleation sites. Imaging the sample at a variety of 
different wavenumber values showed that the precipitated solid (Fig. 4.2.13, (d)) had a Raman signal 
very similar to L41 (Fig. 4.2.7). The crystallised ligand is also fluorescent, making for difficulties in 
acquiring Raman images. The fluorescence limited the number of wavelengths that could be 





































[C41] and [GlutathioneDS] when C41 exposed to 10 




Despite these issues, images of the cells could still be obtained at alkyne wavenumbers and appeared 
to show some uptake of C41.  
 
Figure 4.2.13: (a) Stimulated Rama image of HeLa cell treated with C41 (Intensity of Raman signal at 
2230 cm-1). Local Raman sweep (2160-2300 cm-1) of (b) cell cytoplasm, (c) bulk solution, (d) solid 
precipitate. Data collected by Martin Lee. 
A number of cells show an alkyne Raman signal concentrated throughout the cytoplasm that had a 
maximum signal at 2230 cm-1. This broad peak overlaps with both the wavenumber expected for intact 
C41 (2239 cm-1) and precipitated L41 (2220 cm-1), implying that it might represent a mixture of 
different states of cage and may show degradation of the cage within cells. 
Other cells exhibited signals which were concentrated throughout the cells including the nucleus and 
nucleolus (Fig. 4.2.14). Unfortunately, the precipitated solid restricted transmission images, meaning 







Figure 4.2.14: Stimulated Raman spectroscopic images of HeLa cells dosed with C41 (0.1 mM). Intensity 
of Raman signal at respective wavenumber. Data collected by Martin Lee. 
Despite the limitations of the data, it does appear to show that C41 is taken up into HeLa cells and 
appears to be particularly concentrated within the nucleus and nucleolus of these cells. In order to 
distinguish between the precipitated material and that in solution within cells, fluorescence images 
were collected. As the free ligand is fluorescent and this is switched-off upon coordination to the metal 
ions and the assembly of the cage, this was identified as a means to distinguish between cage and 
precipitated ligand. 
Collection of a fluorescence image and overlaying it with the Raman spectra appears to show 
separation of the fluorescence and Raman signal (Fig. 4.2.15), implying that the crystalline material is 
solid ligand and the material taken up by cells is intact C41. This presents the possibility of using Raman 
and fluorescence microscopy in tandem to provide additional information about the state of the 
alkyne containing cages within the cell sample. 




Figure 4.2.15: Overlayed fluorescence image and stimulated Raman image (2225 cm-1) of cells dosed 
with C41 (0.1 mM). Intensity of Raman signal at 2225 cm-1 depicted in red and fluorescence depicted 
in green. Data collected by Martin Lee. 
More data is required to confirm the findings of these experiments and this will would be greatly aided 
by preventing the precipitation from occurring. Development of an effectively stabilised alkyne 
containing cage might be one means of reducing this precipitate. Alternatively, lower concentrations 
of C41 could be administered in order to reduce the amount of precipitate that is formed. Additionally, 
C41 could be administered to the cells in less chemically complex solutions, such as phosphate 
buffered saline or incomplete media. These solutions are compatible with cells for short periods, 
giving a window in which cage compounds could be administered with reduced degradation.23  
4.2.8 Attempted Functionalisation of L41 to Increase Stability 
As C41 showed similar instability to the previous C19 systems, it was proposed that it could be 
modified in a similar manner to increase its stability, prevent degradation and facilitate imaging. 




Figure 4.2.16: Proposed amine functionalised alkyne containing ligand L43. 
L43 was only synthesised with partial success during the course of this investigation (Scheme 4.2.3). 
The synthesis progressed with the Sonogashira coupling of trimethylsilylacetylene and N7 to give N24, 
followed by deprotection to produce N25 and a further coupling with another equivalent of N7 to give 
intermediate N26. Finally, this was subjected to conditions that could selectively reduce nitro groups. 
Unfortunately, L43 appeared to be unstable; it could be precipitated from solution as an off-white 
solid but quickly turned to a black sticky oil upon attempts to isolate. This happened almost 
immediately upon isolation and occurred after further extractions with a number of solvents.  
 
Scheme 4.2.3: Attempted synthesis of L43. 
Repetition of the reaction gave a similar result and it was suggested that the ligand was decomposing 
on contact with air. However, cage formation was attempted in the hope that some of the ligand 
persisted and the decomposition products would not interfere with cage formation. L43 initially 
appeared to behave well in the reaction, forming an orange solution upon heating and resonding 
similarly to previous systems to oxidation and isolation. However, the product was found to have a 
very broad 1H NMR spectrum (Fig. 4.2.17, (b)). 





Figure 4.2.17: Partial 1H NMR (600 MHz, D2O) of (a) C41, (b) The product of the direct cage formation 
with L43. 
This broad spectrum could be a result of the degradation of the ligand or similar speciation issues as 
those encountered with cage formation of L20 and L38 (see Chapters 2 and 3). It was therefore 
proposed that the cage formation could be attempted by ligand exchange in the same manner as C20, 
using the preorganisation of C41 to avoid speciation issues. 
This cage formation by ligand exchange was found to give a similar broad spectrum to the direct 
formation though with slightly better-defined peaks (Fig. 4.2.18). This implies that the broadness of 
the spectra is a result of instability of the ligand rather than kinetically trapped byproducts. It is 
possible that the peaks represent the L43 tetrahedron and that it could be purified, however the issues 






Figure 4.2.18: Partial 1H NMR (600 MHZ, 9:1 D2O/CD3CN) of reaction of C41 and L43. (a) Before 
addition of L43, (b) After addition of L43, (c) After 24 h heating at 75 °C, (d) After 2 days heating at 75 
°C, (e) After 5 days heating at 75 °C, (f) After 7 days heating at 75 °C, (g) After 24 days heating at 75 
°C. C41 highlighted in orange, proposed L43 highlighted in purple. 
An alternative functionalisation to stabilise C41 would be to use a methyl ether functionalised 
bipyridine rather than an amine (Fig. 4.2.19). These groups could be introduced in the same manner 
as in L38 (Chapter 3) and would preclude the need for harsh reduction reactions. Hopefully, the methyl 
ether groups would provide a stable ligand with a robust tetrahedron. 
 












Raman spectroscopy was identified as a potentially powerful means of investigating the in vitro 
behaviour of appropriately labelled robust metallosupramolecular cages. The technique offers several 
advantages over fluorescent imaging, including smaller labels and lack of metal coordination 
quenching. Therefore, the alkyne containing ligand, L41, was synthesised and successfully assembled 
into a tetrahedron C41. Spontaneous Raman spectroscopy of both the ligand and cage found different 
alkyne Raman bands which were dependent on solvent.  
Initial cell uptake studies of C41 were hampered by degradation of the cage in cell media and a 
subsequent glutathione assay indicated that C41 was reductively in a similar manner to C19. Despite 
its instability, cell uptake experiments were undertaken with C41. This experiment was also hampered 
by the degradation of the cage but appeared to show the cellular uptake of C41, proving the potential 
Raman spectroscopy has as a method to investigate the cellular uptake of supramolecular cages. The 
ability to differentiate the state of the cage through the wavenumber of the Raman signal and the 
fluorescence of the free ligands indicates the technique may be used to give significant insight into 
the biological fate of our cage systems that will inform future biomedical applications.  
The synthesis of an amine functionalised variant of the ligand, aiming to increase the stability of the 






As described in Chapter 2. 
Abbreviations used in this text:  
DMSO   Dimethylsulfoxide  
DMF                    N,N-dimethylformamide 
THF   Tetrahydrofuran  
DCM   Dichloromethane 
NMR   Nuclear Magnetic Resonance  
DOSY   Diffusion ordered spectroscopy  
RT  Room temperature  
EDTA   Ethylenediaminetetraacetic acid  
Na4EDTA            Ethylenediaminetetraacetic acid tetrasodium salt 
MS   Mass Spectrometry 
PBS  Phosphate buffered saline 




N22 (507 mg, 2.16 mmol), CuI (85 mg, 0.445 mmol) and Pd(PPh3)4 (147 mg, 0.13 mmol) were placed 
in a Schlenk flask under N2. 2-Methyl-3-butyn-2-ol (0.4 mL, 4.127 mmol) and diisopropylamine (20 mL) 
were added and the reaction was sparged with N2 for five minutes and stirred for 24 h at RT. The black 
reaction was diluted with Na4EDTA (100 mL, 0.25 M, NaOH) and stirred for 0.5 h. The solvent was 
concentrated in vacuo and water (100 mL) was added to the residue and the mixture was extracted 
with dichloromethane (4 × 100 mL). The combined organic fractions were washed with brine (3 × 100 
mL) and dried over MgSO4. The solvent was removed in vacuo and the crude product purified by silica 
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flash chromatography (eluent, gradient: dichloromethane/ triethylamine/diethyl ether 99:1:0 to 
98:1:2) to give a brown oil. This was diluted with saturated NaHCO3 solution (100 mL) and extracted 
with dichloromethane (3 × 100 mL). The organic phases were dried over MgSO4 and the solvent 
removed in vacuo to give a brown oil, which was used without further purification. Crude yield = 571 
mg. 
1H NMR (601 MHz, Chloroform-d) δ 8.70 (dd, J = 2.1, 1.0 Hz, 1HG), 8.68 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, 
HA), 8.40 (dd, J = 8.1, 1.0 Hz, 1H, HD), 8.37 (dd, J = 8.1, 1.0 Hz, 1H, HE), 7.85 – 7.80 (m, 2H, HC&F), 7.32 
(ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HB), 2.17 (s, 1H, HI), 1.66 (s, 6H, HH). Not isolated. 
4.2 
 
N23 (571 mg, 2.39 mmol) and NaOH (982 mg, 24.55 mmol) were suspended in toluene (100 mL) and 
refluxed for 5 h. The reaction was allowed to cool and diluted with dichloromethane (50 mL) and water 
(50 mL), separated and the aqueous phase was extracted with dichloromethane (3 × 30 mL). The 
combined organic phases were collected and dried over MgSO4. The solvent was removed in vacuo. 
The crude product was purified by silica gel chromatography (eluent: ethyl acetate/ hexane (1:9)) to 
give the product as a colourless solid. Yield (two steps) = 260 mg (67%). 
1H NMR (500 MHz, Chloroform-d) δ 8.77 (d, J = 2.0 Hz, 1H, HG), 8.69 (ddd, J = 4.7, 1.8, 0.9 Hz, 1H, HA), 
8.44 –8.38 (m, 1H, HD), 8.40 –8.38 (m, 1H, HE), 7.90 (dd, J = 8.2, 2.0 Hz, 1H, HF), 7.83 (td, J = 7.6, 1.8 Hz, 
1H, HC), 7.32 (ddd, J = 7.6, 4.7, 1.1 Hz, 1H, HB), 3.29 (s, 1H, HH). 13C NMR (126 MHz, Chloroform-d) δ 
155.6, 155.5, 152.4, 149.5, 140.2, 137.1, 124.2, 121.6, 120.4, 119.3, 81.4, 80.9. HR-ESI MS: m/z 
181.0768 (predicted [M+H]+= 181.0760), 203.0588 (predicted [M+Na]+= 203.0580). 
L41 
 
N24 (235 mg, 1.30 mmol), N22 (313 mg, 1.33 mmol) and Pd(PPh3)4 (152 mg, 0.13 mmol) were 
suspended in toluene (100 mL) and NEt3 (20 mL). The mixture was sparged with N2 and heated at 80 
°C for 12 h. The mixture was allowed to cool and the off-white precipitate was collected by filtration 
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and washed with toluene and acetonitrile. The crude product was crystallised from hot acetonitrile to 
give pale yellow needle crystals. Yield = 339 mg (77%).  
1H NMR (500 MHz, Chloroform-d) δ 8.85 (dd, J = 2.2, 0.9 Hz, 2H, HG), 8.70 (dd, J = 4.8, 1.9 Hz, 2H, HA), 
8.46 –8.44 (m, 2H, HE), 8.44 –8.42 (m, 2H, HD), 7.98 (dd, J = 8.2, 2.1 Hz, 2H, HF), 7.84 (td, J = 7.7, 1.8 Hz, 
2H, Hc), 7.33 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, HB). 13C NMR (126 MHz, Chloroform-d) δ 155.5, 155.5, 151.8, 
149.5, 139.6, 137.1, 124.2, 121.6, 120.6, 119.8, 90.6. HR-ESI MS: m/z 335.1302 (predicted [M+H]+= 
335.1291), 357.1108 (predicted [M+Na]+ = 357.1111). 
L42 
 
N24 (50 mg, 0.28 mmol) and CuCl (27 mg, 0.28 mmol) were suspended in pyridine (11 mL). The 
reaction was sparged with O2 for 1 h and stirred at RT for 12 h. The reaction was diluted with Na4EDTA 
(0.25 M, 6 mL) and water (18 mL) and the mixture was stirred for 1 h. The white crystalline product 
was collected by filtration, washed with diethyl ether and water and then dried in vacuo. Yield = 41 
mg (82 %).  
1H NMR (601 MHz, Chloroform-d) δ 8.83 (s, 1H, HG), 8.70 (d, J = 4.8 Hz, 1H, HA), 8.45 –8.44 (m, 1H, HE), 
8.44 –8.42 (m, 2H, HD), 7.95 (dd, J = 8.3, 2.1 Hz, 1H, HF), 7.84 (td, J = 7.7, 1.7 Hz, 1H, HC), 7.34 (t, J = 6.2 
Hz, 1H, HB). Compound decomposed before 13C could be acquired. HR-ESI MS: m/z 358.1307 (predicted 
[M+H]+= 359.1291), 381.1122 (predicted [M+Na]+= 381.1111). 
N24 
 
N7 (741 mg, 2.65 mmol), PPh3 (20 mg, 0.077 mmol), CuI (14 mg, 0.075 mmol) and Pd(PPh3)2Cl2 (84 mg, 
0.12 mmol) were dissolved in trimethylamine (20 mL) under N2. Trimethylsilylacetylene (0.39 mL, 260 
mg, 2.65 mmol) was added and the mixture was sparged with N2 for ten minutes, then heated at 90 
°C for 16 h. The mixture was allowed to cool and Na4EDTA solution (0.25 M, 100 mL) was added and 
the mixture was stirred for 1 h before being diluted with dichloromethane (70 mL) and water (50 mL), 
the layers were separated and the aqueous phase was extracted with dichloromethane (100 mL × 2). 
The solvent was removed in vacuo from the combined organic phases. The crude product was 
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dissolved in dichloromethane and passed through a silica plug, the solvent removed in vacuo and used 
without further purification. Crude yield = 776 mg.  
1H NMR (500 MHz, Chloroform-d) δ 9.15 (dd, J = 2.2, 0.7 Hz, 1H, HC), 8.94 (dd, J = 5.3, 0.7 Hz, 1H, HA), 
8.78 (dd, J = 2.1, 0.9 Hz, 1H, HF), 8.42 (dd, J = 8.2, 0.9 Hz, 1H, HD), 8.01 (dd, J = 5.3, 2.2 Hz, 1H, HB), 7.91 
(dd, J = 8.2, 2.1 Hz, 1H, HE), 0.29 (s, 9H, HG). Product not isolated or further characterised. 
N25 
 
N24 (712 mg, 2.39 mmol) placed in a flask under N2. Anhydrous THF (20 mL) was added and the 
resulting black solution was cooled to 0 °C. Bu4NF (1 M in THF, 2.61 mL, 2.61 mmol) was added and 
the mixture was stirred at 0 °C for 1 h. The mixture was diluted with water (250 mL) and allowed to 
warm to room temperature. The reaction was extracted with dichloromethane (3 × 50 mL) and the 
combined organic phases were dried over MgSO4 before the solvent was removed in vacuo to give the 
crude product as a brown powder. Crude product purified by dry loading onto a silica gel purification 
column (eluent, gradient: dichloromethane/diethyl ether 100:0 to 70:30) to give product as a brown 
solid. Yield = 392 mg (66%, over two steps). 
1H NMR (601 MHz, Chloroform-d) δ 9.16 (d, J = 2.2 Hz, 1H, HC), 8.95 (d, J = 5.3 Hz, 1H, HA), 8.82 (dd, J 
= 2.2, 0.9 Hz, 1H, HF), 8.45 (dd, J = 8.2, 0.9 Hz, 1H, HD), 8.03 (dd, J = 5.3, 2.2 Hz, 1H, HB), 7.95 (dd, J = 
8.2, 2.2 Hz, 1H, HE), 3.35 (s, 1H, HG). HR-ESI: m/z 226.0613 (predicted [M+H]+ = 226.0857). 
N26 
 
N24 (176 mg, 0.78 mmol), N7 (354 mg, 1.28 mmol), CuI (17 mg, 0.087 mmol), Pd(PPh3)4 (98 mg, 0.85 
mmol) were dissolved in THF (10 mL) and Et2NH (5 mL) and heated at 60 °C for 5 days. Na4EDTA 
solution (50 mL, 0.25 mM) was added and the mixture stirred for 30 minutes before being extracted 
with chloroform (3 × 50 mL). The combined organic phases were dried over MgSO4, the solvent was 
removed in vacuo. The residue was then extracted with toluene and the solvent removed in vacuo. 
The crude product was crystallized from hot isopropanol. Yield = 107 mg (30 %).   
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1H NMR (500 MHz, Chloroform-d) δ 9.20 (dd, J = 2.2, 0.7 Hz, 2H, HF), 8.98 (dd, J = 5.3, 0.7 Hz, 2H, HE), 
8.92 (dd, J = 2.1, 0.9 Hz, 2H, HC), 8.53 (dd, J = 8.2, 0.9 Hz, 2H, HA), 8.06 – 8.03 (m, 4H, HB&E). HR-ESI: m/z 
425.0972 (predicted [M+H]+ = 425.0993).  
C43 
 
N26 (107 mg, 0.29 mmol) and Fe (powdered, 138 mg, 2.48 mmol) were suspended in acetic acid (20 
mL) and sparged with N2 and heated at 100 °C for 2 h. The mixture was allowed to cool and a solution 
of EDTA (1.4461 g) and NaOH (994.3 mg) dissolved in ammonium hydroxide (60 mL, 30%) and water 
(20 mL) were added. The mixture was stirred for 2 days. The crude product was collected by filtration 
and extracted with chloroform/methanol (1:1, 3 × 50 mL) and the solvent was removed in vacuo. The 
residue was extracted with acetonitrile (3× 50 mL) and precipitated with diethyl ether to give a 
grey/black waxy solid. Crude yield = 40 mg. 
1H NMR (500 MHz, DMSO-d6) δ 8.85 (dd, J = 2.2, 0.9 Hz, 1H, HF), 8.38 (dd, J = 8.2, 0.9 Hz, 1H, HD), 8.12 
(d, J = 5.5 Hz, 1H, HA), 8.09 (dd, J = 8.2, 2.2 Hz, 1H, HE), 7.66 (d, J = 2.4 Hz, 1H, HC), 6.54 (dd, J = 5.5, 2.4 




L41 (27.5 mg, 82.3 μmol) and cobalt (II) nitrate hexahydrate (16.0 mg, 54.9 μmol) were suspended in 
a degassed mixture of water and acetonitrile (1:2, 3.8 mL). The mixture was sparged with N2, then 
heated at 50 °C for 0.5 h. The reaction was allowed to cool before (NH₄)₂Ce(NO₃)₆ (45.1 mg, 82.3 μmol) 
in acetonitrile (1.5 mL) was added via syringe pump (25 μLmin-1). Some turbidity was observed, 
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addition of acetonitrile (20 mL) fully precipitated the product, which was collected onto celite and 
washed with acetonitrile. The product was eluted with water and the solution freeze-dried to give a 
yellow solid. Yield = 29 mg (71%). 
1H NMR (500 MHz, D2O) δ 8.87 (d, J = 7.7 Hz, 12H, HD), 8.85 (d, J = 8.6 Hz, 12H, HE), 8.58 (apt, J = 7.7 
Hz, 12H, HC), 8.51 (d, J = 8.6 Hz, 12H, HF), 7.81 (apt, J = 6.9 Hz, 12H, HB), 7.59 (s, 12H, HG), 7.45 (d, J = 
6.0 Hz, 12H, HA).13C NMR (126 MHz, D2O) δ 155.3, 155.0, 152.7, 151.1, 146.5, 144.2, 131.68, 128.1, 
126.8, 124.9, 90.2. Calculated hydrodynamic radius = 11.6 Å. 
C42 
 
L42 (20.2 mg, 56.4 µmol) and cobalt (II) nitrate hexahydrate (10.8 mg, 37.2 μmol) were suspended in 
a degassed mixture of water and acetonitrile (1:2, 2.6 mL). The mixture was sparged with N2, then 
heated at 50 °C for 0.5 h. The reaction was allowed to cool before (NH₄)₂Ce(NO₃)₆ (30.6 mg, 55.8 μmol) 
in acetonitrile (0.96 mL) was added via syringe pump (25 μLmin-1). Some turbidity was observed, 
addition of acetonitrile (20 mL) fully precipitated the product, which was collected onto celite and 
washed with acetonitrile. The product was eluted with water and the solution freeze-dried to give the 
yellow title compound. Yield = 29 mg (100%). 
1H NMR (601 MHz, D2O) δ 8.86 (d, J = 8.2 Hz, 12H, HD), 8.85 (d, J = 8.5 Hz, 12H, HE), 8.67 (d, J = 8.5, 1.8 
Hz, 12H, HF), 8.58 (t, J = 7.9 Hz, 12H, HC), 7.82 (t, J = 6.7 Hz, 12H, HB), 7.55 (d, J = 1.6 Hz, 12H, HG), 7.42 
(d, J = 6.0 Hz, 12H, HA). 13C NMR (126MHz, D2O) δ 155.3, 155.0, 153.6, 151.2, 147.2, 144.3, 131.8, 








L43 (27.5 mg, 0.78 mmol) and cobalt (II) nitrate hexahydrate (14.6 mg, 0.05 mmol) were suspended in 
degassed mixture of water and acetonitrile (3.45 mL, 5:1) under N2. The mixture was sparged with N2 
and heated at 60 °C for 24 h. The reaction was allowed to cool before (NH₄)₂Ce(NO₃)₆ (42.2 mg, 0.077 
mmol) in acetonitrile (1.5 mL) was added via syringe pump (25 μLmin-1). Acetonitrile (20 mL) was 
added causing an orange precipitate, which was collected onto celite, washed with acetonitrile and 
eluted with water and the mixture freeze dried to give an orange solid.   
By ligand exchange  
L43 (impure, 7.9 mg, 0.021 mmol) was added to a solution of C41 (5.8 mg, 842 µL D2O, 98 µL CD3CN) 
in an NMR tube. The tube was sealed and a 1H NMR was taken before the tube was heated at 75 °C, 
while periodically being allowed to cool for 30 minutes to be analysed by 1H NMR, before being 
returned to heating. 
Glutathione Assay 
A 1 mM solution of cage was prepared in deuterated PBS (1 M, pH 7.4, 1mM tBuOH). NMR samples 
were prepared (0.5 mL) and to one PBS (0.1 mL) was added and to another glutathione (100 mM, 0.1 








C41 in PBS 
 
1H NMR (500 MHz, D2O) δ 8.94 – 8.84 (m, 24H, HD/E), 8.67 – 8.52 (m, 24H, HC/F), 7.84 (t, J = 7.0 Hz, 12H, 
HB), 7.58 (s, 12H, HG), 7.48 (d, J = 6.0 Hz, 12H, HA). 
Spontaneous Raman Spectroscopy 
William Grantham, Alisia Sim 
The spontaneous Raman spectra were obtained using a confocal Raman spectrometer (inVia Raman 
microscope, Renishaw) at room temperature. A 297 mW (206 mW after objective) 785 nm diode laser 
was used to excite the sample through a 20× N.A.075 objective (Leica Biosystems). The recorded 
spectral range for a grating was 1200 g mm-1. The total data acquisition was performed during 60 s 
using Wire software. All spectra acquired at λex = 785 nm were background subtracted using a 
background correction algorithm. 
Two-photon fluorescence and Stimulated Raman Scattering (SRS) Microscopy 
Kristal Sepp, Martin Lee 
Images were obtained using a custom-built multi-modal microscope setup. A picoEmerald (APE, Berlin, 
Germany) laser provided tuneable pump laser (720-990 nm, 7ps, 80 MHz repetition rate) and a 
spatially and temporally overlapped Stokes laser (1064 nm, 5-6- ps, 80 MHz repetition rate). The 
output beam was inserted into the scanning unit of an Olympus FV1000MPE microscope using a series 
of dielectric mirrors and 2× lens based beam-expanding module. The resulting 2.4 mm beam were 
expanded by a further 3.6× lens within the microscope and directed into an Olympus XLP25XWMP 
N.A. 1.05 objective lens using a short-pass 690 nm dichroic mirror (Olympus). The objective was under 
filled to achieve higher power transmissions through the microscope which were shown to be 
essential to detect the SRS signal. Backscattered emission signals from two-photon fluorescence was 
separated from any backscattered excitation light using a short pass 690 nm dichroic mirror and IR cut 
filter (Olympus). A series of filters and dichroic mirrors were then used to deconvolve the different 
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emission signals onto one of 4 available photo-multiplier tubes (PMT). ER-Tracker Green two-photon 
fluorescence signals were filtered using FF552-Di02,FF483/639-Di01 and FF510/84 (Semrock). 
Cellular Uptake Studies 
HeLa cells were treated with either C41 (1 mM, in DMEM complete eagle media,  30 min), or DMEM 
complete eagle media (2 h) and then washed with PBS prior to fixing with formaldehyde (3.7% in PBS, 
10 min, 37 °C) before washing with PBS prior to trypsinisation and dilution with DMEM. The resulting 
cell suspension was centrifuged at 175 g and the cell pellet was washed with DMEM/PBS (1/1 v/v; 10 
mL) and re-centrifuged (2×). The cell pellet was transferred to CaF2 coverslips for analysis by 
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This project explored the biomedical applications of robust metallosupramolecular cages.  This 
included identification and solution of an instability issue, the development of a cage capable of 
altering the biological uptake of radiotracer, progress towards bioconjugation of the cages, and a 
means of investigating their cellular behaviour. 
The previously developed C19 cobalt (III) tetrahedra were found to be reductively degraded by 
biological reductants and therefore unsuitable for biological applications. Therefore, a more stable 
variant of the cage, C20, was developed. Synthesis of this tetrahedron was complicated by the 
strengthened interactions leading to kinetically trapped biproducts during the self-assembly process. 
This problem was overcome by utilising C19 as a tetrahedral template for the formation of C20 to 
prevent formation of these biproducts. 
C20 proved to possess similar properties to C19 but with the desired resistance to degradation, as 
shown by persistent binding of [99mTc]TcO4- in serum, and significantly reduced degradation by 
glutathione in PBS. Therefore, C20 was trialled in vivo by administering [99mTc]TcO4-  bound within C20 
to mice. The bound guest proved to significantly increase the uptake in the liver over the free anion, 
in a novel example of a guest molecule being retained by a “naked” metallosupramolecular capsule in 
vivo. 
Methods of altering the biological properties of C20 were explored to allow control of the cage’s 
uptake. A pendant primary alkyne was introduced into the ligand, suitable for functionalisation via 
copper catalysed alkyne azide cycloaddition reactions with a wide variety of groups. Additionally, a 
methylether group was explored as an alternative to the amine group of L20, successfully resulting in 
the C38 tetrahedron. 
Stimulated Raman spectroscopy was identified as a promising means of investigating the cellular 
behaviour of cages. This required the incorporation of a Raman active alkyne group into the ligand 
L41, which was successfully assembled into the tetrahedron C41. Degradation of the cage led to 
precipitation of fluorescent ligand, interfering with the Raman technique. However, the Raman signal 
of the intact cage appeared to be present within the cells, indicating the potential of the technique 
with further refinement.   
A cage capable of a biomedical application was developed and progress made towards biological 
targeting and in-depth investigation of the cellular interactions of the cages. These results clearly 
demonstrate the potential for these cage systems as viable biomedical tools, capable of altering the 
biological behaviour of a guest molecule with clear avenues for expansion to further develop and 
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